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1 M f b6c inh TBA MXB 24m24
a M f b6c inh liv MXB 24m24
b M f b6c inh lun MXB 24m24
2 M m b6c inh TBA MXB 24m24
a M m b6c inh liv MXB 24m24
b M m b6c inh lun MXB 24m24
3 R f f34 inh mgl MXA 24m24
a R f f34 inh TBA MXB 24m24
b R f f34 inh liv MXB 24m24
4 R m f34 inh amd MXA 24m24
a R m f34 inh amd MXA 24m24
b R m f34 inh ski MXA 24m24
c R m f34 inh ski ker 24m24
d R m f34 inh liv hpa 24m24
e R m f34 inh liv MXA 24m24
f R m f34 inh liv hpc 24m24
g R m f34 inh TBA MXB 24m24
h R m f34 inh liv MXB 24m24
10Ong...:lug * :.-10 ..... :.-100 :.... g :.-10 :.-10 0 . . . . :*lg * .... 10
> no dre P=1.
no dre P-1.
no dre P=1.
:> no dre P=1.
90.4mg Z P<.2
318.mg * P<.3







156.mg * P<.09 e
168.mg * P<.2 e
398.mg * P<.3 e
no dre P=1.
168.mg * P<.2
2 -ACETYLAMINOFLUORENE*** 10Ong*.: . - lg ..10..... :100 . 1. :..lmg .... 10. :*100 .... :.-lg .... 10
5 P b rhe eat npl adc 5y26 jw + 33.Omg P<.
a P b rhe eat tba mal 5y26 Wjw no dre P=1
2,7-ACETYLAMINOFLUORENE
6 P b cym eat lun a/c 5y29 w
a P b cym eat bre car 5y29 w
b P b cym eat tba mal 5y29 w
7 P b rhe eat tba mal 5y32 w
ACROLEIN***
8 M f cdl gav lun a/c 78w78 e
a M f cdl gav lun a/a 78w78 e
b M f cdl gav liv hpa 78w78 e
9 M m cdl gav lun a/c 78w78 es
a M m cdl gav lun a/a 78w78 es
b M m cdl gav liv hpc 78w78 es
c M m cdl gav liv hpa 78w78 es
10 R f sda gav liv tum 52w52 k
11 R f sda gav adr phe 24m24 es
a R f sda gav liv hpa 24m24 es
b R f sda gav adr coa 24m24 es
12 R m sda gav liv tum 52w52 k
13 R m sda gav adr coa 24m24 es
a R m sda gav liv hpa 24m24 es
b R m sda gav adr coc 24m24 es
c R m sda gav adr phe 24m24 es
d R m sda gav liv hpc 24m24 es
ACRYLIC ACID
14 R f wis wat liv tum 52w52 e
15 R f wis wat pit ade 28m28 e
a R f wis wat liv hpa 28m28 e
b R f wis wat --- mly 28m28 e
16 R m wis wat liv tum 52w52 e
17 R m wis wat liv hpc 26m26 e
a R m wis wat liv hpa 26m26 e































ADRIAMYCIN 10Ong.. :_ lug....:_10 . :_100.... : *-lmg -:_1° *.. .. -10 .l01










P b cym ivj leg fbs 5yl5 sw
P b cym ivj tba mix Syl5 Wsw
P b cym ivj tba ben SylS Wsw
P b cym ivj tba mal SylS Wsw
P b cym ivj tba mal 10yl5 Wsw
P b rhe ivj --- anl 2y9 sw
P b rhe ivj tba mal 2y9 Wsw
P b rhe ivj tba mal 5y13 Wsw
P b rhe ivj col adp 10y16 sw
P b rhe ivj ute ley 10yl6 Wsw












AFLATOXIN Bl*** b0Ong. .. lug . 10 :.- 100....1 :*-lmg.... ._10. :100 .:..--- .. . .... 10
23 P b cym mix MXB MXB 17y17 jmw + 9.
a P b cym mix bil mix 17y17 jmw 20
b P b cym mix gab adc 17y17 jmw 40
c P b cym mix bon ost 17yl7 jmw 62
d P b cym mix liv hes 17yl7 jmw 73
e P b cym mix k/p tcc 17y17 jmw 44
f P b cym mix liv clc 17y17 jmw 44
g P b cym mix liv hpc 17y17 jmw 44
h P b cym mix pel fbs 17yl7 jmw .1
i P b cym mix pnd adc 17yl7 jmw .3
j P b cym mix bil scc 17y17 jmw .3
k P b cym mix tba mal 17yl7 Wjmw 8.
24 P b rhe mix MXB MXB 15yl5 jmw + : 5.
a P b rhe mix liv clc 15y15 jmw 8.
b P b rhe mix bil mix 15yl5 jmw 11








































































RefNum LoCont UpCont Cntrl lDose lInc 2Dose 2Inc Citation or Pathology
ACETONITRILE (methyl cyanide) 75-05-8
1 TR447 103.mg n.s.s. 35/50 25.9mg
a TR447 168.mg n.s.s. 9/50 25.9mg
b TR447 105.mg n.s.s. 8/50 25.9mg
2 TR447 109.mg n.s.s. 32/50 21.6mg
a TR447 33.1mg n.s.s. 19/50 21.6mg
b TR447 91.8mg n.s.s. 10/50 21.6mg
3 TR447 4.97mg n.s.s. 17/48 12.3mg
a TR447 40.7mg n.s.s. 47/48 12.3mg
b TR447 307.mg n.s.s. 0/48 12.3mg
4 TR447 7.33mg 275.mg 4/48 8.65mg
a TR447 7.75mg n.s.s. 4/48 8.65mg
b TR447 36.6mg n.s.s. 0/48 8.65mg
c TR447 48.1mg n.s.s. 0/48 8.65mg
d TR447 56.8mg n.s.s. 0/48 8.65mg
e TR447 53.1mg n.s.s. 1/48 8.65mg
f TR447 85.4mg n.s.s. 1/48 8.65mg
g TR447 24.8mg n.s.s. 45/48 8.65mg





































2-ACETYLAMINOFLUORENE*** (N-2-fluorenylacetamide, 2-AAF) 53 -96-3
5 2004 5.37mg n.s.s. 0/16 6.77mg 1/5
a 2004 9.02mg n.s.s. 6/74 6.77mg 1/10
2,7-ACETYLAMINOFLUORENE 304-28-9
6 2003 4.17mg n.s.s. 0/2
a 2003 5.76mg n.s.s. 1/15
b 2003 7.84mg n.s.s. 3/15




































1982/Thorgeirsson 1994/Dalgard 1997/Thorgeirsson&Seiber pers.comm.
Adamson;ossc,129-156;
1982/Thorgeirsson 1994/Dalgard 1997/Thorgeirsson&Seiber pers.comm.
ACROLEIN' 107-02-8
8 2181 19.5mg n.s.s.
a 2181 19.6mg n.s.s.
b 2181 27.2mg n.s.s.
9 2181 14.8mg n.s.s.
a 2181 12.9mg n.s.s.
b 2181 42.4mg n.s.s.
c 2181 16.2mg n.s.s.
10 2053m 23.Oug n.s.s.
11 2053n 1.47mg n.s.s.
a 2053n 17.8mg n.s.s.
b 2053n .525mg n.s.s.
12 2053m 23.Oug n.s.s.
13 2053n .163mg n.s.s.
a 2053n 7.78mg n.s.s.
b 2053n 14.2mg n.s.s.
c 2053n 16.2mg n.s.s.
d 2053n 34.2mg n.s.s.
ACRYLIC ACID 79-10-7
14 2128m 5.73mg n.s.s.
15 2128n 14.4mg 198.mg
a 2128n 796.mg n.s.s.
b 2128n 359.mg n.s.s.
16 2128m 4.81mg n.s.s.
17 2128n 405.mg n.s.s.
a 2128n 485.mg n.s.s.
ADRIAMYCIN 23214-92-8























































































































































































0/20 Hellwig; fctx, 31, 1-18;1993
0/20
Adamson;ossc, 129-156;
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P b rhe mix liv hes 15y15 jmw
P b rhe mix pnd adc 15y15 jmw
P b rhe mix liv hpc 15y15 jmw
P b rhe mix bon ost 15yl5 jmw
P b rhe mix tba mal 15yl5 Wjmw
1 -AMINO-2,4 -DIBROMOANTHRAQUINONE
25 M f b6c eat liv MXA 24m24
a M f b6c eat liv hpa 24m24
b M f b6c eat MXB MXB 24m24
c M f b6c eat for MXA 24m24
d M f b6c eat liv hpc 24m24
e M f b6c eat for sqp 24m24
f M f b6c eat lun MXA 24m24
g M f b6c eat lun a/a 24m24
h M f b6c eat pit pda 24m24
M f b6c eat for sqc 24m24
j M f b6c eat ute MXA 24m24
k M f b6c eat TBA MXB 24m24
1 M f b6c eat liv MXB 24m24
m M f b6c eat lun MXB 24m24
26 M m b6c eat liv hpa 24m24
a M m b6c eat MXB MXB 24m24
b M m b6c eat liv MXA 24m24
c M m b6c eat liv MXA 24m24
d M m b6c eat lun MXA 24m24
e M m b6c eat lun a/a 24m24
f M m b6c eat for MXA 24m24
g M m b6c eat for sqp 24m24
h M m b6c eat liv MXA 24m24
i M m b6c eat liv hpc 24m24
j M m b6c eat for sqc 24m24
k M m b6c eat liv hpb 24m24
1 M m b6c eat TBA MXB 24m24
m M m b6c eat liv MXB 24m24
n M m b6c eat lun MXB 24m24
27 R f f34 eat MXB MXB 24m24
a R f f34 eat liv MXA 24m24
b R f f34 eat liv hpa 24m24
c R f f34 eat MXA pla 24m24
d R f f34 eat rec pla 24m24
e R f f34 eat liv hpc 24m24
f R f f34 eat ubl MXA 24m24
g R f f34 eat kid MXA 24m24
h R f f34 eat kid rua 24m24
i R f f34 eat MXA adc 24m24
j R f f34 eat rec adc 24m24
k R f f34 eat liv hcc 24m24
1 R f f34 eat ubl tcc 24m24
m R f f34 eat ubl tpp 24m24
n R f f34 eat ski sqp 24m24
o R f f34 eat TBA MXB 24m24
p R f f34 eat liv MXB 24m24
28 R f f34 eat liv MXA 66w66
a R f f34 eat liv hpc 66w66
b R f f34 eat liv hpa 66w66
c R f f34 eat MXA pla 66w66
d Rf f t34 eat kid MXA 66w66
e R f f34 eat kid rua 66w66
f R f f34 eat ubl MXA 66w66
g R f f34 eat ubl tcc 66w66
h R f f34 eat MXA adc 66w66
i R f f34 eat liv hcc 66w66
j R f f34 eat kid ruc 66w66
k R f f34 eat TBA MXB 66w66
1 R f f34 eat liv MXB 66w66
29 R f t34 eat liv MXA 40w66
a R f f34 eat liv hpc 40w66
b R f f34 eat liv hpa 40w66
c R f f34 eat rec pla 40w66
d R f f34 eat MXA pla 40w66
e R f f34 eat kid MXA 40w66
f R f f34 eat kid rua 40w66
g R f f34 eat MXA adc 40w66
h R f f34 eat liv hcc 40w66
i R f f34 eat kid ruc 40w66
j R f f34 eat ubl tcc 40w66
k R f f34 eat ubl MXA 40w66
1 R f f34 eat TBA MXB 40w66
m R f f34 eat liv MXB 40w66
30 R m f34 eat liv MXA 24m24






R m f34 eat liv hpc 24m24
R m f34 eat MXA pla 24m24
R m f34 eat rec pla 24m24
R m f34 eat liv hpa 24m24
R m f34 eat tes MXA 24m24
R m f34 eat kid MXA 24m24
R m f34 eat kid rua 24m24
R m f34 eat MXA adc 24m24






l0Ong lug. 1-...... l: 1°. :_1° .. :lmg .. :10 :1°° ... :lg . :10




1. 53gm * P<.0005c
1. 76g * P<.0005c
1.99gm \ P<.003 c








465 .mg P< .0005
467 .mg P<.0005c
467.mg P<.0005c







9.25gm * P<.004 c
566..mg \ P<.002
467.mg \ P<.0005
817 .mg \ P<.0005
31.0mg Z P<.0005










566.mg Z P< .0005c
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25 TR383 312.mg 912.mg 6/50
a TR383 327.mg 965.mg 6/50
b TR383 328.mg 1.18gm 12/50
c TR383 856.mg 2.04gm 2/50
d TR383 1.08gm 2.28gm 0/50
e TR383 1.15gm 3.28gm 2/50
f TR383 966.mg 10.9gm 4/50
g TR383 966.mg 10.9gm 4/50
h TR383 1.64gm 38.3gm 1/50
i TR383 2.39gm 8.33gm 0/50
j TR383 2.57gm 107.gm 0/50
k TR383 461.mg n.s.s. 32/50
1 TR383 312.mg 912.mg 6/50
m TR383 966.mg 10.9gm 4/50
26 TR383 275.mg 955.mg 10/50
a TR383 261.mg 1.17gm 24/50
b TR383 269.mg 1.06gm 18/50
c TR383 269.mg 1.06gm 18/50
d TR383 445.mg 2.18gm 10/50
e TR383 461.mg 2.03gm 7/50
f TR383 773.mg 1.72gm 0/50
g TR383 1.07gm 2.87gm 0/50
h TR383 1.07gm 5.46gm 9/50
i TR383 1.22gm 8.72gm 9/50
j TR383 1.67gm 4.97gm 0/50
k TR383 4.12gm 55.1gm 0/50
1 TR383 289.mg 2.58gm 37/50
m TR383 269.mg 1.06gm 18/50
n TR383 445.mg 2.18gm 10/50
27 TR383 20.8mg 48.8mg 0/50
a TR383 26.2mg 65.7mg 0/50
b TR383 34.1mg 92.2mg 0/50
c TR383 57.1mg 94.9mg 0/50
d TR383 57.9mg 96.4mg 0/50
e TR383 68.5mg 116.mg 0/50
f TR383 208.mg 466.mg 0/50
g TR383 254.mg 628.mg 0/50
h TR383 254.mg 628.mg 0/50
i TR383 266.mg 699.mg 0/50
j TR383 246.mg 798.mg 0/50
k TR383 343.mg 1.02gm 0/50
1 TR383 394.mg 1.18gm 0/50
m TR383 446.mg 1.54gm 0/50
n TR383 933.mg n.s.s. 1/50
0 TR383 93.Omg 457.mg 46/50
p TR383 26.2mg 65.7mg 0/50
28 TR383a 65.9mg 289.mg 0/10
a TR383a 66.9mg 309.mg 0/10
b TR383a 106.mg 787.mg 0/10
c TR383a 381.mg n.s.s. 0/10
d TR383a 373.mg n.s.s. 0/10
e TR383a 373.mg n.s.s. 0/10
f TR383a 535.mg n.s.s. 0/10
g TR383a 787.mg n.s.s. 0/10
h TR383a n.s.s. n.s.s. 0/10
i TR383a n.s.s. n.s.s. 0/10
j TR383a n.s.s. n.s.s. 0/10
k TR383a 71.1mg 803.mg 2/10
1 TR383a 65.9mg 289.mg 0/10
29 TR383b 54.5mg 484.mg 0/10
a TR383b 68.3mg 1.16gm 0/10
b TR383b 77.5mg 1.30gm 0/10
c TR383b 82.6mg 3.52gm 0/10
d TR383b 82.6mg 3.52gm 0/10
e TR383b 127.mg n.s.s. 0/10
f TR383b 127.mg n.s.s. 0/10
g TR383b n.s.s. n.s.s. 0/10
h TR383b n . s.s. n.s.s. 0/10
i TR383b n.s.s. n.s.s. 0/10
j TR383b n.s.s. n.s.s. 0/10
k TR383b n.s.s. n.s.s. 0/10
1 TR383b 51.5mg n.s.s. 2/10
m TR383b 54.5mg 484.mg 0/10
30 TR383 40.4mg 76.2mg 2/50
a TR383 40.3mg 80.3mg 4/50
b TR383 42.2mg 88.5mg 1/50
c TR383 48.4mg 86.9mg 0/50
d TR383 48.4mg 86.9mg 0/50
e TR383 52.5mg 105.mg 1/50
f TR383 70.4mg 630.mg 43/50
g TR383 157.mg 637.mg 2/50
h TR383 168.mg 782.mg 2/50
i TR383 197.mg 556.mg 0/50
























































































































































































































































































































cec:pla; col:adc,pla; kid:rua,ruc; liv:hcc,hpa,























198.mg 57/60 396.mg 47/50









































































Spe Strain Site Xpo+Xpt
Sex Route Hist Notes
R m f34 eat ubl MXA 24m24
R m f34 eat lun MXA 24m24
R m f34 eat ubl tpp 24m24
R m f34 eat liv hcc 24m24
R m f34 eat ubl tcc 24m24
R m f34 eat col adc 24m24
R m f34 eat lun a/a 24m24
R m f34 eat col pla 24m24
R m f34 eat TBA MXB 24m24
R m f34 eat liv MXB 24m24
R m f34 eat liv MXA 66w66
R m f34 eat liv hpc 66w66
R m f34 eat liv hpa 66w66
R m f34 eat rec pla 66w66
R m f34 eat MXA pla 66w66
R m f34 eat kid MXA 66w66
R m f34 eat kid rua 66w66
R m f34 eat MXA adc 66w66
R m f34 eat ubl tcc 66w66
R m f34 eat ubl MXA 66w66
R m f34 eat liv hcc 66w66
R m f34 eat TBA MXB 66w66
R m f34 eat liv MXB 66w66
R m f34 eat liv MXA 39w66
R m f34 eat liv hpc 39w66
R m f34 eat liv hpa 39w66
R m f34 eat kid MXA 39w66
R m f34 eat kid rua 39w66
R m f34 eat rec pla 39w66
R m f34 eat MXA pla 39w66
R m f34 eat liv hcc 39w66
R m f34 eat MXA adc 39w66
R m f34 eat ubl tcc 39w66
R m f34 eat ubl MXA 39w66
R m f34 eat TBA MXB 39w66




1.23gm * P<.005 c
































6-AMINOCAPROIC ACID l OOng..:..ug.. :1. 0 :.1 .... :1lmg. 10 : .1° .. : 100.10 :*-lg ..... : 10
33 R m f3d eat for tum 52w52 er .> no dre
ARSENATE, SODIUM*** 10Ong..:. .lug. :..10.10.... :.:100. : g. 1: 100.1
34 P b cym eat kcx ade 14yl4 jw ± 29.Oug
a P b cym eat tba ben 14yl4 jw .169mg P<.9
L-ASCORBIC ACID*a** 1Ong ..:. .lug. 1 . :10 :01° .. :lmg... 0 :.. -1 ... : 100.:.-lg ... 10 :1
35 R m f3d eat for tum 52w52 er .> no dre
ASPIRIN*** 1Ong...:*ug .... m* . .g.. :10 100 . :g. 1 100 ... : * lg * : 10
36 R m f34 eat col tum 56w56 r .> no dre
37 R m wis eat liv tum 52w52 r .> no dre
DL-ATENOLOL.HCl 0Ong. .. : * lug. .... : 1°00 .... :1.-mg.... :1.1 00 :1° .. : l : 10
38 R f f34 gav liv mix 89w91 r .> no dre
39 R m f34 gav liv mix 89w91 r .> no dre
AZATHIOPRINE*** lOOng..: . .lug. 1 . :10 :0.. -1° .... :mg. 1 .100. g :.*10







P b rhe eat slg ade 15y16 Ww
P b rhe eat ute ley 15y16 Ww
P b rhe eat lep lcl 15y16 w
P b rhe eat tba mix 15y16 Ww
P b rhe eat tba ben 15y16 Ww








42 M f nmr eat --- lym 25m25 ev
a M f nmr eat lun a/a 25m25 ev
b M f nmr eat liv hpa 25m25 ev
c M f nmr eat lun acb 25m25 ev
43 M m nmr eat liv hpc 28m28 ev
a M m nmr eat lun a/a 28m28 ev
b M m nmr eat lun acb 28m28 ev
c M m nmr eat liv hpa 28m28 ev
44 R f sda eat liv hct 28m28 ev
45 R m sda eat thy fca 27m27 ev
a R m sda eat liv hpc 27m27 ev
b R m sda eat liv hpa 27m27 ev
BENZENE***
46 R m cdr inh liv mix 29m29 s
a R m cdr inh zym car 29m29 s
b R m cdr inh --- grl 29m29 s
c R m cdr inh mgl adc 29m29 s
d R m cdr inh tba mix 29m29 s
e R m cdr inh tba mal 29m29 s
f R m cdr inh tba ben 29m29 s




























BENZOIC ACID 10Ong ..:. .lug.... 10:. 1O - - l-00 .... :lmg :. :--10 .... -g.. : 1°
47 R m f3d eat for tum 52w52 er .> no dre P=1.












































































33 2192 20.6mg n.s.s. 0/10
ARSENATE, SODIUM*** 7631-89-2
34 2004 7.14ug n.s.s. 0/11




L-ASCORBIC ACID*** (vitamin C) 50-81-7
35 2098 412.mg n.s.s. 0/10 800.mg
ASPIRIN*** 50-78-2
36 2125 11.5mg n.s.s. 0/12 16.0mg
37 2184 433.mg n.s.s. 0/17 400.mg
DL-ATENOLOL.HCl 51706-40-2
38 2219 436.mg n.s.s. 1/24 251.mg
39 2219 436.mg n.s.s. 1/21 251.mg
AZATHIOPRINE*** (imuran) 446-86-6





































1982/Thorgeirsson 1994/Dalgard 1997/Thorgeirsson&Seiber pers.comm.
Shibata;carc, 14,275-280;1993






















(2-hydroxy-5-( (4-carboxyphenyl)azo]benzoic acid) 64896-26-0
467.mg n.s.s. 36/50 lOO.mg 33/50 300.mg 48/50 1.63gm 44/50
983.mg n.s.s. 1/50 100.mg 0/50 300.mg 6/50 (1.63gm 5/50)
782.mg n.s.s. 2/50 100.mg 0/50 300.mg 0/50 1.63gm 0/50
9.92gm n.s.s. 8/50 100.mg 3/50 300.mg 6/50 1.63gm 3/50
6.27gm n.s.s. 1/50 100.mg 0/50 300.mg 3/50 1.65gm 4/50
3.91gm n.s.s. 5/50 100.mg 5/50 300.mg 9/50 1.65gm 10/50
3.63gm n.s.s. 6/50 100.mg 13/50 300.mg 10/50 1.65gm 13/50
7.85gm n.s.s. 1/50 100.mg 1/50 300.mg 2/50 1.65gm 3/50
2.77gm n.s.s. 0/50 300.mg 0/50 900.mg 0/50 2.31gm 0/50
6.65gm 270.gm 4/50 300.mg 1/50 900.mg 1/49 2.31gm 11/50
32.1gm n.s.s. 0/50 300.mg 1/50 900.mg 0/50 2.31gm 0/50
36.3gm n.s.s. 3/50 300.mg 1/50 900.mg 1/50 2.31gm 0/50
BENZENE`55 71-43-2
46 2305 52.6mg n.s.s.
a 2305 76.9mg n.s.s.
b 2305 103.mg n.s.a.
c 2305 103.mg n.s.s.
d 2305 27.7mg n.s.s.
e 2305 35.5mg n.s.s.









1982/Thorgeirsson 1994/Dalgard 1997/Thorgeirsson&Seiber pers .comm.
Herzog; arzn, 44,1371-1381; 1994








47 2098 412.mg n.s.s. 0/10 800.mg 0/10 Shibata;carc,14,275-280;1993
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48 M f icm gav lun mix 25w78
a M f icm gav for mix 25w78
b M f icm gav for sqc 25w78
c M f icm gav lun adc 25w78
d M f icm gav --- mix 25w78
e M f icm gav tba mix 25w78





BENZYL ISOTHIOCYANATE 10Ong ..: lug-....-: ... . .... 100 .. :lmg.. .100 ... i :* °g ..g ..10
49 R m ain eat liv tum 53w53 r .> no dre P=1.
BENZYL THIOCYANATE b00ng.. :..*ug .:* 10 .....: 100 . 1 :lmg .... 10 . 100 : .1g.. 10
50 R m ain eat liv tum 53w53 r .i> no dre P=1.
2,2-BIS(BROMOMETHYL)-1,3-PROPANEDIOL,
51 M f b6c eat MXB MXB 24m25
a M f b6c eat hag MXA 24m25
b M f b6c eat lun MXA 24m25
c M f b6c eat lun a/a 24m25
d M f b6c eat hag MXA 24m25
e M f b6c eat sub MXA 24m25
f M f b6c eat hag car 24m25
g M f b6c eat sub sar 24m25
h M f b6c eat lun a/c 24m25
i M f b6c eat for sqp 24m25
j M f b6c eat liv hpa 24m25
k M f b6c eat --- MXA 24m25
1 M f b6c eat mgl car 24m25
m M f b6c eat --- hes 24m25
n M f b6c eat TBA MXB 24m25
o M f b6c eat liv MXB 24m25
p M f b6c eat lun MXB 24m25
52 M m b6c eat MXB MXB 24m24
a M m b6c eat hag MXA 24m24
b M m b6c eat hag MXA 24m24
c M m b6c eat lun MXA 24m24
d M m b6c eat lun a/a 24m24
e M m b6c eat lun a/c 24m24
f M m b6c eat for MXA 24m24
g M m b6c eat thy fca 24m24
h M m b6c eat kid rua 24m24
i M m b6c eat TBA MXB 24m24
j M m b6c eat liv MXB 24m24
k M m b6c eat lun MXB 24m24
53 R f f34 eat mgl fba 24m24
a R f f34 eat mgl MXA 24m24
b R f f34 eat mgl MXA 24m24
c R f f34 eat MXB MXB 24m24










446.mg * P<.002 e
301.mg Z P<.05
846.mg * P<.03 e








218.mg * P<.007 c
270.mg Z P<.005
334.mg * P<.008
581.mg * P<.02 e
835.mg * P<.04








R f f34 eat pit pda 24m24
R f f34 eat --- mnl 24m24
R f f34 eat MXA MXA 24m24
R f f34 eat MXA sqp 24m24
R f f34 eat ton MXA 24m24
R f f34 eat ton sqp 24m24
R f f34 eat eso sqp 24m24
R f f34 eat thy MXA 24m24
R f f34 eat thy fca 24m24
R f f34 eat ute MXA 24m24
R f f34 eat ute esp 24m24
R f f34 eat sub MXA 24m24
R f f34 eat sub MXA 24m24
R f f34 eat TBA MXB 24m24
R f f34 eat liv MXB 24m24
R m f34 eat tes MXA 24m24
R m f34 eat MXB MXB 24m24
R m f34 eat --- mnl 24m24
R m f34 eat ski MXA 24m24
R m f34 eat pni MXA 24m24
R m f34 eat sub MXA 24m24
R m f34 eat ski ker 24m24
R m f34 eat mgl MXA 24m24
R m f34 eat sub fib 24m24
R m f34 eat mgl fba 24m24
R m f34 eat MXA MXA 24m24
R m f34 eat MXA sqp 24m24
R m f34 eat -- msm 24m24
R m f34 eat ton sqp 24m24
R m f34 eat pan ana 24m24
R m f34 eat thy MXA 24m24
R m f34 eat ski MXA 24m24
R m f34 eat lun MXA 24m24
R m f34 eat pal sqp 24m24
R m f34 eat col adp 24m24
R m f34 eat sub MXA 24m24
R m f34 eat ski sqp 24m24
R m f34 eat ski MXA 24m24
R m f34 eat lun a/c 24m24
R m f34 eat eso sqp 24m24
R m f34 eat ski bca 24m24






























































































RefNum LoConf UpConf Cntrl !Dose lInc 2Dose 2Inc Citation or Pathology
BENZOTRICHLORIDE (BTC) 98-07-7
48 2187 .267mg .671mg 2/39
a 2187 .628mg 1.51mg 0/39
b 2187 .684mg 1.69mg 0/39
c 2187 .737mg 2.44mg 1/39
d 2187 2.56mg 24.5mg 1/39







7/39 .456mg 26/39 1.83mg 35/40
0/39 .456mg 2/39 1.83mg 23/40
0/39 .456mg 2/39 1.83mg 21/40
1/39 .456mg 9/39 1.83mg 16/40
2/39 .456mg 1/39 1.83mg 3/40









49 2114 3.85mg n.s.s. 0/18 4.00mg 0/18
BENZYL THIOCYANATE 3012-37-1
50 2114 3.85mg n.s.s. 0/18 4.00mg 0/18
2,2-BIS(BROMOMETHYL)-1,3-PROPANEDIOL, TECHNICAL GRADE*** (DIBROMONEOPENTYL GLYCOL) 3296-90-0
51 TR452 45.6mg 118.mg 8/52 39.9mg 17/50 79.9mg 27/51 160.mg 32/50 hag:a(
a TR452 76.2mg 254.mg 3/52 39.9mg 12/50 79.9mg 13/51 160.mg 19/50
b TR452 77.3mg 263.mg 5/52 39.9mg 5/50 79.9mg 15/51 160.mg 19/50
c TR452 101.mg 367.mg 3/52 39.9mg 3/50 79.9mg 9/51 160.mg 17/50
d TR452 109.mg 429.mg 2/52 39.9mg 6/50 79.9mg 8/51 160.mg 15/50
e TR452 176.mg 656.mg 0/52 39.9mg 1/50 79.9mg 4/51 160.mg 12/50
f TR452 161.mg 2.27gm 1/52 39.9mg 6/50 79.9mg 5/51 160.mg 7/50
g TR452 188.mg 737.mg 0/52 39.9mg 1/50 79.9mg 4/51 160.mg 11/50
h TR452 176.mg 9.86gm 2/52 39.9mg 2/50 79.9mg 6/51 160.mg 5/50
i TR452 206.mg 1.90gm 0/52 39.9mg 1/50 79.9mg 5/51 160.mg 3/50
j TR452 116.mg n.s.s. 16/52 39.9mg 12/50 79.9mg 5/51 160.mg 16/50
k TR452 307.mg n.s.s. 1/52 39.9mg 2/50 79.9mg 0/51 160.mg 5/50
1 TR452 472.mg n.s.s. 0/52 39.9mg 0/50 79.9mg 1/51 160.mg 3/50
m TR452 437.mg n.s.s. 0/52 39.9mg 0/50 79.9mg 0/51 160.mg 3/50
n TR452 33.5mg 153.mg 35/52 39.9mg 42/50 79.9mg 43/51 160.mg 42/50
o TR452 99.3mg n.s.s. 20/52 39.9mg 19/50 79.9mg 9/51 160.mg 18/50
p TR452 77.3mg 263.mg 5/52 39.9mg 5/50 79.9mg 15/51 160.mg 19/50
52 TR452 60.8mg 321.mg 18/50 37.2mg 18/51 74.4mg 28/50 149.mg 37/49 hag:as
a TR452 96.0mg 347.mg 4/50 37.2mg 7/51 74.4mg 16/50 149.mg 22/49
b TR452 114.mg 481.mg 3/50 37.2mg 6/51 74.4mg 12/50 149.mg 18/49
c TR452 106.mg 3.37gm 15/50 37.2mg 11/51 74.4mg 16/50 149.mg 25/49
d TR452 133.mg 2.59gm 12/50 37.2mg 4/51 74.4mg 12/50 149.mg 21/49
e TR452 161.mg 8.52gm 3/50 37.2mg 7/51 74.4mg 8/50 149.mg 11/49
f TR452 283.mg n.s.s. 0/50 37.2mg 3/51 74.4mg 3/50 149.mg 4/49
g TR452 360.mg n.s.s. 0/50 37.2mg 3/51 74.4mg 0/50 149.mg 4/49
h TR452 451.mg n.s.s. 0/50 37.2mg 0/51 74.4mg 3/50 149.mg 2/49
i TR452 54.4mg n.s.s. 37/50 37.2mg 42/51 74.4mg 45/50 149.mg 45/49
j TR452 144.mg n.s.s. 27/50 37.2mg 32/51 74.4mg 27/50 149.mg 23/49
k TR452 106.mg 3.37gm 15/50 37.2mg 11/51 74.4mg 16/50 149.mg 25/49
53 TR452 56.7mg 138.mg 25/50 124.mg 45/51 248.mg 46/53 496.mg 45/52
a TR452 56.7mg 138.mg 25/50 124.mg 45/51 248.mg 46/53 496.mg 45/52
b TR452 57.Omg 141.mg 27/50 124.mg 47/51 248.mg 47/53 496.mg 47/52
c TR452 57.2mg 142.mg 28/50 124.mg 47/51 248.mg 48/53 496.mg 47/52 eso:sqp; m
16/50 124.mg 24/51 248.mg
15/50 124.mg 13/51 248.mg
2/50 124.mg 3/51 248.mg
2/50 124.mg 2/51 248.mg
1/50 124.mg 2/51 248.mg
1/50 124.mg 2/51 248.mg
0/50 124.mg 0/51 248.mg
0/50 124.mg 0/51 248.mg
0/50 124.mg 0/51 248.mg
5/50 124.mg 9/51 248.mg
5/50 124.mg 8/51 248.mg
2/50 124.mg 4/51 248.mg
1/50 124.mg 0/51 248.mg
45/50 124.mg 51/51 248.mg
0/50 124.mg 0/51 248.mg
49/51 99.4mg 48/53 199.mg



































































3de,anb,car,cnb; kid:rua; lun:a/a,a/c. C













24/53 496.mg 15/52 S
19/53 496.mg 19/52 S
5/53 496.mg 6/52 pal:sqc,sqp; ton:sqc,sqp.
4/53 496.mg 5/52 pal:sqp; ton:sqp. S
4/53 496.mg 5/52 ton:sqc,sqp. S
4/53 496.mg 4/52 S
1/53 496.mg 10/52
2/53 496.mg 4/52 thy:fca,fcc.
2/53 496.mg 3/52 S
6/53 496.mg 6/52 ute:esp,ess. S
6/53 496.mg 6/52 S
1/53 496.mg 6/52 sub:fbs,fib,sar. S
0/53 496.mg 4/52 sub:fbs,sar. S
53/53 496.mg 52/52
0/53 496.mg 0/52 liv:hpa,hpb,hpc.
51/51 398.mg 51/55 tes:iab,ica. S
49/51 398.mg 52/55 ---:mnl,msm; col:adp; eso:sqp; gnv:sqc; jej:car;
pal:sqp; ski:bca,bcc,ker,sqc,sqp,tri; sub:fbs,fib,sar; thy:fca,fcc; ton:


























ski :bca,bcc, ker, sqc, sqp, tri.
pni:isa,isc. S
















































































































































499.mg 11.5gmSpe Strain Site Xpo+Xpt
Sex Route Hist Notes
R m f34 eat kid rua 24m24
R m f34 eat zym ade 24m24
R m f34 eat ubl MXA 24m24
R m f34 eat pit MXA 24m24
R m f34 eat pit pda 24m24
R m f34 eat thy MXA 24m24
R m f34 eat pre MXA 24m24
R m f34 eat pre ade 24m24
R m f34 eat thy fcc 24m24
R m f34 eat zym MXA 24m24
R m f34 eat thy MXA 24m24
R m f34 eat jej car 24m24
R m f34 eat for sqp 24m24
R m f34 eat sev MXA 24m24
R m f34 eat TBA MXB 24m24
R m f34 eat liv MXB 24m24
R m f34 eat tes MXA 3m24
R m f34 eat ski MXA 3m24
R m f34 eat ski MXA 3m24
R m f34 eat --- mnl 3m24
R m f34 eat pre ade 3m24
R m f34 eat MXA MXA 3m24
R m f34 eat MXA sqp 3m24
R m f34 eat - e-- msm 3m24
R m f34 eat ton sqp 3m24
R m f34 eat pre MXA 3m24
R m f34 eat ski ker 3m24
R m f34 eat ski sqp 3m24
R m 0f34 eat lun MXA 3m24
R m f34 eat ski MXA 3m24
R m f34 eat lun a/a 3m24
R m f34 eat mgl fba 3m24
R m f34 eat ski bca 3m24
R m f34 eat thy MXA 3m24
R m f034 eat sub MXA 3m24
R m f34 eat sub fib 3m24
R m f34 eat pal sqp 3m24
R m f34 eat thy fca 3m24
R m f034 eat zym MXA 3m24
R m f34 eat zym MXA 3m24
R m f34 eat MXA MXA 3m24
R m f34 eat MXA adp 3m24
R m f34 eat for sqp 3m24
R m f34 eat ubl MXA 3m24
R m f34 eat lun a! 3m24
R m f34 eat MXA MXA 3m24
R m f34 eat MXA car 3m24
R m f34 eat pit pda 3m24
R m f34 eat pan ana 3m24
R m f034 eat sev MXA 3m24
R m f34 eat lun sqc 3m24
R m f34 eat sub MXA 3m24
R m f34 eat kid rua 3m24
R m f34 eat eso sqp 3m24
R m f034 eat TBA MXB 3m24














eat lun a/c 78w83
eat lun a/a 78w83
eat liv tum 78w83
eat tba tum 78w83
eat tba mal 78w83
eat liv hpa 78w83
eat lun a/a 78w83
eat liv hpc 78w83
eat lun a/c 78w83
eat tba tum 78w83
eat tba mal 78w83
BROMOCRIPTINE MESYLATE
58 M f ofl eat lun ade 74w74 e
a M f ofl eat liv nnd 74w74 e
b M f ofl eat tba mix 74w74 e
59 M m ofl eat liv nnd 74w74 e
a M m ofl eat lun ade 74w74 e
b M m ofl eat tba mix 74w74 e
60 R f ofs eat ute mix 23m23 e
a R f ofs eat ute mal 23m23 e
b R f ofs eat ute ben 23m23 e
c R f ofs eat liv hct 23m23 e
d R f ofs eat tba mix 23m23 e
61 R m ofs eat liv hct 23m23 e
a R m ofs eat tba mix 23m23 e
tert-BUTYL ALCOHOL
62 M f b6c wat thy MXA 24m24
a M f b6c wat TBA MXB 24m24
b M f b6c wat liv MXB 24m24
c M f b6c wat lun MXB 24m24
63 M m b6c wat thy MXA 24m24
a M m b6c wat TBA MXB 24m24
b M m b6c wat liv MXB 24m24
TD50 2Tailpvl
DR AuOp
1.55gm * P<.004 e
1.95g}n * P<.C07
2. 32gm * P< .009
462.mg * P<.43
493 .mg * P<.04
G7<.mg Z .05
793 .niq t PC .0D
819.mcg * .04
. 1gm * P<.02
L.6Ogc * P.03 4
1.92gm * P-.05
S.66gm * P .04 c
16 gm * P.2
0o dre P 1.
63.8rrig * P<.000C
1.84gm * P<.5
5. 4m,Q p< 0005
6. 9 Fy P .0005












', 3 Im0 PF .004










52 .mg P 0005
217 .mg P< .0005c
223.m11 P< .007




















































TRIMETHYLCYCLOHEXANE-.1 ....:-100 ....:..1mg ...:. 1° ....1 0 -:lg
10Ong*.:.*lug ..........100 .... :*1 mg ......... :..!g
00ng* :..-ug :...... :* 100 ....1 Img :. 10 100 :.0 l0




:27.3gm * P<.2 e
5.71gm * P<.5
6.92gm * P<.5

















































































































































































































































































































































































































































































































BIS (tert-BUTYLPEROXY) -3,3, 5-TRIMETHYLCYCLOHEXANE 6731-86-8
2127 3.25gm n.s.s. 0/50 305.mg 1/50 611.mg 0/50
2127 2.92gm n.s.s. 1/50 305.mg 1/50 611.mg 1/50
2127 1.34gm n.s.s. 0/50 305.mg 0/50 611.mg 0/50
2127 562.mg n.s.s. 19/50 305.mg 18/50 611.mg 21/50
2127 721.mg n.s.s. 14/50 305.mg 15/50 611.mg 15/50
2127 428.mg n.s.s. 15/50 282.mg 20/50 564.mg 20/50
2127 2.25gm n.s.s. 1/50 282.mg 2/50 564.mg 1/50
2127 1.24gm n.s.s. 8/50 282.mg 7/50 564.mg 7/50
2127 758.mg n.s.s. 5/50 282.mg 4/50 (564.mg 0/50)
2127 360.mg n.s.s. 29/50 282.mg 30/50 564.mg 30/50
2127 1.1Ogm n.s.s. 22/50 282.mg 16/50 564.mg 15/50
BROMOCRIPTINE MESYLATE (Parlodel) 22260-51-1
58 2302 102.mg n.s.s. 10/50 2.00mg 11/50 10.Omg 11/50 50.Omg 7/50
a 2302 262.mg n.s.s. 1/50 2.00mg 3/50 10.Omg 1/50 50.0mg 0/50
b 2302 26.9mg n.s.s. 29/50 2.00mg 22/50 10.Omg 26/50 50.Omg 28/50
59 2302 37.Omg n.s.s. 19/50 2.00mg 17/50 10.Omg 20/50 50.Omg 20/50
a 2302 48.3mg n.s.s. 19/50 2.00mg 15/50 10.Omg 10/50 50.0mg 17/50
b 2302 18.0mg n.s.s. 32/50 2.00mg 26/50 10.Omg 32/50 50.0mg 34/50
60 2302 16.4mg 120.mg 0/50 1.80mg 2/50 9.90mg 8/49 (44.5mg 9/50)
a 2302 55.2mg 649.mg 0/50 1.80mg 2/50 9.90mg 7/49 44.5mg 9/50
b 2302 310.mg n.s.s. 0/50 1.80mg 0/50 9.90mg 1/49 44.5mg 0/50
c 2302 14.Omg n.s.s. 0/50 1.80mg 0/50 9.90mg 0/49 44.5mg 0/50
d 2302 3.94mg n.s.s. 44/50 1.80mg 29/50 (9.90mg 26/49 44.5mg 20/50)
61 2302 14.0mg n.s.s. 0/50 1.80mg 0/50 9.90mg 0/50 44.5mg 0/50

















































Mitsui; fctx, 31,929-933; 1993
Richardson;stnd, 19-63;1984/pers.comm.
tert-BUTYL ALCOHOL 75-65-0
62 TR436 8.89gm n.s.s. 2/60
a TR436 3.91gm n.s.s. 54/60
b TR436 6.19gm n.s.s. 41/60
c TR436 17.4gm n.s.s. 4/60
63 TR436 8.73gm n.s.s. 1/60
a TR436 1.31gm n.s.s. 56/60
b TR436 1.43gm n.s.s. 48/60
982.mg 3/60 1.96gm 2/60 3.95gm 9/60
982.mg 54/60 1.96gm 55/60 3.95gm 53/60
982.mg 44/60 1.96gm 40/60 3.95gm 36/60
982.mg 5/60 1.96gm 6/60 3.95gm 3/60
824.mg 0/60 1.65gm 4/60 3.30gm 2/60
824.mg 56/60 1.65gm 56/60 3.30gm 43/60
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Brkly Code
545Spe Strain Site Xpo+Xpt
Sex Route Hist Notes
TD50 2Tailpvl
DR AuOp
M m b6c wat lun MXB 24m24
R f f34 wat TBA MXB 24m24
R f f34 wat liv MXB 24m24
R m f34 wat tes MXA 24m24
R m f34 wat kid MXA 24m24
R m f34 wat kid MXA 24m24
R m ft34 wat TBA MXB 24m24
R m f34 wat liv MXB 24m24
R m f34 wat kid rua 24m24 with step











BUTYLATED HYDROXYANISOLE* 10Ong.:.-lug ... :o. 10 .... 1 :1°00 . :.-lmg .... :.-10 ......... 100 .... :.lg . :10
67 R m f3d eat for sqp 52w52 er + 442.mg
a R m f3d eat for sqc 52w52 er no dre
68 R m f3d eat for sqc 51w51 Cer ( 591.mg
a R m f3d eat for sqp 51w51 Cer 591.mg
b R m f3d eat stg tum 51w51 Cer no dre
69 R m f3d eat for tum 52w52 er .> no dre
70 R m f3d eat for sqp 24m24 er + 289.mg



















2,4,6-TRI-tert-BUTYLPHENOL O l0ng*-:* lug ............ 100.......g.... 10 .....:.-100 .... :..ig ..... .:10
71 R f wis eat liv tum 52w52 ekr .> rio dre P=1.
R f wis eat liv tum 78w78 ekr
R f wis eat liv tum 24m24 er
R m wis eat liv tum 52w52 er
R m wis eat liv tum 78w78 er






CAFFEINE` 10Ong. :_ *lug :_10 :_100 : *-lmo : .-.10 .-- -:*100.i-*: *- g..... :*.10
77 M f chh wat mgl adc 24m24 gr :> 58.1mg
78 R m sda eat k/p mix 88w88 e . no dre
a R m sda eat liv tum 88w88 e no dre
b R m sda eat ubl mix 88w88 e no dre
CALCIUM VALPROATE l 0Ong... :lug ......10.0 :_1 lmg :..10 100 -:*lg :*.10
79 R f crw eat ute adc 24m24 + 1.30gm
a R f crw eat liv tum 24m24 no dre
b R f crw eat ute esp 24m24 no dre














CAMOSTAT MESYLATE 10Ong. .:. .lug 10..1..... :.-100 :1..-mg :.-100 10 .......10
81 R m f3d eat for tum 52w52 er .> no dre P=1.
CAPTAFOL***
82 M f cdl eat --- lys 24m26 er
a M f cdl eat --- hes 24m26 er
83 M m cdl eat hag ade 24m26 er
a M m cdl eat --- lys 24m26 er
b M m cdl eat --- hes 24m26 er
84 R f cdr eat liv mix 24m24 er
a R f cdr eat liv nnd 24m24 er
b R f cdr eat kid rcc 24m24 er
c R f cdr eat mgl fba 24m24 er
d R f cdr eat liv hpc 24m24 er
e R f cdr eat kid mix 24m24 er
f R f cdr eat kid rca 24m24 er
85 R m cdr eat kid mix 24m24 er
a R m cdr eat kid rcc 24m24 er
b R m cdr eat kid rca 24m24 er
CAPTAN***
86 M f cdl eat smi mix 26m26 rs:
a M f cdl eat smi car 26m26 rsa
b M f cdl eat smi ade 26m26 rs:
87 M m cdl eat smi mix 26m26 rsj
a M m cdl eat smi car 26m26 rsv
b M m cdl eat smi ade 26m26 rsv
88 R f cdr eat kid mix 24m24 r
a R f cdr eat kid ruc 24m24 r
b R f cdr eat kid rua 24m24 r
89 R m cdr eat kid mix 24m24 r
a R m cdr eat kid rua 24m24 r
b R m cdr eat kid ruc 24m24 r
90 R f wis eat ute sar 30m30 r
CATECHOL***
91 R m f3d eat stg ade 51w51 Cer
a R m f3d eat stg adc 51w51 Cer
b R m f3d eat for tum 51w51 Cer
92 R m lwj eat stg ade 24m24 e
a R m lwj eat stg adc 24m24 e
b R m lwj eat stg sar 24m24 e
c R m lwj eat liv hnd 24m24 e
d R m lwj eat for tum 24m24 e
93 R m sdj eat stg ade 24m24 e
a R m sdj eat stg adc 24m24 e
b R m sdj eat for sqp 24m24 e
c R m sdj eat for sqc 24m24 e
d R m sdj eat liv tum 24m24 e
94 R m wky eat gam tum 60w60 er
95 R m wky eat stg ade 24m24 e
0Ong. .: .. lug 10 ....1:mg 10. :100 :lg 10
+ 1.49gm *P<.004 +
3.13gm *P<.006 +







781 .mg *P< .05
916.mg *P< .08
no dre P=1.
+ 272.mg *P<.003 +
426.mg *P<.02
733.mg *P<.08
l0Ong..... .............. :.:*mg ......10 :1mg -- .1..... 10
v + 1.74gm Z P<.0005+
v 2.11gm Z P<.0005+
v 13.3gm *P<.04 +
v . + 2.69gm *P<.0005+
v 3.50gm *P<.0005+




+ 2.69gm *P<.09 +
3.81gm *P<.2
11.5gm *P<.6
+ +hist 1.7Ogm P<.004 +
















































RefNum LoConf UpConf Cntrl lDose oInc 2Dose 2Inc Citation or Pathology
TR436 8.92gm n.s.s. 15/60
TR436 153.mg n.s.s. 48/50
TR436 2.03gm n.s.s. 1/50
TR436 30.4mg 926.mg 34/50
TR436 68.3mg n.s.s. 1/50
TR436 68.3mg n.s.s. 1/50
TR436 29.Omg 1.37gm 49/50
TR436 1.94gm n.s.s. 1/50
TR436 31.8mg 226.mg 8/50
TR436 31.7mg 242.mg 8/50
824.mg 8/60 1.65gm 9/60 3.30gm 6/60
141.mg 47/50 282.mg 43/50 564.mg 45/50
141.mg 1/50 282.mg 0/50 564.mg 1/50
61.7mg 31/50 123.mg 31/50 247.mg 33/50
61.7mg 3/50 123.mg 4/50 247.mg 3/50
61.7mg 3/50 123.mg 4/50 247.mg 3/50
61.7mg 48/50 123.mg 49/50 247.mg 46/50
61.7mg 1/50 123.mg 0/50 247.mg 0/50
61.7mg 11/50 123.mg 19/50 247.mg 13/50








BUTYLATED HYDROXYANISOLE*** (BHA, 2 (3)-tert-butyl-4-hydroxyanisole) 25013-16-5
67 2098 152.mg n.s.s. 0/10 800.mg 4/15
a 2098 618.mg n.s.s. 0/10 800.mg 0/15
68 2162 178.mg n.s.s. 0/15 800.mg 3/15
a 2162 178.mg n.s.s. 0/15 800.mg 3/15
b 2162 595.mg n.s.s. 0/15 800.mg 0/15
69 2192m 412.mg n.s.s. 0/10 400.mg 0/20
70 2192n 144.mg 625.mg 0/17 800.mg 17/20
a 2192n 846.mg n.s.s. 0/17 800.mg 4/20
2,4,6-TRI-tert-BUTYLPHENOL 732-26-3
71 2340m .378mg n.s.s. 0/7 1.50mg 0/7 5.00mg 0/7 15.Omg 0/7 50.Omg
72 2340n .851mg n.s.s. 0/7 1.50mg
73 2340o 4.11mg n.s.s. 0/19 1.50mg
74 2340m .303mg n.s.s. 0/7 1.20mg
75 2340n .681mg n.s.s. 0/7 1.20mg






0/7 15.Omg 0/7 50.Omg
0/19 15.Omg 0/19 50.Omg
0/7 12.Omg 0/7 40.Omg
0/7 12.Omg 0/7 40.Omg
0/19 12.Omg 0/19 40.Omg
Shibata;carc, 14, 275-280; 1993











77 2270 14.6mg n.s.s. 17/18 100.mg 15/16
78 2211 169.mg n.s.s. 0/30 40.8mg 0/28
a 2211 169.mg n.s.s. 0/30 40.8mg 0/28




79 2275 649.mg 15.1gm 4/50 125.mg
a 2275 736.mg n.s.s. 0/50 125.mg
b 2275 2.30gm n.s.s. 5/50 125.mg










CAMOSTAT MESYLATE (FOY 305) 59721-29-8
81 2192 20.6mg n.s.s. 0/10 40.Omg 0/10 Shibata;carc,14,1265-1269;1993/pers.comm.
CAPTAFOL*** 2425-06-1
82 2133 722.mg 13.2gm
a 2133 1.52gm 44.2gm
83 2133 188.mg 598.mg
a 2133 822.mg 4.46gm
b 2133 1.42gm n.s.s.
84 2133 64.Omg 325.mg
a 2133 65.9mg 332.mg
b 2133 235.mg 31.3gm
c 2133 31.1mg n.s.s.
d 2133 236.mg n.s.s.
e 2133 245.mg n.s.s.
f 2133 22.5mg n.s.s.
85 2133 110.mg 2.11gm
a 2133 143.mg n.s.s.
b 2133 196.mg n.s.s.
CAPTAN*** 133-06-2
86 2133m 1.03gm 3.62gm
a 2133m 1.23gm 4.33gm
b 2133m 6.09gm n.s.s.
87 2133m 1.95gm 4.12gm
a 2133m 2.49gm 5.51gm
b 2133m 4.85gm 44.6gm
88 2133m 2.92gm n.s.s.
a 2133m 2.92gm n.s.s.
b 2133m 267.mg n.s.s.
89 2133m 902.mg n.s.s.
a 2133m 1.16gm n.s.s.
b 2133m 1.55gm n.s.s.












































































































































































CATECHOL*** (1, 2-dihydroxybenzene) 120-80-9
91 2162 n.s.s. 32.6mg 0/15 320.mg 15/15
a 2162 48.8mg 1.23gm 0/15 320.mg 5/15
b 2162 238.mg n.s.s. 0/15 320.mg 0/15
92 22380 28.5mg 131.mg 0/20 320.mg 29/30
a 2238o 95.3mg 314.mg 0/20 320.mg 22/30
b 2238o 629.mg n.s.s. 0/20 320.mg 3/30
c 2238o 1.98gm n.s.s. 1/20 320.mg 0/30
d 2238o 1.98gm n.s.s. 0/20 320.mg 0/30
93 2238r n.s.s. 97.3mg 0/21 320.mg 30/30
a 2238r 86.6mg 283.mg 0/21 320.mg 23/30
b 2238r 400.mg 33.9gm 0/21 320.mg 6/30
c 2238r 1.05gm n.s.s. 0/21 320.mg 1/30
d 2238r 1.98gm n.s.s. 0/21 320.mg 0/30
94 2122 285.mg n.s.s. 0/10 320.mg 0/13
95 2238n n.s.s. 97.3mg 0/20 320.mg 30/30
Kawabe;gann, 85, 17-25; 1994
Tanaka; fctx, 33, 93-98; 1995/pers.comm.
Tatematsu;carc, 14, 1415-1419;1993
Tanaka;fctx, 33, 93-98;1995/pers.comm.
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Sex Route Hist Notes
R m wky eat stg adc 24m24 e
R m wky eat for sqp 24m24 e
R m wky eat liv mix 24m24 e
R m wsj eat stg ade 24m24 e
R m wsj eat stg adc 24m24 e
R m wsj eat stg sar 24m24 e
R m wsj eat liv hnd 24m24 e
R m wsj eat for sqp 24m24 e
R m wsj eat liv hpc 24m24 e













CHLORDANE, TECHNICAL GRADE--* *0Ong. .: _lug.... 10....... :.100.*.:..:mg. ... :. - 10 .... :.-100.... -:*lg..... :.*10
97 M m b6c eat liv mix 60w61 ekrv . + . .583mg
a M m b6c eat liv hpa 60w61 ekrv .903mg
b M m b6c eat liv hpc 60w61 ekrv 1.91mg
98 M m b6c eat liv hpa 60w68 erv <+ noTD50
a M m b6c eat liv mix 60w68 erv noTD50
b M m b6c eat liv hpc 60w68 erv 1.49mg
99 M m b6c eat liv hpa 68w68 ekrv <+ noTD50
a M m b6c eat liv mix 68w68 ekrv noTD50
b M m b6c eat liv hpc 68w68 ekrv .878mg
100 M m b6c eat liv hpa 60w72 erv + . .727mg
a M m b6c eat liv hpc 60w72 erv 2.67mg
101 M m b6c eat liv mix 72w72 erv . + . 1.68mg
a M m b6c eat liv hpa 72w72 erv 1.96mg
b M m b6c eat liv hpc 72w72 erv 2.96mg
102 M m c5j eat liv mix 24m24 Cr . + 13.1mg
103 M m d2b eat liv mix 60w61 ekrv + . 1.93mg
a M m d2b eat liv hpa 60w61 ekrv 2.33mg
b M m d2b eat liv hpc 60w61 ekrv 6.09mg
104 M m d2b eat liv mix 69w69 ekrv + 1.03mg
a M m d2b eat liv hpa 69w69 ekrv 1.29mg
b M m d2b eat liv hpc 69w69 ekrv 3.31mg
105 M m d2b eat liv mix 87w87 erv .+ . 3.83mg
a M m d2b eat liv hpa 87w87 erv 4.98mg
b M m d2b eat liv hpc 87w87 erv 5.21mg
CHLORINATED WATER***
106 R f sda wat --- 1km 24m32
a R f sda wat for ama 24m32
b R f sda wat liv hpc 24m32
c R f sda wat lun ade 24m32
d R f sda wat tba mal 24m32
e R f sda wat tba ben 24m32
107 R m sda wat --- lkm 24m32
a R m sda wat for ama 24m32
b R m sda wat stg sar 24m32
c R m sda wat for sqc 24m32
d R m sda wat lun tum 24m32
e R m sda wat liv hpc 24m32
f R m sda wat tba mal 24m32
g R m sda wat tba ben 24m32
10Ong..: lug.... :.-10 .... :.100.... : *-mg.... :10. :.-100. ..... :..10














[4-CHLORO-6-(2,3-XYLIDINO)-2-PYRIMIDINYLTHIO]ACETIC ACID**-..: .-100 ....: .. - .mg*...: . -10...0:0..1°°....:*lg.*. -.-10
108 H m smb eat liv mix 60w60 Cr .> no dre P=1.
109 R m f34 eat liv hpa 37w52 Cr .> 95.1mg P<.3
110 R m f34 eat liv mix 9m24 Cr _ 60.0mg P<.06
a R m f34 eat liv hpc 9m24 Cr 92.6mg P<.2
b R m f34 eat liv hpa 9m24 Cr 190.mg P<.3
111 R m f34 eat liv mix 52w52 Cr <+ noTD5O P<.0005+
a R m f34 eat liv hpa 52w52 Cr 2.29mg P<.0005+
b R m f34 eat liv hpc 52w52 Cr 19.2mg P<.003 +
112 R m f34 eat liv mix 12m24 Cr + . 22.9mg P<.0005+
a R m f34 eat liv hpc 12m24 Cr 26.8mg P<.002 +
b R m f34 eat liv hpa 12m24 Cr 84.3mg P<.06
113 R m f3d eat liv mix 52w52 ekr . + . 4.26mg P<.0005+
114 R m f3d eat liv mix 78w78 er <+ noTD5O P<.003 +
115 R m sda eat liv mix 60w60 Cr <+ noTD5O P<.0005+
CITRIC ACID 10Ong. .:_*lug............. :.-100.... :*-1*mg.... :.-10... :.-100. ... :.lg ..... :10
116 R m f3d eat for tum 52w52 er .> no dre P=1.
CODEINE
117 M f b6c eat TBA MXB 24m24
a M f b6c eat liv MXB 24m24
b M f b6c eat lun MXB 24m24
118 M m b6c eat TBA MXB 24m24
a M m b6c eat liv MXB 24m24
b M m b6c eat lun MXB 24m24
119 R f f34 eat TBA MXB 24m24
a R f f34 eat liv MXB 24m24
120 R m f34 eat TBA MXB 24m24
a R m f34 eat liv MXB 24m24
10Ong. : * .lug. 10 :100 .- - -:..lnmg.... : * -10.... :*.100.... :* lg.....* -.10
: > no dre P=1.
no dre P=1.
3.20gm * P<.4
: > no dre P=1.
no dre P=1.
no dre P=1.
: > no dre P=1.
no dre P=1.
:> 689.mg * P<.9
no dre P=1.
CYCASIN AND METHYLAZOXYMETHANOL ACETATE***.-lug ....10..... ..... :1 : 100 °. :.-lmg .... : 10..... :*-100.... : * -lg . - :.* g10
121 P b cym eat liv hpc 18y24 jmw 19.44mg P<.04 +
P b cym eat tba mal 18y24 jmw
P b rhe ipj liv hpc 8y8 jw
P b rhe ipj MXB MXB 8y8 jw
P b rhe ipj eso sqc 8y8 jw
P b rhe ipj kid rcc 8y8 jw





































































CHLORDANE, TECHNICAL GRADE*** 57-74-9
97 2246m .228mg 1.94mg 7/15 6.86mg
a 2246m .430mg 3.39mg 6/15 6.86mg
b 2246m 1.02mg 5.61mg 1/15 6.86mg
98 2246n n.s.s. 1.42mg 0/5 6.11mg
a 2246n n.s.s. 1.42mg 0/5 6.11mg
b 2246n .591mg 9.61mg 0/5 6.11mg
99 2246o n.s.s. 1.08mg 0/5 6.90mg
a 2246o n.s.s. 1.08mg 0/5 6.90mg
b 2246o .417mg 2.02mg 0/5 6.90mg
100 2246r .368mg 1.47mg 7/43 5.82mg
a 2246r 1.44mg 6.43mg 3/43 5.82mg
101 2246s .966mg 3.34mg 10/70 6.91mg
a 2246s 1.13mg 3.92mg 8/70 6.91mg
b 2246s 1.67mg 6.13mg 3/70 6.91mg
102 2135 7.63mg 27.6mg 3/102 6.00mg
103 2246u 1.07mg 4.73mg 0/10 6.86mg
a 2246u 1.26mg 6.90mg 0/10 6.86mg
b 2246u 2.62mg n.s.s. 0/10 6.86mg
104 2246v .579mg 2.15mg 0/5 6.90mg
a 2246v .742mg 3.02mg 0/5 6.90mg
b 2246v 1.76mg n.s.s. 0/5 6.90mg
105 2246w 2.52mg 6.58mg 1/27 6.96mg
a 2246w 3.18mg 9.47mg 1/27 6.96mg
b 2246w 3.30mg 10.1mg 1/27 6.96mg
CHLORINATED WATER*** ---
106 BT7003 85.Omg 2.21gm
a BT7003 510.mg n.s.s.
b BT7003 59.0mg n.s.s.
c BT7003 748.mg n.s.s.
d BT7003 79.6mg n.s.s.
e BT7003 77.9mg n.s.s.
107 BT7003 154.mg n.s.s.
a BT7003 204.mg n.s.s.
b BT7003 411.mg n.s. s.
c BT7003 665.mg n.s.s.
d BT7003 51.6mg n.s.s.
e BT7003 605.mg n.s.s.
f BT7003 92.7mg n.s.s.













































































































[4-CHLORO-6-(2,3-XYLIDINO)-2-PYRIMIDINYLTHIO]ACETIC ACID*** (WY14643) 50892-23-4
108 2190 12.6mg n.s.s. 0/9 23.0mg 0/8
109 2156m 15.5mg n.s.s. 0/20 28.5mg 1/20
110 2156n 18.1mg n.s.s. 0/16 14.2mg 3/20
a 2156n 22.7mg n.s.s. 0/16 14.2mg 2/20
b 2156n 30.9mg n.s.s. 0/16 14.2mg 1/20
111 2156o n.s.s. 3.65mg 0/20 40.Omg 20/20
a 2156o .941mg 5.24mg 0/20 40.0mg 19/20
b 21560 7.78mg 100.mg 0/20 40.Omg 6/20
112 2156r 10.6mg 69.5mg 0/16 20.Omg 9/20
a 2156r 12.Omg 96.Omg 0/16 20.Omg 8/20
b 2156r 25.5mg n.s.s. 0/16 20.Omg 3/20
113 2161m 1.67mg 13.4mg 0/10 40.0mg 8/10
114 2161n n.s.s. 15.9mg 0/8 40.Omg 7/7
115 2190 n.s.s. 1.61mg 0/8 10.Omg 12/12
CITRIC ACID 77-92-9







Lake;enhp, 101 (Supp5), 241-247;1993/pers.comm.
Shibata;carc, 14,275-280;1993
CODEINE 76-57-3
117 TR455 418.mg n.s.s.
a TR455 1.17gm n.s.s.
b TR455 843.mg n.s.s.
118 TR455 227.mg n.s.s.
a TR455 330.mg n.s.s.
b TR455 984.mg n.s.s.
119 TR455 26.4mg n.s.s.
a TR455 n.s.s. n.s.s.
120 TR455 35.8mg n.s.s.





















36/51 195.mg 38/51 390.mg 31/51
15/51 195.mg 15/51 390.mg 8/51
3/51 195.mg 7/51 390.mg 4/51
39/50 180.mg 36/50 (360.mg 28/50)
30/50 180.mg 23/50 (360.mg 16/50)
9/50 180.mg 16/50 360.mg 10/50
44/50 40.0mg 47/51 (80.0mg 37/51)
0/50 40.Omg 0/51 80.Omg 0/51
47/50 32.Omg 45/50 64.Omg 44/50







CYCASIN AND METHYLAZOXYMETHANOL ACETATE*** (CAS# 592-62-1 and 14901-08-7) mixture
121 2004 3.16mg n.s.s. 0/51 3.61mg 1/6 Adamson;ossc,129-156;
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Sex Route Hist Notes
TD50 2Tailpvl
DR AuOp
P b rhe ipj
P b rhe eat
P b rhe eat
P b rhe eat
P b rhe eat
P b rhe eat
P b rhe eat
P b rhe eat
P b rhe eat
P b rhe eat
P b rhe eat
tba mal 8y8 Wjw
asc adc 18y24 jmw
bil ppa 18y24 jmw
pan adc 18y24 jmw
MXB MXB 18y24 jmw
liv hpc 18y24 jmw
kid rcc 18y24 jmw
bil adc 18y24 jmw
tba mal 18y24 Wjmw
tba mix 18y24 Wjmw























CYCLAMATE, SODIUM* .. 10Ong..:. jug . - :.* -10*- -:*.100.* - -:*lmg . - :* 10 * --- :..1°00.* - -:*Lg..... 10
124 P b cym eat pro adc 24y24 w + 35.6mg \ P<.1
P b cym eat liv hpc
P b cym eat tba mal
P b rhe eat thy ppa
P b rhe eat col adc
P b rhe eat ute ley
P b rhe eat tba mal
P b rhe eat tba ben

















CYCLOPHOSPHAMIDE*** b0Ong. .:. jug . - :.* -10** -:*.100.* *:.*mg :*.1°0 :*.1°00 . j - :*-lg :*.10
126 P b cym eat bre pam 11y13 w + 1.04mg
P b cym eat hea car 1lyl3 w
P b cym eat lun car 11y13 w
P b cym eat ute ley llyl3 Ww
P b cym eat tba mix 1lyl3 Ww
P b cym eat tba ben 11y13 Ww
P b cym eat tba mal llyl3 Ww
P b rhe eat liv hem 1lyl3 w
P b rhe eat liv fbl 11y13 w
P b rhe eat bre pam 11y13 Ww
P b rhe eat ubl tcc 11y13 w
P b rhe eat tba mix 11y13 Ww
P b rhe eat tba ben 11y13 Ww





































128 M f swi eat --- lkm 80w80
a M f swi eat liv hpc 80w80
b M f swi eat lun ade 80w80
c M f swi eat tba mix 80w80
129 M f swi gav --- lkm 80w80
a M f swi gav lun ade 80w80
b M f swi gav liv hpc 80w80
c M f swi gav tba mix 80w80
130 M m swi eat --- lkm 80w80
a M m swi eat lun ade 80w80
b M m swi eat liv hpc 80w80
c M m swi eat tba mix 80w80
131 M m swi gav --- lkm 80w80
a M m swi gav lun ade 80w80
b M m swi gav liv hpc 80w80
c M m swi gav tba mix 80w80


























P b cym eat liv hpc lly25 w
P b cym eat pro car 11y25 w
P b cym eat ute ley 11y25 w
P b cym eat tba mix 1ly25 w
P b cym eat tba ben 1ly25 w
P b cym eat tba mal lly25 w
P b rhe eat ute ley lly25 w


































DEHYDROEPIANDROSTERONE 10Ong..:_-ug ...........100 :.-1 ° g :.- :.-10 :10.l 10
134 R m f3d eat liv mix 52w52 ekr + 230.mg * P<.09
135 R m f3d eat liv mix 78w78 er + 68.1mg * P<.0005+
DEXAMETHAZONE 1bOng :. .lug : 1° ..... :10..100 .1mg .... -10.0.*.---00: .* -ig :*.10
136 R m f3d eat for tum 52w52 ersv .> no dre P=1.
DICHLOROACETIC ACID*** 0Ong ..: lug :.-1° :..1 ° ° .... :.-mg. ..... :.-100 .... :.-1g ..... :..10
137 M f b6c wat liv hpa 51w51 Cekr (+) . 238.mg
a M f b6c wat liv hpc 51w51 Cekr 2.56gm
138 M f b6c wat liv hpa 82w82 Cer + 197.mg
a M f b6c wat liv hpc 82w82 Cer 1.23gm
139 M m b6c wat liv hpa 61w61 er + 62.1mg
a M m b6c wat liv hpc 61w61 er 119.mg
140 M m b6c wat liv mix 60w60 ekr + 89.2mg
a M m b6c wat liv hpc 60w60 ekr 114.mg
b M m b6c wat liv hpa 60w60 ekr 128.mg
141 M m b6c wat liv hpa 75w75 er .> 1.77gm
a M m b6c wat liv hpc 75w75 er no dre
b M m b6c wat liv mix 75w75 er no dre
* P< 0005+
* P<.1










1,4-DICHLOROBENZENE*5** b00ng. lug .10 : 100 :.*1mg : .1 ° :*-100 : : .10
142 M f swi inh liv nnd 57w76 e .> 12.5gm * P<.6
a M f swi inh lun ade 57w76 e no dre P=1.



































RefNum LoConf UpConf Cntrl lDose lInc 2Dose 2Inc Citation or Pathology
2004 10.7ug .360mg 1/84 .795mg 4/5
2004m 1.83mg n.s.s. 0/12 7.27mg 1/2
2004m 3.06mg n.s.s. 0/13 7.27mg 1/3
2004m 5.50mg n.s.s. 0/37 7.27mg 1/5
2004m 6.73mg n.s.s. 0/43 7.27mg 1/6
2004m 6.73mg n.s.s. 0/43 7.27mg 1/6
2004m 6.73mg n.s.s. 0/43 7.27mg 1/6
2004m 7.69mg n.s.s. 1/74 7.27mg 1/7
2004m 2.66mg n.s.s. 6/74 7.27mg 3/7
2004m 2.07mg n.s.s. 17/108 7.27mg 4/10
2004m 3.89mg n.s.s. 12/108 7.27mg 1/10
CYCLAMATE, SODIUM*** 139-05-9
124 2003 5.81mg n.s.s. 0/3 71.4mg 1/1 (357.mg 0/4)
a 2003 203.mg n.s.s. 0/3 71.4mg -/- 357.mg 1/4
b 2003 285.mg n.s.s. 3/15 71.4mg 1/3 357.mg 1/4
125 2003 29.6mg n.s.s. 0/12 71.4mg 1/3 357.mg -/-
a 2003 124.mg n.s.s. 0/13 71.4mg 0/3 357.mg 1/2
b 2003 42.2mg n.s.s. 6/29 71.4mg 1/4 357.mg 0/2
c 2003 193.mg n.s.s. 6/74 71.4mg 0/4 357.mg 1/5
d 2003 77.5mg n.s.s. 12/108 71.4mg 2/4 357.mg 0/5
e 2003 80.2mg n.s.s. 17/108 71.4mg 2/4 357.mg 1/5
CYCLOPHOSPHAMIDE*** (endoxan) 50-18-0















128 2176m 8.35mg n.s.s.
a 2176m 15.1mg n.s.s.
b 2176m 16.3mg n.s.s.
c 2176m 4.68mg 138.mg
129 2176n 4.59mg n.s.s.
a 2176n 6.37mg n.s.s.
b 2176n 6.98mg n.s.s.
c 2176n 1.64mg 9.24mg
130 2176m 7.70mg n.s.s.
a 2176m 8.51mg n.s.s.
b 2176m 12.5mg n.s.s.
c 2176m 2.52mg 30.6mg
131 2176n 5.87mg n.s.s.
a 2176n 5.77mg n.s.s.
b 2176n 11.3mg n.s.s.
c 2176n 3.09mg n.s.s.
132 2003 2.70mg n.s.s.
a 2003 8.11mg n.s.s.
b 2003 17.1mg n.s.s.
c 2003 21.0mg n.s.s.
d 2003 3.57mg n.s.s.
e 2003 4.77mg n.s.s.
f 2003 5.33mg n.s.s.
133 2003 7.35mg n.s.s.








































1982/Thorgeirsson 1994/Dalgard 1997/Thorgeirsson&Seiber pers.comm.
Adamson;ossc, 129-156;
1982/Thorgeirsson 1994/Dalgard 1997/Thorgeirsson&Seiber pers.comm.
Kashyap;ijcn,19,725-729;1977/pers.comm.
Adamson;ossc, 129-156;
1982/Thorgeirsson 1994/Dalgard 1997/Thorgeirsson&Seiber pers.comm'.
DEHYDROEPIANDROSTERONE 53-43-0
134 2161m 79.2mg n.s.s. 0/10
135 2161n 30.5mg 174.mg 0/8
Hayashi; carc, 15,2215-2219; 1994 200.mg 2/10 400.mg 2/10
200.mg 5/9 400.mg 7/7
DEXAMETHAZONE 50-02-2
136 2192 37.8ug n.s.s. 0/10 73.Sug 0/10 Shibata;carc, 14,1265-1269;1993/pers .comm.
DICHLOROACETIC ACID' 79-43-6
137 2191m 112.mg 765.mg 1/40
a 2191m 417.mg n.s.s. 0/40
138 2191n 119.mg 362.mg 2/90
a 2191n 473.mg 7.47gm 2/90
139 2071 26.3mg 137.mg 2/22
a 2071 65.6mg 234.mg 0/22
140 2073m 50.8mg 177.mg 0/9
a 2073m 68.5mg 232.mg 0/9
b 2073m 74.Omg 237.mg 0/9
141 2073n 75.1mg n.s.s. 0/19
a 2073n 105.mg n.s.s. 2/19
b 2073n 79.3mg n.s.s. 2/19
51.6mg 0/40 172.mg 3/20 516.mg 7/20
51.6mg 0/40 172.mg 0/20 516.mg 1/20
51.6mg 3/50 172.mg 7/28 516.mg 16/19
51.6mg 0/50 172.mg 1/28 516.mg 5/19
833.mg 25/26
833.mg 21/26
8.33mg 2/9 83.3mg 1/9 833.mg 27/30
8.33mg 2/9 83.3mg 1/9 833'.mg 25/30
8.33mg 0/9 83.3mg 0/9 833.mg 24/30
8.33mg 2/20 83.3mg 1/18
8.33mg 3/20 83.3mg 1/18
8.33mg 5/20 83.3mg 2/18
Pereira;faat, 31,192-199;1996/pers.comm.
Herren-Freund;txap, 90, 183-189; 1987
DeAngelo; faat, 16,337-347; 1991/pers. comm.
1, 4-DICHLOROBENZENE.** 106-46-7
142 2304 1.56gm n.s.s. 0/48 88.6mg 1/47 591.mg 1/50
a 2304 1.77gm n.s.s. 3/48 88.6mg 3/47 591.mg 2/50
Loeser;fctx,21, 825-832;1983
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M f swi inh tba mal 57w76 e
M f swi inh tba tum 57w76 e
R f aap inh liv hpa 18m26 e
R f aap inh tba tum 18m26 e
R f aap inh tba mal 18m26 e
R m aap inh liv tum 18m26 e
R m aap inh tba tum 18m26 e









DIETHYLMALEATE*** 10Ong..: *jug . - :.* -10*- -:*.100.* - -:* mg . - :.* -10 * .:*.100.* - -:*lg :*.10
145 R m f3d eat for tum 52w52 er .> no dre
146 R m f3d eat for sqp 24m24 er .> 1.07gm
a R m f3d eat for sqc 24m24 er no dre
DIETHYLSTILBESTROL*** lOOng. . : * -jlug. 1 100 .: * -1° * - : * 1°° * -: * - mg.. 0 .: * -1° : * -100 . - -:*lg. 1 0: * -1
147 R f sda gav liv hpc 52w52 + 4.80mg
a R f sda gav pit ade 52w52 7.68mg







2-(DIFLUOROMETHYL)-DL-ORNITHINE 10Ong. : lug.... 10......... 100 .... :1.-mg. ... :..-1 ... :.-100....-:j.-g..... :*.10
148 R f cdr gav liv tum 52w52 .> no dre P=1.
149 R m cdr gav liv tum 52w52 .> no dre P=1.
N,N-DIMETHYL-4-AMINOAZOBENZENE*** 10Ong . .-lug .... -10 ....0:0..1° ° ....:1. -mg ....:..1*0 -:*.1°00....-:*-Lg. 10
150 P b rhe eat lun a/c 5y20 Wjw : + 4.84mg P<.02
a P b rhe eat tba mal 5y20 Wjw 17.2mg P<.3
DIMETHYLFORMAMIDE 100ng.. lug.... :. 10*- -:*.100 -:*.1mg.... : ....10 -:*100.* - -: *-g..... 10
151 M f cdl inh liv hpa 78w78 Ce .> 15.8gm * P<.8
152 M m cdl inh liv hpc 78w78 Ce .> 3.07gm * P<.4
a M m cdl inh liv hpa 78w78 Ce no dre P=1.
153 R f cdr inh liv hpa 24m24 Ce . no dre P=1.
154 R m cdr inh liv hpa 24m24 Ce .> 2.64gm * P<.7
a R m cdr inh liv hpc 24m24 Ce 3.34gm * P<.2
2,4-DINITRO-6-tert-BUTHYLPHENYL METHANESULFONATE. -10 . :.-100 . :1.-mg.. :.-10 . :.-100 . * lg * 10
155 R f sda eat liv tum 52w52 e .> no dre P=1.
a R f sda eat tba mix 52w52 e 2.66mg * P<.2
156 R m sda eat liv tum 52w52 e .> no dre P=1.
a R m sda eat tba tum 52w52 e no dre P=1.
2,4-DINITROTOLUENE (CONTAINING 1.0-1.5% 2,6-DINITROTOLUENE)*** ..1.00.... ..1°mg.... :1.10 0 : 01 .. :*lg ..... 10
157 M f cdl eat kid tlt 52w52 ek .> no dre P=1.
a M f cdl eat liv hct 52w52 ek no dre P=1.
158 M f cdl eat kid tlt 23m24 aes .> 11.6gm * P<.2
a M f cdl eat liv hct 23m24 aes no dre P=1.
159 M m cdl eat kid tlt 52w52 ek + 423.mg * P<.03
a M m cdl eat liv hct 52w52 ek no dre P=1.
160 M m cdl eat kid tlt 22m24 aes + 29.4mg Z P<.0005+
a M m cdl eat liv hct 22m24 aes no dre P=1.
161 R f cdr eat liv nnd 52w52 ek + 4.31mg * P<.0005+
a R f cdr eat liv hpc 52w52 ek 52.8mg * P<.2
162 R f cdr eat liv hpc 24m24 e + 52.Omg * P<.0005+
a R f cdr eat mgl mix 24m24 e 7.05mg Z P<.02 +
b R f cdr eat liv nnd 24m24 e 123.mg * P<.03
c R f cdr eat ski mix 24m24 e 213.mg * P<.1
163 R m cdr eat liv nnd 52w52 ek + 4.28mg * P<.0005+
a R m cdr eat liv hpc 52w52 ek no dre P=1.
164 R m cdr eat ski mix 24m24 e + 27.7mg * P<.0005+
a R m cdr eat liv hpc 24m24 e 84.7mg * P<.004 +
b R m cdr eat mgl mix 24m24 e 281.mg * P<.03
c R m cdr eat liv nnd 24m24 e 979.mg * P<.8
2, 6-DINITROTOLUENE***
165 R m f34 eat liv mix 52w52 er
a R m f34 eat liv nnd 52w52 er
b R m f34 eat liv hpc 52w52 er
166 R m f34 eat liv mix 52w52 er
167 R m f34 eat liv mix 52w52 er
5, 5-DIPHENYLHYDANTOIN***
168 M m d2b eat liv hpa 53w53 e
a M m d2b eat liv mix 53w53 e











OOng. .: . .lug.10 * -: .100.* -:*-mg.- :.*10*- .....*-.100.- :*lg .....* -.10
. > 116.mg * P<.3
116.mg * P<.3
3-0-DODECYLCARBOMETHYLASCORBIC ACID .. lug . -:*-10. 100 . :. -1°° * : mg. : ...10..:.-100.. g. 10
169 R f f3d eat liv tum 52w52 e .> no dre P=1.
DOXYLAMINE SUCCINATE 1 0bOng -1ug................ .... :**lmg............... :**1°°......**g . . . . . :10010
170 M f b6c eat lun a/a 65w65 ek .> 78.7mg Z P<.3
a M f b6c eat liv hpc 65w65 ek no dre P=1.
b M f b6c eat thy fct 65w65 ek no dre P=1.
171 M f b6c eat liv hpa 24m24 e + 633.mg * P<.002 +
a M f b6c eat thy fct 24m24 e 672.mg * P<.0005+
b M f b6c eat thy fca 24m24 e 740.mg * P<.0005+
c M f b6c eat lun mix 24m24 e 170.mg Z P<.06
d M f b6c eat lun a/c 24m24 e no dre P=1.
e M f b6c eat lun a/a 24m24 e no dre P=1.
M f b6c eat livhpc 24m24 e no dre P=1.
g M f b6c eat thy fdc 24m24 e no dre P=1.
172 M m b6c eat liv hpa 65w65 ek + 77.8mg * P<.008
a M m b6c eat lun a/a 65w65 ek 3.18gm * P<.9
b M m b6c eat thy fct 65w65 ek no dre P=1.
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552CARCINOGENIC POTENCY DATABASE
RefNum LoConf UpConf Cntrl lDose lInc 2Dose 2Inc Citation or Pathology
Brkly Code
b 2304 124.mg n.s.s. 16/48 88.6mg 12/47 (591.mg 5/50)
c 2304 949.mg n.s.S. 23/48 88.6mg 22/47 591.mg 16/50
143 2304 240.mg n.s.s. 1/61 19.1mg 0/61 127.mg 0/58
a 2304 57.1mg n.s.s. 55/61 19.1mg 54/61 127.mg 53/58
b 2304 203.mg n.s.s. 19/61 19.1mg 22/61 127.mg 23/58
144 2304 167.mg n.s.s. 0/60 13.4mg 0/60 89.1mg 0/60
a 2304 141.mg n.s.s. 39/60 13.4mg 31/60 89.1mg 35/60
b 2304 216.mg n.s.s. 19/60 13.4mg 13/60 89.1mg 18/60
DIETHYLMALEATE*** 141-05-9
145 2192m 41.2mg n.s.s. 0/10 80.Omg 0/10
146 2192n 174.mg n.s.s. 0/17 80.Omg 1/20
a 2192n 330.mg n.s.s. 0/17 80.0mg 0/20
DIETHYLSTILBESTROL*** (DES) 56-53-1
147 2136 1.44mg n.s.s. 0/10 10.0mg 3/10
a 2136 1.88mg n.s.s. 0/10 10.0mg 2/10
b 2136 2.64mg n.s.s. 0/10 10.Omg 1/10
2- (DIFLUOROMETHYL) -DL-ORNITHINE 70052-12-9
148 2194 294.mg n.s.s. 0/25 400.mg 0/25 800.mg 0/25 1.60gm 0/25
149 2194 294.mg n.s.s. 0/25 400.mg 0/25 800.mg 0/25 1.60gm 0/25
N,N-DIMETHYL-4-AMINOAZOBENZENE*** (butter yellow) 60-11-7
150 2004 .788mg n.s.s. 0/23 14.3mg 1/1
1982/Thorgeirss





on 1994/Dalgard 1997/Thorgeirsson&Seiber pers.comm.
DIMETHYLFORMAMIDE 68-12-2
151 2145 1.22gm n.s.s. 0/61
152 2145 629.mg n.s.s. 0/60
a 2145 559.mg n.s.s. 13/60
153 2145 1.17gm n.s.s. 0/60
154 2145 310.mg n.s.s. 1/57
a 2145 543.mg n.s.s. 0/57
23.5mg 1/63 94.Omg 2/61 376.mg 1/63
19.6mg 1/62 78.3mg 4/60 313.mg 2/59
19.6mg 11/62 78.3mg 11/60 313.mg 11/59
5.60mg 1/59 22.4mg 0/59 89.5mg 0/60
3.92mg 1/59 15.7mg 3/58 62.7mg 2/60
3.92mg 0/59 15.7mg 0/58 62.7mg 1/60
Malley; faat, 23,268-279; 1994
2,4-DINITRO-6-tert-BUTHYLPHENYL METHANESULFONATE (HE 166) 29110-68-7
155 2336 .491mg n.s.s. 0/6 1.25mg 0/10 5.00mg 0/8
a 2336 .800mg n.s.s. 0/6 1.25mg 1/10 5.00mg 2/8
156 2336 .247mg n.s.s. 0/6 1.00mg 0/6 4.00mg 0/6
a 2336 .247mg n.s.s. 0/6 1.00mg 0/6 4.00mg 0/6
2,4-DINITROTOLUENE (CONTAINING 1.0-1.5% 2,6-DINITROTOLUENE)*** 121-14-2
157 2221m 4.61mg n.s.s. 0/8 13.Omg 0/8 91.Omg 0/8 650.mg 0/8
a 2221m 4.61mg n.s.s. 0/8 13.Omg 0/8 91.Omg 0/8 650.mg 0/8
158 2221n 1.88gm n.s.s. 0/23 13.0mg 0/20 91.0mg 0/22 650.mg 1/23
a 2221n 49.0mg n.s.s. 0/23 13.0mg 0/21 91.0mg 0/23 650.mg 0/25
159 2221m 103.mg n.s.s. 0/8 12.0mg 0/8 84.0mg 0/8 600.mg 2/8
a 2221m 4.25mg n.s.s. 0/8 12.0mg 0/8 84.0mg 0/8 600.mg 0/8
160 2221n 16.5mg 56.9mg 0/24 12.0mg 6/22 84.0mg 16/19 (600.mg 10/29)
a 2221n 51.8mg n.s.s. 0/25 12.0mg 0/25 84.0mg 0/20 600.mg 0/32
161 2222m 1.66mg 14.5mg 0/8 .750mg 0/8 5.00mg 0/8 35.Omg 7/8
a 2222m 8.57mg n.s.s. 0/8 .750mg 0/8 5.00mg 0/8 35.0mg 1/8
162 2222n 25.9mg 128.mg 0/23 .750mg 0/28 5.00mg 1/26 35.Omg 10/25
a 2222n 2.97mg n.s.s. 11/23 .750mg 1/28 5.00mg 16/26 (35.0mg 21/25)
b 2222n 46.1mg n.s.s. 0/23 .750mg 2/28 5.00mg 2/26 35.0mg 5/25
c 2222n 58.5mg n.s.s. 1/23 .750mg 2/28 5.00mg 0/26 35.0mg 4/25
163 2222m 1.60mg 19.4mg 0/8 .600mg 1/8 4.00mg 0/8 28.0mg 6/8
a 2222m .211mg n.s.s. 0/7 .600mg 0/8 4.00mg 0/8 28.0mg 0/7
164 2222n 13.9mg 83.Omg 2/25 .600mg 4/27 4.00mg 3/19 28.Omg 15/27
a 2222n 33.6mg 747.mg 1/25 .600mg 0/27 4.00mg 1/19 28.0mg 6/27
b 2222n 69.1mg n.s.s. 0/25 .600mg 0/27 4.00mg 0/19 28.0mg 2/27
c 2222n 72.3mg n.s.s. 1/25 .600mg 2/27 4.00mg 1/19 28.0mg 2/27
2, 6-DINITROTOLUENE*** 606-20-2
165 2223m 82.Oug .503mg 0/10
a 2223m .229mg 2.82mg 0/10
b 2223m .318mg 2.97mg 0/10
166 2223n .279mg n.s.s. 0/10















5, 5-DIPHENYLHYDANTOIN*** (phenytoin) 57-41-0
168 2121 28.5mg n.s.s. 0/15 30.0mg 1/15 60.0mg 1/15
a 2121 28.5mg n.s.s. 0/15 30.0mg 1/15 60.0mg 1/15
3-0-DODECYLCARBOMETHYLASCORBIC ACID ---
169 2249 258.mg n.s.s. 0/10 500.mg 0/10
DOXYLAMINE SUCCINATE 562-10-7
170 2268m 27.1mg n.s.s. 0/12
a 2268m 19.5mg n.s.s. 1/12
b 2268m 19.5mg n.s.s. 0/12
171 2268n 326.mg 2.28gm 0/46
a 2268n 337.mg 2.05gm 0/44
b 2268n 361.mg 2.08gm 0/44
c 2268n 62.5mg n.s.s. 3/48
d 2268n 1.22gm n.s.s. 0/48
e 2268n 281.mg n.s.s. 3/48
f 2268n 199.mg n.s.s. 0/46
g 2268n 1.43gm n.s.s. 0/44
172 2268m 35.1mg 1.39gm 0/12
a 2268m 128.mg n.s.s. 1/12



























































Environmental Health Perspectives * Vol 107, Supplement 4 * August 1999 553Spe Strain Site Xpo+Xpt
Sex Route Hist Notes
TDO50 2Tailpvl
DR AuOp
liv mix 24m24 e
liv hpa 24m24 e
thy fca 24m24 e
liv hpc 24m24 e
lun a/c 24m24 e
lun mix 24m24 e
lun a/a 24m24 e
liv mix 65w65 ek
liv mix 24m24 e
liv hpa 65w65 ek
liv hpc 65w65 ek
liv mix 24m24 e
liv hpa 24m24 e
liv hpc 24m24 e
--- mnl 24m24 e
alpha-ECDYSONE
178 M f swa gav mgl adc 95w95
a M f swa gav lun adc 95w95
b M f swa gav tba mal 95w95
179 M m swa gav lun adc 95w95
a M m swa gav tba mal 95w95






ELLAGIC ACID 10Ong. :. lg. 100 1mg :.-10 .....:.-100 .... :*g....... 10
180 R f f3d eat liv tum 52w52 e .> no dre P=1.
(-)-EPIGALLOCATECHIN GALLATE (85% (-)-EPIGALLOCATECHIN GALLATE, 10% (-)-EPIGALLOCATECHIN, 58 (-)-EPICATECHIN GALLATE)
181 M m cen wat liv mix 58w58 r .> no dre P=1.
ETHINYL ESTRADIOL
182 R f sls gav liv hpc 52w52 Cr
ETHOXYQUIN***
183 R f f34 eat kid tum 58w58 r
184 R f f34 eat kid tum 78w78 r
185 R m f34 eat kid tum 58w58 r
186 R m f34 eat kid tum 78w78 r
ETHYL ACRYLATE`
187 R m f34 gav for mix 26w91
a R m f34 gav liv tum 26w91
188 R m f34 gav for mix 52w52
a R m f34 gav liv tum 52w52
189 R m f34 gav for sqp 52w60
a R m f34 gav for sqc 52w60
b R m f34 gav liv tum 52w60
190 R m f34 gav for mix 52w91
a R m f34 gav for sqc 52w91
b R m f34 gav for sqp 52w91













191 R f sda wat pan ade 24m28 Ie
a R f sda wat mgl mix 24m28 Ie
b R f sda wat mgl ben 24m28 Ie
c R f sda wat mgl fba 24m28 Ie
d R f sda wat liv hpc 24m28 Ie
e R f sda wat liv mix 24m28 Ie
f R f sda wat mgl car 24m28 Ie
R f sda wat liv hpa 24m28 Ie
h R f sda wat tba ben 24m28 Ie
i R f sda wat tba mal 24m28 Ie
j R f sda wat tba mix 24m28 Ie
192 R f sda wat pit nen 24m28 Ie
a R f sda wat liv hpa 24m28 Ie
b R f sda wat liv hpc 24m28 Ie
c R f sda wat pan mix 24m28 Ie
d R f sda wat tba mix 24m28 Ie
e R f sda wat tba ben 24m28 Ie
f R f sda wat tba mal 24m28 Ie
193 R m sda wat pan car 24m28 Ie
a R m sda wat liv hpc 24m28 Ie
b R m sda wat liv hpa 24m28 Ie
c R m sda wat tba mix 24m28 Ie
d R m sda wat tba mal 24m28 Ie
e R m sda wat tba ben 24m28 Ie
194 R m sda wat pan mix 24m28 Ie
a R m sda wat liv hpc 24m28 Ie
b R m sda wat liv hpa 24m28 Ie
c R m sda wat tba ben 24m28 Ie
d R m sda wat tba mal 24m28 Ie
e R m sda wat tba mix 24m28 Ie
195 R m sls wat liv mix 28m28 er
a R m sls wat liv hpc 28m28 er
b R m sls wat liv hpa 28m28 er
3 - -ETHYLASCORBIC ACID
196 R f f3d eat liv tum 52w52 e
ETHYLBENZENE***
197 R f sda gav hed car 24m29
a R f sda gav orc car 24m29
b R f sda gav nas ene 24m29
0Ong*.:.. .... 10. :1 .. :* lmg ......10. :.-100 ......19 .... :* 10
.200mg P<.04 +



































































































b0Ong. .: _ug .:*-10 ... .100.- .--:1* mg.... -10. :* 100. :* lg 10
> no dre P=1.





















N m b6c eat
M m b6c eat
M m b6c eat
M m b6c eat
M m b6c eat
M m b6c eat
M m b6c eat
N 6 634 eat
R f f34 eat
R m f34 eat
R m f34 eat
R m f34 eat
R m f34 eat
R m f34 eat

























































178 2094 13.6ug .117mg
a 2094 .106mg n.s.s.
b 2094 13.6ug .117mg
179 2094 19.3ug n.s.s.


































































































180 2249 25.8mg n.s.s. 0/10 50.Omg 0/10 Hirose; carc, 16,217-221; 1995/pers .comm.
(-)-EPIGALLOCATECHIN GALLATE (85% (-)-EPIGALLOCATECHIN GALLATE, 10% (-)-EPIGALLOCATECHIN, 5% (-)-EPICATECHIN GALLATE) 989-51-5
181 2214 80.5mg n.s.s. 15/20 83.3mg 14/26 167.mg 12/26 Nishida;gann,85,221-225;1994
ETHINYL ESTRADIOL 57-63-6
182 2247 68.3ug n.s.s. 0/8
ETHOXYQUIN*** 91-53-2
183 2307m 144.mg n. s.s. 0/19
184 2307n 377.mg n.s.s. 0/20
185 2307m 115.mg n.s.s. 0/18
























.429mg 4/13 Machishi; carc, 16,2965-2971; 1995



























191 2257m 6.63gm n.s.s.
a 2257m 981.mg n.s.s.
b 2257m 1.62gm n.s.s.
c 2257m 1.98gm n.s.s.
d 2257m 20.4gm n.s.s.
e 2257m 20.4gm n.s.s.
f 2257m 5.29gm n.s.s.
g 2257m 20.4gm n.s.s.
h 2257m 1.08gm n.s.s.
i 2257m 3.35gm n.s.s.
j 2257m 340.mg n.s.s.
192 2257n 2.40gm n.s.s.
a 2257n 32.8gm n.s.s.
b 2257n 61.1gm n.s.s.
c 2257n 30.0gm n.s.s.
d 2257n 782.mg n.s.s.
e 2257n 3.71gm n.s.s.
f 2257n 7.94gm n.s.s.
193 2257m 4.90gm n.s.s.
a 2257m 16.6gm n.s.s.
b 2257m 16.6gm n.s.s.
c 2257m 305.mg n.s.s.
d 2257m 1.95gm n.s.s.
e 2257m 1.36gm n.s.s.
194 2257n 8.52gm n.s.s.
a 2257n 26.8gm n.s.s.
b 2257n 49.9gm n.s.s.
c 2257n 6.88gm n.s.s.
d 2257n 8.94gm n.s.s.
e 2257n 2.25gm n.s.s.
195 2185 14.4gm n.s.s.
a 2185 35.7gm n.s.s.
































































2.50gm 10/41 10.Ogm 12/43
2.50gm 2/41 10.Ogm 3/43




196 2249 258.mg n.s.s. 0/10 500.mg 0/10
ETHYLBENZENE*** 100-41-4
197 BT912 1.24gm n.s.s. 3/50 387.mg 7/50
a BT912 1.96gm n.s.s. 1/50 387.mg 3/50
b BT912 2.99gm n.s.s. 0/50 387.mg 1/50
Hirose;carc, 16, 217-221;1995/pers.comm.
Maltoni;anya, 837, 15-52;1997




























555Spe Strain Site Xpo+Xpt
Sex Route mist Notes
R f ada gav nas car 24m29
R f ada gav edu car 24m29
R f sda gav zym car 24m29
R f sda gav tba mal 24m29
R f ada gav tba mix 24m29
R f ada gav tba mal 24m33 ej
R f sda gav tba mix 24m33 j
R m sda gav hed car 24m29
R m ada gav nas ene 24m29
R m sda gav edu car 24m29
R m ada gav orc car 24m29
R m ada gav zym car 24m29
R m sda gav tba mal 24m29
R m sda gav tba mix 24m29
R m sda gav tba mix 24m33 j




















DI(2-ETHYLHEXYL)PHTHALATE*** 10Ong..:. jlug.... : 10. :100.. . :.Ims . 1 .......:.100 .... :.*lg... : 10
201 R m f3d eat liv mix 52w52 ekr .> no dre P=1.
202 R m f3d eat liv mix 78w78 er . ± 551.mg P<.03 +
ETODOLAC
203 M f cdl eat liv hpa 78w78
a M f cdl eat lun a/c 78w78
b M f cdl eat tba mal 78w78
c M f cdl eat tba mix 78w78
d M f cdl eat tba ben 78w78
204 M m cdl eat liv hpc 78w78 s
a M m cdl eat liv hpa 78w78 s
b M m cdl eat tba mix 78w78 s
c M m cdl eat tba mal 78w78 s
d M m cdl eat tba ben 78w78 s
205 R f cdr eat liv nnd 24m24
a R f cdr eat liv hpc 24m24
b R f cdr eat tba ben 24m24
c R f cdr eat tba mal 24m24
d R f cdr eat tba mix 24m24
206 R m cdr eat liv nnd 24m24
a R m cdr eat liv hpc 24m24
b R m cdr eat tba ben 24m24
c R m cdr eat tba mal 24m24
d R m cdr eat tba mix 24m24





















FENVALERATE*** 10Ong .:....jug .... :..10 ... :..100.. g....:.:ls ....:.1100 .. :I..,g..... :. 10
207 M f b6c eat liv hpa 24m24 es .> no dre P=1.
M f b6c eat lun bcd 24m24 es
M f b6c eat lun bro 24m24 es
M f b6c eat liv hpc 24m24 es
M f b6c eat tba tum 24m24 es
M m b6c eat liv hpa 24m24 es
M m b6c eat aki fbs 24m24 es
M m b6c eat lun bro 24m24 es
M m b6c eat lun bcd 24m24 es
M m b6c eat liv hpc 24m24 es












209 M f b6c wat liv hpc 22m23 e
a M f b6c wat lun a/a 22m23 e
b M f b6c wat liv hpa 22m23 e
c M f b6c wat liv hct 22m23 e
d M f b6c wat tba mix 22m23 e
210 M m b6c wat liv hpa 22m23 e
a M m b6c wat liv hct 22m23 e
b M m b6c wat lun a/c 22m23 e
c M m b6c wat lun a/a 22m23 e
d M m b6c wat liv hpc 22m23 e
e M m b6c wat tba mix 22m23 e
FINASTERIDE
211 M m cdl gav tea lya 83w83 er
FLUCONAZOLE
212 M f cdl eat liv hpa 24m24 e
a M f cdl eat liv hpc 24m24 e
b M f cdl eat tba mix 24m24 e
213 M m cdl eat liv hpa 24m24 e
a M m cdl eat liv hpc 24m24 e
b M m cdl eat tba mix 24m24 e
214 R f cdr eat liv hpa 24m24 e
a R f cdr eat mgl ade 24m24 e
b R f cdr eat liv hpc 24m24 e
c R f cdr eat mgl car 24m24 e
d R f cdr eat mgl fba 24m24 e
e R f cdr eat mgl mix 24m24 e
f R f cdr eat tba mix 24m24 e
215 R m cdr eat liv hpa 24m24 e
a R m cdr eat amd phe 24m24 e
b R m cdr eat liv hpc 24m24 e
c R m cdr eat tba mix 24m24 e
10Ong . .: .Iug....10.: * ..100.° .*.:.* .l.ng.... : * 10 .:.100 .... I.:lg . 10.. :..1°











10Ong..*: .lug. 10.*. - . . :*-100.... - .:lmg.....: * .10.. :. 100 ........ lg ... :.10
+ . 326.mg * P<.0005+






















































































































































DI(2-ETHYLHEXYL)PHTHALATE*** (di-sec-octyl phthalate, DEHP) 117-81-7
201 2161m 412.mg n.s.s. 0/10 800.mg 0/10 Haya
202 2161n 162.mg n.s.s. 0/8 800.mg 3/7
ETODOLAC (1,8-diethyl-1,3,4,9-tetrahydropyrano-[3,4-6]indole-1-acetic acid) 41340-25-4
203 2341 11.3mg n.s.s. 1/50 3.00mg 0/50 9.00mg 0/50 15.Omg 0/50
a 2341 45.2mg n.s.s. 2/50 3.00mg 3/50 9.00mg 3/50 15.Omg 2/50
b 2341 21.4mg n.s.s. 10/50 3.00mg 9/50 9.00mg 11/50 15.Omg 10/50
c 2341 25.7mg n.s.s. 15/50 3.00mg 13/50 9.00mg 12/50 15.Omg 12/50
d 2341 73.8mg n.s.s. 7/50 3.00mg 4/50 9.00mg 1/50 15.0mg 3/50
204 2341 63.5mg n.s.s. 1/50 3.00mg 5/50 9.00mg 1/49 15.0mg 1/49
a 2341 79.4mg n.s.s. 7/50 3.00mg 0/50 9.00mg 2/49 15.0mg 2/49
b 2341 43.6mg n.s.s. 13/50 3.00mg 14/50 9.00mg 6/49 15.0mg 8/49
c 2341 44.1mg n.s.s. 7/50 3.00mg 12/50 9.00mg 5/49 15.0mg 5/49
d 2341 56.1mg n.s.s. 7/50 3.00mg 3/50 9.00mg 2/49 15.Omg 4/49
205 2338 85.7mg n.s.s. 0/SO 3.00mg 2/50 9.00mg 1/50 15.0mg 1/50
a 2338 139.mg n.s.s. 1/50 3.00mg 0/50 9.00mg 2/50 15.0mg 0/50
b 2338 31.9mg n.s.s. 43/50 3.00mg 47/50 9.00mg 37/50 15.Omg 33/50
c 2338 52.8mg n.s.s. 12/50 3.00mg 15/50 9.00mg 10/50 15.Omg 10/50
d 2338 24.2mg n.s.s. 47/50 3.00mg 49/50 9.00mg 42/50 15.0mg 38/50
206 2338 128.mg n.s.s. 1/50 3.00mg 0/50 9.00mg 1/50 15.Omg 1/50
a 2338 105.mg n.s.s. 1/50 3.00mg 3/50 9.00mg 0/50 15.Omg 2/50
b 2338 9.99mg n.s.s. 26/50 3.00mg 33/50 9.00mg 27/50 (15.Omg 11/50)
c 2338 55.8mg n.s.s. 15/50 3.00mg 16/50 9.00mg 11/50 15.Omg 11/50
d 2338 9.30mg n.s.s. 33/50 3.00mg 39/50 9.00mg 32/50 (15.0mg 19/50)
FENVALERATE*** (cyano- (3-phenoxyphenyl)methyl-4-chloro-alpha- (1-methylethyl)benzene acetate) 51630-58-1














































































































209 2200 1.69gm n.s.s.
a 2200 1.69gm n.s.s.
b 2200 2.22gm n.s.s.
c 2200 1.53gm n.s.s.
d 2200 375.mg n.s.s.
210 2200 658.mg n.s.s.
a 2200 763.mg n.s.s.
b 2200 819.mg n.s.s.
c 2200 1.09gm n.s.s.
d 2200 1.39gm n.s.s.
e 2200 530.mg n.s.s.
FINASTERIDE 98319-26-7














































1/100 2.50mg 0/50 25.Omg 0/50 250.mg 16/50
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216 R f cdr gav liv hpc 24m24 e
a R f cdr gav sto pam 24m24 e
b R f cdr gav liv hpa 24m24 e
217 R m cdr gav thy fca 24m24 e
a R m cdr gav thy fdc 24m24 e
b R m cdr gav sto pam 24m24 e
c R m cdr gav sto sqc 24m24 e
d R m cdr gav liv hpc 24m24 e
e R m cdr gav liv hpa 24m24 e










FORMALDEHYDE*** 10Ong..:. lug . - : ..10...:* 100 . - :1mg . - :* 10 . - :* 100.... -:.*-g. 10
218 R f sda inh nac sqc 24m24 er .> 12.1mg P<.3
GALLIC ACID*** 10ng ..:..lug . 10 . :100 .. mg. : 10 : 100 .. g. :10
219 R m f3d eat for tum 52w52 er .> no dre P=1.
HEXACHLOROBENZENE*** 1b0Ong. :. ug ......10 . . ... :.1° ° * .... :. - mg....1 :0.1 .... :.-100 .... -: *-g. - 10
220 R f f34 eat liv tum 64w64 er 5.52mg P<.03 +
1-O-HEXYL-2,3,5-TRIMETHYLHYDROQUINONE .... lug... :0 . 00. g. 10 .. 1 :100:...- .log... ::10
221 R f f3d eat liv tum 52w52 e .> no dre P=1.
INDOMETHACIN 100ng*.: .. ....1u 0 ... :10 . 1:00 .. :.-1mg .... . 1°00 .... -lg o.... *-10
222 R m f3d eat for tum 52w52 er .> no dre P=1.
IPAZILIDE FUMARATE 100ng. ...lug. .10 .100 . 1 : mg. :10 .100 . :lg. 10
223 R f cdr gav liv tum 52w52 .> no dre P=1.






















P b cym gav liv hpc 9y9 jw
P b cym gav tba mal 9y9 jw
R f f34 eat zym tum 53w78
R f f34 eat pre tum 53w78
R f f34 eat mgl tum 53w78
R f f34 eat liv hpc 53w78
R f f34 eat lun ade 53w78
R f f34 eat sbg mix 53w78
R m f34 eat sbg mix 53w63
R m f34 eat zym tum 53w63
R m f34 eat pre tum 53w63
R m f34 eat liv hpc 53w63
R m f34 eat col tum 53w63
R m f34 eat lun mix 53w63
R m f34 gav zym sqc 35w52 e
R m f34 gav liv hpc 35w52 e
R m f34 gav ski sqc 35w52 e
R m f34 gav col adc 35w52 e
R m f34 gav smi adc 35w52 e
R m f34 gav tba mix 35w52 e
ISOBUTYL NITRITE
229 M f b6c inh lun MXA 24m24
a M f b6c inh lun MXA 24m24
b M f b6c inh TBA MXB 24m24
c M f b6c inh liv MXB 24m24
d M f b6c inh lun MXB 24m24
230 M m b6c inh lun MXA 24m24
a M m b6c inh lun a/a 24m24
b M mb6c inh thy MXA 24m24
c M m b6c inh TBA MXB 24m24
d M m b6c inh liv MXB 24m24
e M m b6c inh lun MXB 24m24
231 R f f34 inh lun MXA 24m24
a R f f34 inh lun a/a 24m24
b R f f34 inh TBA MXB 24m24
c R f f34 inh liv MXB 24m24
232 R m f34 inh lun a/a 24m24
a R m f34 inh lun MXA 24m24
b R m f34 inh TBA MXB 24m24
c R m f34 inh liv MXB 24m24
ISOPRENE
233 M f b6c inh pit pda 19m24
a M f b6c inh hag ade 19m24
b M f b6c inh spl hes 19m24
c M f b6c inh liv hpc 19m24
d M f b6c inh liv hpa 19m24
e M f b6c inh lun a/a 19m24
234 M m b6c inh hag MXA 26w53
a M m b6c inh hag ade 26w53
b M m b6c inh liv hpa 26w53
c M mb6c inh liv MXA 26w53
d M mb6c inh MXB MXB 26w53
M m b6c inh lun MXA 26w53
M m b6c inh lun a/a 26w53
M m b6c inh liv hpc 26w53
M m b6c inh for MXA 26w53
M m b6c inh for sqp 26w53
M m b6c inh lun a/c 26w53
M m b6c inh for sqc 26w53









































0Ong* ..... lug*.1.0.....10..01 ° .. :1mg ....:.-10 ..... :1°00 .. :*ilg ..... 10
417.mg * P<.04 p




247.mg * P<.03 p
279.mg * P<.02 p
1.45gm * P<.04 e
258.mg * P<.2
no dre P=1.
247.mg * P< .03





38.8mg * P<.002 c
no dre P=1.
no dre P=1.
00ng. :. 1ug. :10*...100 .: mg .10 . -1°00 .. 1°g . -10
247.mg * P< .03 +
319.mg * P<.03 +




96.8mg Z P<.003 c
96.8mg Z P< .003 c
150.mg Z P< .0005
183.mg Z P<..0005c































RefNum LoConf UpConf Cntrl lDose lInc 2Dose 2Inc Citation or Pathology
93957-54-1
225.mg n.s.s. 0/150 6.00mg 0/75 9.00mg
225.mg n.s.s. 0/150 6.00mg 0/75 9.00mg
141.mg n.s.s. 7/150 6.00mg 4/75 9.00mg
61.6mg 655.mg 4/150 6.00mg 4/75 9.00mg
97.2mg n.s.s. 5/150 6.00mg 1/75 9.00mg
185.mg n.s.s. 0/150 6.00mg 0/75 9.00mg
226.mg n.s.s. 0/150 6.00mg 1/75 9.00mg
283.mg n.s.s. 1/150 6.00mg 3/75 9.00mg












218 2205 1.97mg n.s.s. 0/15 1.14mg 1/16
GALLIC ACID*** 149-91-7
219 2098 412.mg n.s.s. 0/10 800.mg 0/10
HEXACHLOROBENZENE ** 118-74-1
220 2118 1.64mg n.s.s. 0/8 10.0mg 3/8
1-O-HEXYL-2, 3, 5-TRIMETHYLHYDROQUINONE 148081-72-5
221 2249 129.mg n.s.s. 0/10 250.mg 0/10
INDOMETHACIN 53-86-1
222 2192 1.03mg n.s.s. 0/10 2.00mg 0/10
IPAZILIDE FUMARATE (WIN 54177-4) 115436-74-3
223 2189 14.6mg n.s.s. 0/15 26.Omg 0/15 104.mg 0/15 208.mg 0/15
224 2189 14.6mg n.s.s. 0/15 26.0mg 0/15 104.mg 0/15 208.mg 0/15
Holmstrom;acot, 108,274-283; 1989
Shibata;carc, 14, 275-280; 1993
Smith;carc, 14, 1381-1387; 1993
Hirose;carc, 16,217-221;1995/pers.comm.
Shibata;carc, 14, 1265-1269;1993/pers.comm.
Greener; faat, 20, 147-154; 1993
IQ*** (2-amino-3-methylimidazo[4,5-flquinoline) 76180-96-6
225 2007 .175mg .743mg 0/10 7.14mg 15/18 14.3mg 18/18 Adamson;enhp,102,190-193;1994/Dalgard 1997/Thorgeirsson pers.comm.
a 2007 .175mg .743mg 0/10 7.14mg 15/18 14.3mg 18/18
226 2148 1.15mg 7.85mg 0/15 2.55mg 12/34 Weisburger;pseb,205,347-352;1994/pers.comm.
a 2148 1.50mg 37.3mg 0/15 2.55mg 9/34
b 2148 1.47mg n.s.s. 1/15 2.55mg 10/34
c 2148 2.06mg n.s.s. 0/15 2.55mg 6/34
d 2148 3.98mg n.s.s. 0/15 2.55mg 2/34
e 2148 5.36mg n.s.s. 0/15 2.55mg 1/34
227 2148 .550mg 2.31mg 0/15 2.52mg 16/34
a 2148 .638mg 3.22mg 0/15 2.52mg 14/34
b 2148 2.08mg n.s.s. 0/15 2.52mg 3/34
c 2148 2.57mg n.s.s. 0/15 2.52mg 2/34
d 2148 2.57mg n.s.s. 0/15 2.52mg 2/34
e 2148 2.41mg n.s.s. 1/15 2.52mg 3/34
228 2263 .147mg .646mg 0/20 2.02mg 14/20 Guo;clet,95,161-165;1995/pers.comm.
a 2263 .268mg 1.63mg 0/20 2.02mg 9/20
b 2263 .268mg 1.63mg 0/20 2.02mg 9/20
c 2263 .343mg 3.04mg 0/20 2.02mg 7/20
d 2263 .534mg n.s.s. 0/20 2.02mg 4/20
e 2263 .147mg .646mg 0/20 2.02mg 14/20
ISOBUTYL NITRITE 542-56-3
229 TR448 177.mg n.s.s. 6/51
a TR448 186.mg n.s.s. 4/51
b TR448 151.mg n.s.s. 37/51
c TR448 464.mg n.s.s. 10/51
d TR448 180.mg n.s.s. 6/51
230 TR448 112.mg n.s.s. 8/50
a TR448 127.mg n.s.s. 7/50
b TR448 495.mg n.s.s. 1/50
c TR448 83.9mg n.s.s. 33/50
d TR448 294.mg n.s.s. 24/50
e TR448 112.mg n.s.s. 8/50
231 TR448 62.2mg 230.mg 0/46
a TR448 68.5mg 354.mg 0/46
b TR448 44.6mg n.s.s. 40/46
c TR448 342.mg n.s.s. 0/46
232 TR448 22.7mg 96.9mg 0/46
a TR448 22.2mg 192.mg 1/46
b TR448 37.5mg n.s.s. 45/46
c TR448 171.mg n.s.s. 1/46
ISOPRENE (2-methyl-1, 3-butadiene)
233 2258o 97.1mg n.s.s. 1/49
a 2258o 122.mg n.s.s. 2/49
b 2258o 201.mg n.s.s. 1/50
c 22580 322.mg n.s.s. 2/50
d 2258o 310.mg n.s.s. 4/50
e 22580 227.mg n.s.s. 5/50
234 TX31 45.4mg 603.mg 2/30
a TX31 45.4mg 603.mg 2/30
b TX31 82.Omg 425.mg 4/30
c TX31 92.Omg 753.mg 7/30



















































































































































































































































13/30 2.51gm 12/30) hag:ade,car.
13/30 2.551gm 12/30)
18/30 (2.51gm 16/30) S
18/30 (2.51gm 17/30) liv:hpa,hpc.
25/30 2.51gm 23/30 for:sqc,sqp; hag:
ade,car; liv:hpa,hpc; lun:a/a,a/c. C
10/30 2.51gm 9/30 lun:a/a,a/c.
10/30 2.51gm 8/30 S
4/30 2.51gm 9/30 S
4/30 2.51gm 6/30 for:sqc,sgp.
2/30 2.51gm 5/30 S
1/30 2.51gm 3/30 S
2/30 2.51gm 1/30 S
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Sex Route Hist Notes
TD50 2Tailpvl
DR AuOp
N m b6c inh hag car 26w53
N m b6c inh TBA MXB 26w53
M m b6c inh liv MXB 26w53
M m b6c inh lun MXB 26w53
N m b6c inh hag ade 9m24 e
N m b6c inh lun a/a 9m24 e
M m b6c inh liv hpa 9m24 e
N m b6c inh lmr hcs 9m24 e
M m b6c inh liv hpc 9m24 e
N m b6c inh lun a/c 9m24 e
. m b6c inh for sqp 9m24 e
M m b6c inh hea hes 9m24 e
M m b6c inh hag car 9m24 e
M m b6c inh spl hes 9m24 e
N m b6c inh hag ade 80w96 e
N m b6c inh lmr hcs 80w96 e
M . b6c inh liv hpa 80w96 e
N m b6c inh lun a/c 80w96 e
N i b6c inh liv hpc 80w96 e
M i b6c inh lun a/a 80w96 e
N i b6c inh hag car 80w96 e
N i b6c inh for sqp 80w96 e
N m b6c inh hea hes 80w96 e
M m b6c inh for sqc 80w96 e
N i b6c inh spl hes 80w96 e
N i b6c inh hag ade l9m24 e
M mb6c inh liv hpa l9m24 e
N i b6c inh lun a/a l9m24 e
N i b6c inh lun a/c l9m24 e
N m i6c inh for sqc l9m24 e
N m b6c inh liv hpc l9m24 e
M i b6c inh hag car l9m24 e
N i b6c inh for sqp 19m24 e
N i b6c inh hea hes 19m24 e
N m b6c inh lmr hcs 19m24 e
N i b6c inh spl hes 19m24 e
MeA-alpha-C ACETATE***
238 R m f3d eat sub fib 23m23 Ce
a R m f3d eat pan ana 23m23 Ce
b R m f3d eat liv hpc 23m23 Ce
c R m f3d eat ubl tcc 23m23 Ce
d R m f3d eat pni isa 23m23 Ce
e R m f3d eat slg fbs 23m23 Ce
MeIQx***
239 R m f3d eat liv mix 56w56 e
a R m f3d eat liv hpc 56w56 e
b R m f3d eat liv hpa 56w56 e
c R m f3d eat zym mix 56w56 e
d R m f3d eat zym sqc 56w56 e
e R m f3d eat ski mix 56w56 e
f R m f3d eat zym sqp 56w56 e
g R m f3d eat ski tri 56w56 e
h R m f3d eat zym sea 56w56 e
i R m f3d eat ski sea 56w56 e
j R m f3d eat ski sqc 56w56 e





+ 739..mg * P<.0005+
908.mg * P<.0005+
1.07gm * P<.0005+
4.43gm * P< .003 +
2.33gm * P<.02 +




















22.2gm * P<.008 +
4.85gm * P<.03 +
15.0gm * P<.02 +
45.Ogm * P<.07
+hist 39.Ogm * P<.4 +
150.gm * P<.9
no dre P=1.







OOngn. .: ug * - - .1-0 .1*00 .. : : .1mg. 1.0 0.: -1° -: * -1°° -: * -lg. 1 0: .g 10












MELPHALAN*' 1Ong. : lug - :*.1°0 -:*.100.° -:* 1mg :*.1°0 :*.1°00.* -: *-g :*.10
240 P b cym gav kid rca 16yl8 w + .lOOmg
P b cym gav pnm ngs 16y18 w
P b cym gav ute mix 16y18 w
P b cym gav ute ena 16y18 w
P b cym gav ute ley 16y18 w
P b cym gav ski pam 16y18 w
P b cym gav pal sqc 16y18 w
P b cym gav pro car 16yl8 w
P b cym gav scl ecc 16yl8 w
P b cym gav tba mix 16y18 Ww
P b cym gav tba mal 16y18 Ww
P b cym gav tba ben 16yl8 w
P b rhe gav ute ley 16y19 Ww
P b rhe gav lun ade 16y19 w















3-METHOXYCATECHOL 1OOng..-: ug.... :.* -10*- :*.100.* .- -:*-mg :* 10.*- :*-100 .- .--:*lg ..... :*.10
242 R m f3d eat stg ade SlwS1 Cer (+) 48.7mg
a R m f3d eat for sqp 51w51 Cer 425.mg
b R m f3d eat for sqc SlwS1 Cer no dre
c R m f3d eat stg adc SlwS1 Cer no dre
4-METHOXYPHENOL*** 1b0Ong -lug 10 ..... :-1°00 .. 1. :. - mg .... : -1°00 .... :I1g O.. :..10
243 R f f3d eat for sqp 24m24 e + 2.58gm
a R f f3d eat for sqc 24m24 e 3.07gm
b R f f3d eat liv hnd 24m24 e no dre
c R f f3d eat stg tum 24m24 e no dre
244 R m f3d eat for sqc 24m24 e + 377.mg
a R m f3d eat for sqp 24m24 e 832.mg
b R m f3d eat stg ade 24m24 e 16.2gm









































































































































































































































































0/30 787.mg 1/30 2.51gm 0/30
23/30 787.mg 26/30 2.51gm 24/30
15/30 787.mg 18/30 (2.51gm 17/30) liv:hpa,hpb,hpc.












































MeA-alpha-C ACETATE*** (2-amino-3-methyl-9H-pyrido- [2, 3-b] -indole acetate) ---
238 2064 3.53mg 20.3mg 2/20 4.00mg 4/20 8.00mg 14/20
a 2064 4.65mg 23.5mg 0/20 4.00mg 6/20 8.00mg 8/20
b 2064 5.87mg 52.8mg 0/20 4.00mg 5/20 8.00mg 6/20
c 2064 10.8mg n.s.s. 0/20 4.00mg 3/20 8.00mg 2/20
d 2064 14.5mg n.s.s. 0/20 4.00mg 0/20 8.00mg 3/20














239 2093 .827mg 1.93mg 0/15 4.00mg 5/30 8.00mg 26/29 16.Omg
a 2093 1.82mg 5.01mg 0/15 4.00mg 0/30 8.00mg 13/29 16.0mg
b 2093 1.80mg 7.67mg 0/15 4.00mg 5/30 8.00mg 13/29 (16.0mg
c 2093 2.84mg 9.53mg 0/15 4.00mg 1/30 8.00mg 5/29 16.0mg
d 2093 4.41mg 20.5mg 0/15 4.00mg 0/30 8.00mg 3/29 16.0mg
e 2093 5.66mg 39.2mg 0/15 4.00mg 0/30 8.00mg 3/29 16.Omg
f 2093 10.Omg n.s.s. 0/15 4.00mg 1/30 8.00mg 1/29 16.0mg
g 2093 11.8mg n.s.s. 0/15 4.00mg 0/30 8.00mg 1/29 16.Omg
h 2093 11.8mg n.s.s. 0/15 4.00mg 0/30 8.00mg 1/29 16.Omg
i 2093 14.5mg n.s.s. 0/15 4.00mg 0/30 8.00mg 0/29 16.Omg
j 2093 14.6mg n.s.s. 0/15 4.00mg 0/30 8.00mg 1/29 16.0mg
k 2093 14.6mg n.s.s. 0/15 4.00mg 0/30 8.00mg 1/29 16.Omg
MELPHALAN*** (L-sarcolysin) 148-82-3

























































242 2162 18.9mg 124.mg 0/15
a 2162 146.mg n.s.s. 0/15
b 2162 595.mg n.s.s. 0/15
c 2162 595.mg n.s.s. 0/15
4-METHOXYPHENOL* ** 150-76-5
243 2202 1.11gm 10.3gm 0/30
a 2202 1.25gm 17.6gm 0/30
b 2202 3.73gm n.s.s. 1/30
c 2202 6.18gm n.s.s. 0/30
244 2202 217.mg 707.mg 0/30
a 2202 437.mg 2.07gm 1/30
b 2202 2.63gm n.s.s. 0/30
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Sex Route Hist Notes
TDSO 2Tailpvl
DR AuOp
METHYL tert-BUTYL ETHER 10Ong.. :.lug....:..10*....:..100....:.-lmg... :*-10*-.. :*-100....:j-lg.....:.10
245 M f cdl inh liv mix 80w80 C + 6.55gm * P<.0005+
a M f cdl inh liv hpa 80w80 C 8.26gm * P<.0005+
b M f cdl inh lun ala 80w80 C 43.6gm Z P<.2
C M f cdl inh liv hpc 80w80 C 239.gm * P<.6
246 M m cdl inh liv mix 79w79 Cs 10.6gm * P<.09
a M m cdl inh liv hpc 79w79 Cs 15.7gm * P<.03
b M m cdl inh liv hpa 79w79 Cs 21.3gm * P<.4
C M m cdl inh lun a/c 79w79 Cs no dre P=1.
247 R f f34 inh liv hpa 24m24 C :> 24.2gm * P<.3
a R f f34 inh kid rua 24m24 C 60.7gm * P<.7
248 R m f34 inh tes ica 22m24 Cas + 30.7mg Z P<.0005
a R m f34 inh kid mix 22m24 Cas 297.mg * P<.0005+
b R m f34 inh kid rua 22m24 Cas 433.mg * P<.0005+
c R m f34 inh kid ruc 22m24 Cas 1.29gm * P< .003 +
d R m f34 inh liv mix 22m24 Cas 2.48gm * P<.08
249 R f sda gav --- lkm 24m35 e + 2.35gm * P<.002 +
a R f sda gav ute sar 24m35 2.69gm P<.3
b R f sda gav liv hct 24m35 no dre P=1.
c R f sda gav tba ben 24m35 no dre P=1.
d R f sda gav tba mal 24m35 no dre P=1.
250 R m sda gav tes ldc 24m39 e + 2.07gm P<.007 +
a R m sda gav liv hpc 24m39 18.Ogm P<.5
b R m sda gav --- lkm 24m39 e no dre P=1.
c R m sda gav tba ben 24m39 2.31gm P<.2
d R m sda gav tba mal 24m39 no dre P=1.
3' -METHYL-4-DIMETHYLAMINOAZOBENZENE*** ..:..lug .. -ug . 10 ..... :1100 . :10 . 100. lg..... -.:10





P b rhe eat - hem 5y24 jw
P b rhe eat tba mal 5y24 Wjw
P b rhe eat tba ben 5y24 Wjw









N-METHYL-N'NITRO-N- NITROSOGUANIDINE*** ....lug .10 .100.....mg.... 1.. :*100 .... :..lg.......10















P b rhe eat tba ben 23y23 Wjw
R m f3d wat sto ade 30w70 er
R m f3d wat sto adc 30w70 er
R m wis wat pyl mix 28w52 sv
R m wis wat pyl mal 28w52 sv
R m wis wat pyl adc 28w52 sv
R m wis wat duo mal 28w52 sv
R m wis wat duo adc 28w52 sv
R m wis wat liv ccy 28w52 sv
R m wis wat for mix 28w52 sv
R m wis wat duo lei 28w52 sv
R m wis wat duo ade 28w52 sv
R m wis wat duo cas 28w52 sv
R m wis wat pyl ade 28w52 sv
































256 R f f3d eat stg ade 24m24 e
a R f f3d eat for sqp 24m24 e
b R f f3d eat stg adc 24m24 e
c R f f3d eat for sqc 24m24 e
d R f f3d eat stg sar 24m24 e
e R f f3d eat liv hnd 24m24 e
257 R m f3d eat stg ade 24m24 e
a R m f3d eat for sqp 24m24 e
b R m f3d eat stg adc 24m24 e
c R m f3d eat for sqc 24m24 e
d R m f3d eat stg sar 24m24 e
e R m f3d eat liv hnd 24m24 e













3 -METHYLCHOLANTHRENE*** 100ng..:. .lug . * :* 10 . :.*100.... .:*1mg . * :* 10.-* * :* 100....*:*lg :*.10
258 P b cym eat tba mal 5y27 jw :> no dre
















260 M f b6c inh lun mix
a M f b6c inh lun car
b M f b6c inh liv mix
c M f b6c inh liv hpa
d M f b6c inh lun ade
e M f b6c inh liv hpc
261 M f b6c inh lun mix
a M f b6c inh lun car
b M f b6c inh lun ade
c M f b6c inh liv mix
d M f b6c inh liv hpc
e M f b6c inh liv hpa
262 M f b6c inh lun mix
a M f b6c inh liv hpa
b M f b6c inh lun car
c M f b6c inh lun ade
d M f b6c inh liv hpc
e M f b6c inh liv mix
263 M f b6c inh lun mix
0Ong. :. lug . 10.*- .....* -.100.*-:1*mg . - :* 10 .....* -.100.*-:*Ilg :..1*0










12m24 er 4. 96gm
12m24 er 6.25gm






24m24 at + 1.65gm






















RefNum LoConf UpConf Cntrl lDose lInc 2Dose 2Inc Citation or Pathology
Brkly Code







































































































































































Belpoggi;txih, 11, 119-149; 1995/1997
3' -METHYL-4-DIMETHYLAMINOAZOBENZENE* * * 55-80-1
251 2004 10.9mg n.s.s. 0/23 18.5mg 1/4
a 2004 3.37mg n.s.s. 2/108 18.5mg 1/12
b 2004 12.7mg n.s.s. 6/74 18.5mg 1/8
c 2004 6.93mg n.s.s. 12/108 18.5mg 1/12
d 2004 6.59mg n.s.s. 17/108 18.5mg 2/12
N-METHYL-N'-NITRO-N-NITROSOGUANIDINE*** (MNNG) 70-25-7































256 2202 n.s.s. 304.mg
a 2202 130.mg 487.mg
b 2202 579.mg 2.40gm
c 2202 747.mg 3.71gm
d 2202 1.97gm n.s.s.
e 2202 3.73gm n.s.s.
257 2202 n.s.s. 243.mg
a 2202 265.mg 941.mg
b 2202 364.mg 1.34gm
c 2202 394.mg 1.50gm
d 2202 1.32gm n.s.s.





























258 2004 9.22mg n.s.s. 3/15























































1982/Thorgeirsson 1994/Dalgard 1997/Thorgeirsson&Seiber pers.comm.
Adamson;ossc, 129-156;
























Tatematsu;carc, 14, 1415-1419; 1993















1982/Thorgeirsson 1994/Dalgard 1997/Thorgeirsson&Seiber pers.comm.
METHYLENE CHLORIDE*** (dichloromethane, Freon 30) 75-09-2
260 2117m 676.mg 4.60gm 5/67 546.mg 21/68
a 2117m 820.mg 8.84gm 4/67 546.mg 17/68
b 2117m 681.mg n.s.s. 18/67 546.mg 27/67
c 2117m 978.mg n.s.s. 8/67 546.mg 16/67
d 2117m 1.41gm n.s.s. 1/67 546.mg 8/68
e 2117m 1.30gm n.s.s. 11/67 546.mg 14/67
261 2117n 521.mg 1.37gm 5/67 1.09gm 40/63
a 2117n 609.mg 1.66gm 4/67 1.09gm 36/63
b 2117n 1.88gm 13.1gm 1/67 1.09gm 12/63
c 2117n 1.18gm n.s.s. 18/67 1.09gm 28/64
d 2117n 1.77gm n.s.s. 11/67 1.09gm 18/64
e 2117n 2.12gm n.s.s. 8/67 1.09gm 14/64
262 2117o 971.mg 2.68gm 5/67 1.64gm 38/68
a 2117o 1.54gm 8.13gm 8/67 1.64gm 28/68
b 2117o 1.63gm 6.56gm 4/67 1.64gm 25/68
c 2117o 2.04gm 7.83gm 1/67 1.64gm 19/68
d 2117o 1.92gm 87.8gm 11/67 1.64gm 25/68
e 2117o 1.17gm n.s.s. 27/67 1.64gm 42/68
263 2117r 1.08gm 2.77gm 5/67 2.18gm 42/67
Kari;carc, 14, 819-826;1993


























563Spe Strain Site Xpo+Xpt
Sex Route Hist Notes
TD50 2Tailpvl
DR AuOp
M f b6c inh liv mix 24m24 er
M f b6c inh lun a/c 24m24 er
M f b6c inh liv hpc 24m24 er
M f b6c inh liv hpa 24m24 er






2,2-METHYLENEBIS(4-METHYL-6-tert-BUTYLPHENOL) .... 10.. :100.... :j.-mg.... :.* 10.... :*.100 . . : 10
264 R f wis eat liv tum 52w52 ek .> no dre P=1.
265 R f wis eat liv tum 78w78 e .> no dre P=1.
266 R m wis eat tes ict 52w52 ek .> 44.5mg * P<.2
a R m wis eat liv tum 52w52 ek no dre P=1.
267 R m wis eat tes ict 78w78 e .> 36.6mg Z P<.8
a R m wig eat liv hpa 78w78 e no dre P=1.
1-METHYLNAPHTHALENE
268 M f b6c eat liv hpa 81w81
a M f b6c eat liv hpc 81w81
b M f b6c eat lun a/a 81w81
c M f b6c eat lun a/c 81w81
d M f b6c eat lun mix 81w81
e M f b6c eat tba tum 81w81
269 M m b6c eat lun mix 81w81
a M m b6c eat lun a/a 81w81
b M m b6c eat lun a/c 81w81
c M m b6c eat liv hpc 81w81
d M m b6c eat liv hpa 81w81
e M m b6c eat tba tum 81w81
100ng* .1ug.. :* 10. * - :* 100.*- .. :.* ..g.I*-- : * *10 .:*100.... -:*lg ..... :.*10












4- -(MET0YLNITROSAMINO).-110-.(131-PYRIDYL)-110-0(1BUTANONE)*** .-10 *... :-1°°.. : .lmg.... : *-1* - -:*-100.... : * -lg * . :.*-1
270 H f syg wat liv hpc 87w87 .> 5.13mg * P<*.3
a H f syg wat lun mix 87w87 no dre P=1.
b H f syg wat pan adc 87w87 no dre P=1.
c H f syg wat pni isa 87w87 no dre P=1.
271 R m f34 wat lun mix 26m26 e + 68.8ug P<.0005+
a R m f34 wat lun adc 26m26 e .148mg P<.0005+
b R m f34 wat lun ade 26m26 e .279mg P<.03
c R m f34 wat pae mal 26m26 e .975mg P<.2
d R m f34 wat liv mix 26m26 e 2.97mg P<.8
e R m f34 wat pae ana 26m26 e no dre P=1.
f R m f34 wat pae mix 26m26 e no dre P=1.
METHYLPHENIDATE.HCl
272 M f b6c eat liv hpa 24m24
a M f b6c eat liv MXA 24m24
b M f b6c eat lun MXA 24m24
c M f b6c eat lun a/a 24m24
d M f b6c eat TBA MXB 24m24
e M f b6c eat liv MXB 24m24
f M f b6c eat lun MXB 24m24
273 M m b6c eat liv hpb 24m24
a M m b6c eat liv MXA 24m24
b M m b6c eat liv MXA 24m24
c M m b6c eat liv hpa 24m24
d M m b6c eat liv MXA 24m24
e M m b6c eat TBA MXB 24m24
f M m b6c eat liv MXB 24m24
g M m b6c eat lun MXB 24m24
274 R f f34 eat TBA MXB 24m24
a R f f34 eat liv MXB 24m24
275 R m f34 eat TBA MXB 24m24
a R m f34 eat liv MXB 24m24




















MONOCHLOROACETIC ACID*** 10Ong. .: _ lug .... 10....... :.-100 .... : j.-mg .... : 0. - ..... :.-100 .... : g -10
276 R m f34 wat liv hpc 24m24 C .> no dre P=1.
a R m f34 wat liv hpa 24m24 C no dre P=1.
NAFENOPIN***
277 H m amb eat liv mix 60w60 Cr
278 R m f34 eat liv hpc 25m25 er
a R m f34 eat pan mix 25m25 er
b R m f34 eat pan ana 25m25 er
c R m f34 eat pan acc 25m25 er
279 R m sda eat liv mix 60w60 Cr
280 R f wis eat liv hpc 55w55 kr
a R f wia eat liv mix 55w55 kr
b R f wis eat liv hpa 55w55 kr
281 R f wis eat liv mix 70w70 r
a R f wis eat liv hpa 70w70 r
b R f wis eat liv hpc 70w70 r
282 R m wia eat liv mix 57w57 r
a R m wig eat liv hpa 57w57 r
b R m wia eat liv hpc 57w57 r
NALIDIXIC ACID***
283 M f cdf eat lun adc 76w85 e
a M f cdf eat liv hpa 76w85 e
b M f cdf eat lun mix 76w85 e
c M f cdf eat tba tum 76w85 e
284 M m cdf eat liv hpc 76w85 e
a M m cdf eat liv mix 76w85 e
b M m cdf eat lun adc 76w85 e
c M m cdf eat liv hpa 76w85 e
d M m cdf eat lun mix 76w85 e




































































RefNum LoConf UpConf Cntrl lDose 1Inc 2Dose 2Inc Citation or Pathology
a 2117r 1.05gm 3.74gm 18/67 2.18gm 47/68
b 2117r 1.65gm 5.13gm 4/67 2.18gm 31/67
c 2117r 1.60gm 6.83gm 11/67 2.18gm 35/68
d 2117r 2.50gm 23.3gm 8/67 2.18gm 24/68
e 2117r 2.81gm 11.3gm 1/67 2.18gm 18/67
2,2'-METHYLENEBIS(4-METHYL-6-tert-BUTYLPHENOL) 119-47-1
264 2335m .899mg n.s.s. 0/5 5.00mg 0/5 15.0mg 0/5 50.Omg 0/5
265 2335n 7.71mg n.s.s. 0/20 5.00mg 0/19 15.Omg 0/19 50.0mg 0/20
266 2335m 7.20mg n.s.s. 0/5 4.00mg 0/5 12.0mg 0/5 40.0mg 1/5
a 2335m .719mg n.s.s. 0/5 4.00mg 0/5 12.0mg 0/5 40.0mg 0/5
267 2335n 3.30mg n.s.s. 15/20 4.00mg 11/20 12.0mg 15/20 (40.0mg 0/20)
a 2335n 114.mg n.s.s. 1/20 4.00mg 1/20 12.0mg 0/20 40.0mg 0/20
1-METHYLNAPHTHALENE 90-12-0
268 2115 399.mg n.s.s. 0/50
a 2115 983.mg n.s.s. 0/50
b 2115 581.mg n.s.s. 4/50
c 2115 1.12gm n.s.s. 1/50
d 2115 543.mg n.s.s. 5/50
e 2115 333.mg n.s.s. 14/50
269 2115 116.mg 610.mg 2/50
a 2115 133.mg 1.38gm 2/50
b 2115 555.mg n.s.s. 0/50
c 2115 244.mg n.s.s. 11/50
d 2115 1.31gm n.s.s. 9/50





































4-(METHYLNITROSAMINO)-1- (3-PYRIDYL) -1- (BUTANONE) *** (NNK) 64091-91-4
270 2209 .836mg n.s.s. 0/10 .136mg 0/20 .409mg 1/20
a 2209 .295mg n.s.s. 0/10 .136mg 0/20 .409mg 0/20
b 2209 .295mg n.s.s. 0/10 .136mg 0/20 .409mg 0/20
c 2209 .824mg n.s.s. 1/10 .136mg 1/20 .409mg 1/20
271 2232 44.3ug .124mg 1/18 .100mg 39/56
a 2232 89.4ug .304mg 0/18 .100mg 23/56
b 2232 .138mg n.s.s. 1/18 .100mg 16/56
c 2232 .337mg n.s.s. 0/16 .100mg 4/52
d 2232 .364mg n.s.s. 1/15 .100mg 5/55
e 2232 .951mg n.s.s. 3/16 .100mg 1/52
f 2232 .463mg n.s.s. 3/16 .100mg 5/52
Takagi; jtxs, 19, 77-89; 1994/pers .comm.




272 TR439 48.4mg 380.mg 6/49 6.41mg
a TR439 49.Omg 607.mg 9/49 6.41mg
b TR439 119.mg n.s.s. 1/49 6.41mg
c TR439 144.mg n.s.s. 1/49 6.41mg
d TR439 55.9mg n.s.s. 34/49 6.41mg
e TR439 49.Omg 607.mg 9/49 6.41mg
f TR439 119.mg n.s.s. 1/49 6.41mg
273 TR439 162.mg 8.06gm 0/50 5.90mg
a TR439 43.9mg n.s.s. 24/50 5.90mg
b TR439 43.9mg n.s.s. 24/50 5.90mg
c TR439 51.5mg n.s.s. 18/50 5.90mg
d TR439 78.4mg n.s.s. 10/50 5.90mg
e TR439 43.7mg n.s.s. 41/50 5.90mg
f TR439 43.9mg n.s.s. 24/50 5.90mg
g TR439 269.mg n.s.s. 16/50 5.90mg
274 TR439 58.6mg n.s.s. 46/50 4.93mg
a TR439 483.mg n.s.s. 0/50 4.93mg
275 TR439 37.3mg n.s.s. 43/50 3.97mg
a TR439 369.mg n.s.s. 0/50 3.97mg
MONOCHLOROACETIC ACID*** 79-11-8
276 2327 14.4mg n.s.s. 0/29 2.50mg







































0/32 25.Omg 0/32 57.2mg


































DeAngelo; jtxe, 52,425-445; 1997
NAFENOPIN*** 3771-19-5
277 2190 126.mg n.s.s. 0/9
278 2271 10.4mg 57.7mg 0/10
a 2271 39.9mg n.s.s. 0/10
b 2271 50.7mg n.s.s. 0/10
c 2271 69.7mg n.s.s. 0/10
279 2190 1.45mg 11.5mg 0/8
280 2180m 26.4mg n.s.s. 0/9
a 2180m 26.4mg n.s.s. 0/9
b 2180m 51.9mg n.s.s. 0/9
281 2180o 16.Omg 123.mg 0/11
a 2180o 22.2mg 383.mg 0/11
b 2180o 31.6mg n.s.s. 0/11
282 2180n 9.48mg 49.6mg 0/18
a 2180n 16.5mg 139.mg 0/18
b 2180n 22.3mg 507.mg 0/18
NALIDIXIC ACID*** 389-08-2
283 2294 478.mg n.s.s. 1/51
a 2294 1.05gm n.s.s. 0/51
b 2294 476.mg n.s.s. 7/51
c 2294 130.mg n.s.s. 36/51
284 2294 587.mg n.s.s. 0/49
a 2294 332.mg n.s.s. 4/49
b 2294 305.mg n.s.S. 8/49
c 2294 426.mg n.s.s. 4/49
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Brkly Code
565Spe Strain Site Xpo+Xpt
Sex Route Hist Notes
TD50 2Tailpvl
DR AuOp
e M m cdf eat tba tum 76w85 e
NEFIRACETAM
285 M f b6c eat liv hpa 24m24 e
a M f b6c eat liv hpc 24m24 e
b M f b6c eat lun a/a 24m24 e
c M f b6c eat lun a/c 24m24 e
286 M m b6c eat liv hpa 24m24 e
a M m b6c eat liv hpc 24m24 e
b M m b6c eat lun a/a 24m24 e
c M m b6c eat lun a/c 24m24 e
287 R f f3d eat liv hct 24m24 e
288 R m f3d eat liv hpa 24m24 e
no dre P=1.











NICKEL (II) SULFATE HEXAHYDRATE 10Ong* :-1,ug .... :. l 10 ..... :.100 .... :.-mg .... :10. 100.. g. 10
289 M f b6c inh TBA MXB 24m24 :> nc
a M f b6c inh liv MXB 24m24 nc
b M f b6c inh lun MXB 24m24 3.
290 M m b6c inh TBA MXB 24m24 :> nc
a M m b6c inh liv MXB 24m24 nc
b M m b6c inh lun MXB 24m24 nc
291 R f f34 inh TBA MXB 24m24 :> nc
a R f f34 inh liv MXB 24m24 nc
292 R m f34 inh TBA MXB 24m24 :> nc











NITRITE, SODIUM*** 10Ong.. :.lug .:* 10 -:*.100.* - -:*-mg. 110 0 .: 1° * : * 1°° - *: * - Lg. 1 0: * -1°
293 R m f3d wat for tum 51w51 Cer (.>) no dre
























294 M f b6c inh lun a/a 25m25 e
a M f b6c inh liv hpa 25m25 e
b M f b6c inh mgl adc 25m25 e
c M f b6c inh liv mix 25m25 e
d M f b6c inh lun a/c 25m25 e
e M f b6c inh thy fca 25m25 e
f M f b6c inh lun mix 25m25 e
g M f b6c inh liv hpc 25m25 e
295 M m b6c inh lun mix 25m25 e
a M m b6c inh lun a/a 25m25 e
b M m b6c inh thy fca 25m25 e
c M m b6c inh lun a/c 25m25 e
d M m b6c inh liv mix 25m25 e
e M m b6c inh liv hpc 25m25 e
f M m b6c inh liv hpa 25m25 e
296 R m cdr inh liv hpc 65w65 ek
a R m cdr inh liv hpa 65w65 ek
b R m cdr inh kid tla 65w65 ek
297 R m cdr inh liv mix 25m25 e
a R m cdr inh liv hpa 25m25 e
b R m cdr inh liv hpc 25m25 e
c R m cdr inh thy mix 25m25 e
d R m cdr inh thy fca 25m25 e
e R m cdr inh kid tla 25m25 e
f R m cdr inh kid tlc 25m25 e
g R m cdr inh thy fcc 25m25 e
h R m cdr inh kid mix 25m25 e
298 R f f34 inh ute esp 65w65 ek
a R f f34 inh liv mix 65w65 ek
b R f f34 inh kid mix 65w65 ek
c R f f34 inh thy fct 65w65 ek
299 R f f34 inh ute esp 25m25 e
a R f f34 inh thy mix 25m25 e
b R f f34 inh liv mix 25m25 e
c R f f34 inh thy fca 25m25 e
d R f f34 inh liv hpc 25m25 e
e R f f34 inh liv hpa 25m25 e
f R f f34 inh thy fdc 25m25 e
g R f f34 inh kid mix 25m25 e
300 R m f34 inh kid mix 65w65 ek
a R m f34 inh liv mix 65w65 ek
b R m f34 inh thy fct 65w65 ek
301 R m f34 inh liv mix 25m25 e
a R m f34 inh liv hpa 25m25 e
b R m f34 inh kid mix 25m25 e
c R m f34 inh kid tla 25m25 e
d R m f34 inh thy mix 25m25 e
e R m f34 inh thy fdc 25m25 e
f R m f34 inh liv hpc 25m25 e
g R m f34 inh thy fca 25m25 e
h R m f34 inh kid tlc 25m25 e
0Ong.. :* .lug -:*.1°0 .....* -.100.* - -:*.mg :*.10 . :*-100 . :* lg.....10
*- 46.3mg Z P<.09







200.mg * P<.03 +
238.mg * P<.02 +





















+ 35.9mg * P<.07 +
129.mg P<.04












68.7mg * P<.002 +
38.2mg * P<.02 +




NITROETHANE 10Ong*.:......10....... 1..100.... :1.-mg.... :. 10..... 100 °. :.-lg ..... 10
302 R f leb inh liv hpc 24m24 e .> 2.19gm * P<.3
303 R m leb inh liv tum 24m24 e .> no dre P=1.
NITROGEN DIOXIDE l0Ong..: * .lug ..- :* 1°0 - :..100.* - -:*-mg . - :*-10 -:*.1°00.* - -:*Ilg ..... :*.10
304 R m wis inh lun mix 73w73 er .> no dre P=1.
1-NITROPYRENE
305 R f f3j gav mgl mix 13m24
a R f f3j gav mgl adc 13m24
0Ong*. ._ug. - *10.. - :*-100 .- -:1.mg....: ..10*. ... :*100 . 10 . 10 :*Lg ..... :.*-1
+ 3.33mg * P<.002 +
4.82mg * P<.0005+
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RefNum LoConf UpConf Cntrl lDose lInc 2Dose 2Inc Citation or Pathology
Brkly Code






















































NICKEL (II) SULFATE HEXAHYDRATE 10101-97-0
289 TR454 .407mg n.s.s. 41/61 77.2ug 45/60 .158mg
a TR454 .573mg n.s.s. 18/61 77.2ug 28/60 .158mg
b TR454 .378mg n.s.s. 7/61 77.2ug 6/60 .158mg
290 TR454 .328mg n.s.s. 38/61 63.9ug 35/61 .131mg
a TR454 .398mg n.s.s. 26/61 63.9ug 18/61 .131mg
b TR454 .621mg n.s.s. 13/61 63.9ug 18/61 .131mg
291 TR454 31.3ug n.s.s. 49/53 8.82ug 52/53 18.4ug
a TR454 n.s.s. n.s.s. 0/53 8.82ug 0/53 18.4ug
292 TR454 16.9ug n.s.s. 50/54 6.13ug 50/53 12.8ug
a TR454 98.5ug n.s.s. 2/54 6.13ug 1/53 12.8ug
NITRITE, SODIUM*** 7632-00-0
293 2162 74.3mg n.s.s. 0/15
a 2162 74.3mg n.s.s. 0/15
NITROBENZENE 98-95-3
294 2213m 16.9mg n.s.s.
a 2213m 210.mg n.s.s.
b 2213m 250.mg n.s.s.
c 2213m 196.mg n.s.s.
d 2213m 361.mg n.s.s.
e 2213m 513.mg n.s.s.
f 2213m 493.mg n.s.s.
g 2213m 615.mg n.s.s.
295 2213m 88.Omg n.s.s.
a 2213m 108.mg n.s .s.
b 2213m 226.mg n.s.s.
c 2213m 231.mg n.s.s.
d 2213m 225.mg n.s.s.
e 2213m 345.mg n.s.s.
f 2213m 218.mg n.s.s.
296 2213r .171mg n.s.s.
a 2213r 3.87mg n.s.s.
b 2213r 3.87mg n.s.s.
297 2213s 14.4mg 226.mg
a 2213s 18.1mg 385.mg
b 2213s 36.6mg n.s.s.
c 2213s 29.3mg n.s.s.
d 2213s 34.4mg n.s.s.
e 2213s 83.Omg n.s.s.
f 2213s 86.7mg n.s.s.
g 2213s 49.9mg n.s.s.
h 2213s 83.2mg n.s.s.
298 2213n 1.79mg n.s.s.
a 2213n .245mg n.s.s.
b 2213n .245mg n.s.s.
c 2213n 7.59mg n.s.s.
299 2213o 13.1mg n.s.s.
a 2213o 38.9mg n.s.s.
b 2213o 39.7mg n.s.s.
c 2213o 47.9mg n.s.s.
d 2213n 60.9mg n.s.s.
e 2213o 48.3mg n.s.s.
f 2213o 64.Omg n.s.s.
g 2213o 3.72mg n.s.s.
300 2213n .171mg n.s.s.
a 2213n .171mg n.s.s.
b 2213n .171mg n.s.s.
301 2213o 9.08mg 46.8mg
a 2213o 10.1mg 50.9mg
b 2213o 23.2mg 205.mg
c 2213o 26.1mg 300.mg
d 2213o 15.6mg n.s.s.
e 2213o 20.5mg n.s.s.
f 2213o 22.5mg n.s.s.
g 2213o 30.2mg n.s.s.





















































302 2289 357.mg n.s.s. 0/40
303 2289 106.mg n.s.s. 0/40
NITROGEN DIOXIDE 10102-44-0
304 2325 20.2ug n.s.s. 0/10
1-NITROPYRENE 5522-43-0
305 2329 1.85mg 16.7mg 4/30














































































































































































































































































26.8mg 0/40 53.6mg 1/39
18.8mg 0/40 37.5mg 0/41
22.lug 0/10 .221mg 0/10 2.21mg 0/10
.755mg 13/40 1.51mg 21/40 3.02mg 22/46
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Sex Route Hist Notes
R f f3j gav cli sqc 13m24
R f f3j gav cli mix 13m24
R f f3j gav --- mnl 13m24
R f f3j gav mgl ade 13m24
R f f3j gav ute esp 13m24
R f f3j gav mgl fba 13m24
R f f3j gav cli adc 13m24




6.16mg * P<.003 +






N-NITROSO-N-METHYLUREA' 10Ong* :_*ug ....... ...... . 100. . 10 ..... :..100 . ... :1.0 Lo
306 M m c3h wat lun ade 30w54 e + .794mg Z P<.003
a M m c3h wat spl hms 30w54 e 1.23mg * P<.0005+
b M m c3h wat stg adc 30w54 e 6.19mg * P<.004 +
c M m c3h wat liv nnd 30w54 e 2.53mg Z P<.5
d M m c3h wat liv hpc 30w54 e no dre P=1.
307 P b cym eat ugi sqc 18y22 jw : + 4.52mg P<.0005+
P b cym eat eso mix 18y22 jw
P b cym eat eso sqc 18y22 jw
P b cym eat orc mix 18y22 jw
P b cym eat phr sqc 18y22 jw
P b cym eat pls sqc 18y22 jw
P b cym eat ton sqp 18y22 jw
P b cym eat sku rhb 18y22 jw
P b cym eat eso sqp 18y22 jw
P b cym eat col lei 18y22 jw
P b cym eat sto adc 18y22 jw
P b cym eat hea rhm 18y22 jw
P b cym eat tba mix 18y22 jw
P b cym eat tba mal 18y22 jw
P b cym eat tba ben 18y22 jw
P b rhe eat ugi sqc 18y22 jw
P b rhe eat eso sqc 18y22 jw
P b rhe eat orc mix 18y22 jw
P b rhe eat phr sqc 18y22 jw
P b rhe eat epg sqc 18y22 jw
P b rhe eat sto adc 18y22 jw
P b rhe eat gnv sqc 18y22 jw
P b rhe eat lar sqc 18y22 jw
P b rhe eat chp sqc 18y22 jw
P b rhe eat pls sqc 18y22 jw
P b rhe eat ton sqc 18y22 jw



























N-NITROSODIETHYLAMINE*** 10Ong.. :. .lug .............100 . . . . :..-mg ..10. 1 :100 .. :..ig... 10 :10
309 N b bbb ipj nac mec 32m32 jw (+) 12.2ug
N b bbb ipj liv hpc 32m32 jw
N b bbb ipj tba mal 32m32 Wjw
P b cym ipj liv hpc 16y16 jw
P b cym ipj tba mal 16y16 Wjw
P b cym eat liv hpc 16yl6 jw
P b cym eat tba mal 16yl6 Wjw










































a P b rhe ipj liv bda 20y20 jw
b P b rhe ipj tba mix 20y20 Wjw
c P b rhe ipj tba mal 20y20 Wjw
d P b rhe ipj tba ben 20y20 Wjw
313 P b rhe eat liv hpc 22y22 jw
a P b rhe eat tba mal 22y22 Wjw
314 R f clw wat liv mxp 41m41
a R f clw wat liv hct 41m41
b R f clw wat liv hpc 41m41
c R f clw wat eso mix 41m41
d R f clw wat liv bdh 41m41










.203mg Z P<. 0005+
.561mg * P<.0005
.562mg * P<.0005
f R f clw wat eso mal 41m41 .729mg Z P<. 0005+
g R f clw wat liv bdm 41m41 no dre P=1.
315 R m clw wat liv mxp 40m40 52.Oug Z P<.0005+

























































306 2182 .380mg 3.14mg
a 2182 .814mg 3.95mg
b 2182 3.10mg 36.2mg
c 2182 .538mg n.s.s.
d 2182 16.7mg n.s.s.




































































3/40 1.51mg 9/40 3.02mg
4/40 1.51mg 11/40 3.02mg
23/40 1.51mg 22/40 3.02mg
0/40 1.51mg 0/40 3.02mg
10/40 1.51mg 14/40 3.02mg
11/40 1.51mg 11/40 3.02mg
0/40 1.51mg 1/40 3.02mg
1/40 1.51mg 1/40 3.02mg
10/21 (5.56mg 6/21 ll.lmg
8/21 5.56mg 18/21 11.lmg
1/21 5.56mg 3/21 11.lmg
9/21 (5.56mg 2/21 ll.lmg












































rgeirsson 1994/Dalgard 1997/Thorgeirsson&Seiber pers.comm.
N-NITROSODIETHYLAMINE*** (DEN) 55-18-5
309 2001s 3.36ug 46.Oug 0/9 .897mg 10/13
a 2001s 3.57ug 1.03mg 0/9 .897mg 2/3
b 2001s 3.36ug 46.Oug 0/9 .897mg 10/13
310 2004m 944.ng 22.Oug 0/105 6.3Oug 2/7 .322mg
a 2004m 944.ng 22.Oug 0/105 6.3Oug 2/7 .322mg
311 2004n 1.01mg 4.45mg 0/104 8.07mg 13/16
a 2004n 1.01mg 4.45mg 0/104 8.07mg 13/16
312 2004m 10.lug 59.9ug 0/120 7.4Oug 0/4 80.Oug
2.09mg 51/53
a 2004m 4.4Oug n.s.s. 0/23 7.4Oug -/- 80.Oug
2.09mg -/-
b 2004m 8.79ug 43.7ug 9/120 7.4Oug 0/4 80.Oug
2.09mg 51/53
c 2004m 9.66ug 55.5ug 4/120 7.4Oug 0/4 80.Oug
2.09mg 51/53
d 2004m .130mg n.s.s. 6/108 7,4Oug 0/4 80.Oug
2.09mg 0/45
313 2004n 1.04mg 5.88mg 0/102 6.87mg 11/14
a 2004n .620mg 4.89mg 5/102 6.87mg 11/14
314 2259 37.5ug 64.7ug 16/240 2.0Oug 6/60 4.0Oug
72.Oug 35/60 .107mg 44/60
.287mg 49/60 .358mg 52/60
a 2259 46.6ug 80.8ug 11/240 2.OOug 4/60 4.OOug
72.Oug 31/60 .107mg 42/60
.287mg 48/60 .358mg 50/60
b 2259 75.3ug .139mg 2/240 2.OOug 0/60 4.OOug
72.Oug 22/60 .107mg 39/60
.287mg 46/60 .358mg 47/60
c 2259 .162mg .250mg 0/240 2.OOug 0/60 4.OOug
72.Oug 19/60 .107mg 21/60
.287mg 37/60 .358mg 44/60
d 2259 .200mg 2.73mg 4/240 2.0Oug 2/60 4.0Oug
72.Oug 2/60 .107mg 2/60
.287mg 0/60 .358mg 1/60
e 2259 .210mg 2.63mg 3/240 2.0Oug 2/60 4.0Oug
72.Oug 2/60 .107mg 2/60
.287mg 0/60 .358mg 1/60
f 2259 .531mg .992mg 0/240 2.0Oug 0/60 4.OOug
72.Oug 2/60 .107mg 8/60
.287mg 11/60 .358mg 18/60
g 2259 .657mg n.s.s. 1/240 2.OOug 0/60 4.OOug
72.Oug 0/60 .107mg 0/60
.287mg 0/60 .358mg 0/60
315 2259 37.3ug 72.lug 13/240 1.OOug 4/60 3.OOug
41.Oug 15/60 61.Oug 25/60
.163mg 31/60 .204mg 29/60
Adamson;ossc, 129-156;
1982/Thorgeirsson 1994/Dalgard 1997/Thorgeirsson&Seiber pers.comm.
3/3 .910mg 5/5 1.35mg 5/5 2.29mg 38/40
3/3 .910mg 5/5 1.35mg 5/5 2.29mg 38/40
4/8 .340mg 6/6 .650mg 5/5 1.59mg 6/6
1/1 .340mg -/- .650mg -/- 1.59mg -/-
5/8 .340mg 6/6 .650mg 5/5 1.59mg 6/6
4/8 .340mg 6/6 .650mg 5/5 1.59mg 6/6
1/8 .340mg 0/6 .650mg 0/5 1.59mg 0/6
4/60 9.0Oug 4/60 18.Oug 7/60 36.Oug 12/60
.143mg 47/66 .179mg 47/60 .215mg 46/60














































































































569Spe Strain Site Xpo+Xpt
Sex Route Hist Notes
R m clw wat liv hct 40m40
R m clw wat eso mix 40m40
R m clw wat liv hpc 40m40
R m clw wat eso mal 40m40
R m clw wat liv bdh 40m40
R m clw wat liv bdb 40m40
R m clw wat nsp mix 40m40









2.74mg * P< .0005
5.87mg * P<.02
N-NITROSODIMETHYLAMINE 10Ong..:. .lug .... :..10 ..... :..100.* *mg ..10. 10 g. :*1°° :**19 :**10
316 P b rhe ipj tba mal lOylO Wjw (:>) no dre P=1.
317 R f clw wat liv mxp 41m41 :-+: 42.4ug Z P<.0005+
R f clw wat liv bdh 41m41
R f clw wat liv bdb 41m41
R f clw wat liv hct 41m41
R f clw wat liv hpc 41m41
R f clw wat liv mmx 41m41
R f clw wat liv bdm 41m41
R m clw wat liv mxp 41m41
R m clw wat liv hct 41m41
R m clw wat liv hpc 41m41
R m clw wat liv bdh 41m41
R m clw wat liv bdb 41m41
R m clw wat liv mmx 41m41
R m clw wat lun mix 41m41















N-NIT ROSODIPROPYLAMINE*** lOOng .. : Jug .... :i.n1 ... n1 ° .. :lmg 1: .10 -: ... - - :* 10
319 P b rhe ipj liv hpc 31m31 jw : +) 12. lug
a P b rhe ipj tba mal 31m31 Wjw 12. lug
N-NITROSOHEXAMETHYLENEIMINE** 10Ong. .:.. ju 10 1g ._lug -. : - ...... ..1 .AM ..10..... :..*1°° :. .lmg .:1°... :.*1O-.:*l -. ***:.*1°
320 M f bal gav liv mix 30w49 e (+) .797mg
a M f bal gav nac mix 30w49 e 4.50mg
b M f bal gav lun mix 30w49 e 7.44mg
c M f bal gav eso sqp 30w49 e 19. 7mg
d M f bal gav for mix 30w49 e no dre
321 M f cdl gav liv mix 30w62 e + .746mg
a M f cdl gav lun mix 30w62 e 2.71mg
b M f cdl gav for mix 30w62 e 5.65mg
c M f cdl gav eso sqp 30w62 e 12.7mg
d M f cdl gav nac tum 30w62 e 26.Omg
322 M f sen gav lun mix 30w67 e + .783mg






















































RefNum LoConf UpConf Cntrl lDose lInc 2Dose 2Inc Citation or Pathology
a 2259 62.4ug .133mg
b 2259 77.7ug .115mg
c 2259 89.6ug .198mg
d 2259 .185mg .300mg
e 2259 .150mg 1.15mg
f 2259 .160mg 1.50mg
g 2259 .967mg 9.63mg

















































2/60 5.OOug 3/60 10.Oug
82.Oug 10/60 .102mg 21/60
.245mg 28/60 .326mg 28/60
0/60 5.OOug 0/60 10.Oug
82.Oug 37/60 .102mg 45/60
.245mg 46/60 .326mg 47/60
0/60 5.0Oug 1/60 1O.Oug
82.Oug 8/60 .102mg 18/60
.245mg 28/60 .326mg 28/60
0/60 5.OOug 0/60 1OOug
82.Oug 23/60 .102mg 25/60
.245mg 21/60 .326mg 25/60
0/60 5.OOug 1/60 10.Oug
82.Oug 1/60 .102mg 2/60
.245mg 0/60 .326mg 0/60
0/60 5.0Oug 1/60 1O.Oug
82.Oug 1/60 .102mg 2/60
.245mg 0/60 .326mg 0/60
0/60 5.OOug 0/60 10.Oug
82.Oug 1/60 .102mg 1/60
.245mg 0/60 .326mg 0/60
0/60 5.OOug 0/60 1O.Oug
82.Oug 0/60 .102mg 0/60


























316 2004 .109mg n.s.s. 1/74 1.01mg
317 2259 34.lug 52.8ug 16/240 1.OOug
41.Oug 18/60
.163mg 56/60
a 2259 59.Oug 96.8ug
b 2259 58.Sug 97.6ug
c 2259 92.8ug .226mg
d 2259 .135mg .396mg
e 2259 .356mg 2.01mg
f 2259 .881mg n.s.s.
318 2259 68.4ug .111mg
a 2259 .110mg .224mg
b 2259 .149mg .303mg
c 2259 .188mg .470mg
d 2259 .191mg .479mg
e 2259 .377mg 1.04mg
f 2259 .529mg 5.24mg
g 2259 5.66mg n.s.s.
N-NITROSODIPROPYLAMINE***
319 2004 3.14ug 59.5ug





























































































1982/Thorgeirsson 1994/Dalgard 1997/Thorgeirsson&Seiber pers.comm.
6/60 5.0Oug 5/60 1O.Oug 7/60 20.Oug 12/60
82.Oug 43/60 .102mg 51/60 .122mg 55/60

































































































































1982/Thorgeirsson 1994/Dalgard 1997/Thorgeirsson&Seiber pers.comm.
N-NITROSOHEXAMETHYLENEIMINE*** 932-83-2
320 2207o .402mg 1.81mg 0/19 7.00mg
a 22070 1.55mg n.s.s. 0/19 7.00mg
b 2207o 1.42mg n.s.s. 4/19 7.00mg
c 2207o 3.20mg n.s.s. 0/19 7.00mg
d 2207o 4.03mg n.s.s. 2/19 7.00mg
321 2207m .361mg 1.82mg 2/20 5.49mg
a 2207m 1.11mg n.s.s. 2/20 5.49mg
b 2207m 1.85mg n.s.s. 1/20 5.49mg
c 2207m 3.11mg n.s.s. 0/20 5.49mg
d 2207m 4.24mg n.s.s. 0/20 5.49mg
322 2207n .385mg 1.79mg 1/20 5.08mg
a 2207n .851mg 13.4mg 3/20 5.08mg
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b M f sen gav for mix 30w67 e
c M f sen gav eso sqp 30w67 e






N-NITROSOPIPERIDINE ** 10Ong..:_ jug . * :.* *10-* *:*.100.° *. *:*mg.... :.* 10.- * :**100.* * *:*lg ..... :*.10
323 P b cym eat liv hpc 12y12 jw + 12.1mg P<.0005+
P b cym eat liv hes 12y12 jw
P b cym eat tba mal 12y12 Wjw
P b rhe eat liv hpc 12y12 jw
P b rhe eat tba mal 12y12 Wjw
P b rhe ipj liv hpc 20y20 jw
P b rhe ipj bil hit 20y20 jw
P b rhe ipj tba mix 20y20 Wjw
P b rhe ipj tba mal 20y20 Wjw



















OCTACHLOROSTYRENE** 10Ong. .:. 1ug . 10.... ...::.:-100 .... :..-jsg ..1° - :. 100 . :.*j-lg ..... 10
326 M m c5c eat liv hnd 78w78 r .> no dre P=1.
OLTIPRAZ 10Ong. : ...Jug - :*.1°0 -:*.100 .- .--:.-lng .... :.* -10*- -:*.100 .- .--:j*-g ..... 10
327 R m f34 eat --- lym 52w52 er .> no dre P=1.
OROTIC ACID, MONOSODIUM SALT
328 R m f34 eat liv hpa 52w52 ek
329 R m f34 eat liv hpa 24m24 e
a R m f34 eat --- leu 24m24 e
b R m f34 eat zym tum 24m24 e
gamma-ORYZANOL
330 M f b6c eat --- mly 78w79 e
a M b6c eat liv hpc 78w79 e
b M f b6c eat liv nnd 78w79 e
c M f b6c eat lun a/a 78w79 e
331 M m b6c eat --- mly 78w79 e
a M m b6c eat liv hpc 78w79 e
b M m b6c eat liv nnd 78w79 e
c M m b6c eat lun a/a 78w79 e
d M m b6c eat lun acb 78w79 e
332 R f f3d eat liv nnd 24m24 e
333 R m f3d eat liv nnd 24m24 e
OXOLINIC ACID
334 M f icm eat lun ade 78w78 e
a M f icm eat liv hpa 78w78 e
b M f icm eat lun adc 78w78 e
c M f icm eat tba ben 78w78 e
d M f icm eat tba mal 78w78 e
e M f icm eat tba mix 78w78 e
335 M m icm eat liv hpa 78w78 e
a M m icm eat lun adc 78w78 e
b M m icm eat lun ade 78w78 e
c M m icm eat liv hpc 78w78 e
d M m icm eat tba mix 78w78 e
e M m icm eat tba ben 78w78 e
f M m icm eat tba mal 78w78 e
336 R f wis eat liv hpc 24m24 e
a R f wis eat tba mix 24m24 e
b R f wis eat tba ben 24m24 e
c R f wis eat tba mal 24m24 e
337 R m wis eat tes lya 52w52 er
338 R m wis eat tes lya 78w78 er
339 R m wis eat tes lya 24m24 e
a R m wis eat liv nnd 24m24 e
b R m wis eat tba mal 24m24 e
c R m wis eat tba ben 24m24 e
d R m wis eat tba mix 24m24 e
OZONE***
340 R m sda inh lun ade 86w86 Cr
341 R m wis inh lun mix 13m24 er
PHENAZONE* * *
342 R m sda eat k/p mix 88w88 e
a R m sda eat liv tum 88w88 e
b R m sda eat ubl mix 88w88 e
PHENETHYL ISOTHIOCYANATE
343 R m f34 eat pae mix 26m26 e
a R m f34 eat pae ana 26m26 e
b R m f34 eat pae mal 26m26 e
c R m f34 eat liv mix 26m26 e
d R m f34 eat pni isa 26m26 e


























































.. *:*10. -*--100 ....*:*. L g 10 - . 10g. ..:.- * *:*.*g -.. :..10
204mg Pc.3
o dre P=1.


















PHENOBARBITAL*** 1Ong. :. .lug :.* *10-* *:*.100 *:*.1gmg : ....10:*.100 ....*:..,g ..... :,10
344 R f f34 eat liv hct 89w91 r . 46.5mg P<.06
345 R m f34 eat liv hct 89w91 r .> 328.mg P<.8
PHENOBARBITAL, SODIUM*** 100ng..:. jug .... : 1°0 ..... :..100. 1.:.* ng 100..: 1.
346 M m b6c wat liv hpa 61w61 er .> no dre
a M m b6c wat liv hpc 61w61 er no dre
347 M m cb6 eat liv esn 60w60 kr 184.mg



















RefNum LoConf UpConf Cntrl lDose 1Inc 2Dose 2Inc Citation or Pathology
Brkly Code
b 2207n 1.03mg 9.43mg 1/20 5.08mg 10/20
c 2207n 2.23mg n.s.s. 0/20 5.08mg 4/20
d 2207n 2.23mg n.s.s. 0/20 5.08mg 4/20
N-NITROSOPIPERIDINE*** 100-75-4
323 2004 3.30mg 56.7mg 0/62 176.mg
a 2004 3.53mg 5.75gm 0/35
b 2004 3.30mg 56.7mg 0/62
324 2004 2.35mg 29.5mg 0/94
a 2004 3.04mg 46.4mg 2/94
325 2004m .454mg 11.7mg 0/69
a 2004m .174mg n.s.s. 0/23
b 2004m .279mg 11.5mg 9/108
c 2004m .353mg 20.4mg 4/74





















326 2212 13.9mg n.s.s. 0/8 12.Omg 0/10
OLTIPRAZ 64224-21-1
327 2300 9.89mg n.s.s. 0/12 16.Omg 0/12
OROTIC ACID, MONOSODIUM SALT 154-85-8
328 2126m 150.mg n.s.s. 0/8
329 2126n 189.mg 1.31gm 0/11
a 2126n 509.mg n.s.s. 0/11






1982/Thorgeirsson 1994/Dalgard 1997/Thorgeirsson&Seiber pers.comm.
Smith;clet, 81,145-150; 1994
Rao;canr, 56, 3395-3398; 1996/pers .comm.
Laconi;carc, 14,1901-1905;1993/pers.comm.
gamma-ORYZANOL 11042-64-1
330 2092 2.23gm n.s.s.
a 2092 11.7gm n.s.s.
b 2092 5.44gm n.s.s.
c 2092 8.44gm n.s.s.
331 2092 3.97gm n.s.s.
a 2092 7.14gm n.s.s.
b 2092 3.02gm n.s.s.
c 2092 6.36gm n.s.s.
d 2092 7.14gm n.s.s.
332 2091 20.8gm n.s.s.
333 2091 11.2gm n.s.s.
OXOLINIC ACID 14698-29-4
334 2151o 20.8mg n.s.s.
a 2151o 173.mg n.s.s.
b 21510 141.mg n.s.s.
c 2151o 132.mg n.s.s.
d 2151o 76.4mg n.s.a.
e 2151o 66.0mg n.s.s.
335 2151o 118.mg n.s.s.
a 2151o 134.mg n.s.s.
b 2151o 147.mg n.s.s.
c 21510 337.mg n.s.s.
d 21510 108.mg n.s.s.
e 2151o 119.mg n.s.s.
f 21510 138.mg n.s.s.
336 2151o 398.mg n.s.s.
a 21510 18.6mg n.s.s.
b 2151o 34.Omg n.s.s.
c 2151o 129.mg n.s.s.
337 2151m .432mg n.s.s.
338 2151n .973mg n.s.s.
339 2151o 73.4mg 1.39gm
a 21510 178.mg n.s.s.
b 2151o 87.1mg n.s.s.
c 21510 58.4mg n.s.s.


































































































































3/47 1.97gm 9/50 Tamagawa; fctx, 30, 49-56;1992
2/45 1.97gm 2/48

















































Yamada; fctx, 32,397-408; 1994
OZONE*** 10028-15-6
340 2160 33.lug n.s.s. 0/15
341 2317 48.2ug n.s.s. 0/35
PHENAZONE*** 60-80-0
342 2211 821.mg n.s.s. 0/30
a 2211 821.mg n.s.s. 0/30
b 2211 821.mg n.s.s. 0/30
PHENETHYL ISOTHIOCYANATE
343 2232 18.7mg n.s.s.
a 2232 23.0mg n.s.s.
b 2232 39.2mg n.s.s.
c 2232 51.1mg n.s.s.









Ito;extp, 46, 1-6; 1994
Ichinose;txcy, 74,173-184; 1992








PHENOBARBITAL* ** (phenobarbitone) 50-06-6
344 2219 12.5mg n.s.s. 1/24 24.4mg 3/11
345 2219 22.7mg n.s.s. 1/21 19.6mg 1/13
PHENOBARBITAL, SODIUM*** (phenobarbitone, sodium) 57-30-7
346 2071 62.Omg n.s.s. 2/22 83.3mg 2/22
a 2071 130.mg n.s.a. 0/22 83.3mg 0/22
347 2186n 45.2mg n.s.s. 0/20 85.0mg 2/20
a 2186n 117.mg n.s.s. 0/20 85.0mg 0/20
Hecht;cebp, 5,645-652;1996
Zavanella; carc, 15, 2531-2539; 1994/pers comm.
Herren-Freund;txap, 90, 183-189; 1987
Evans;txpy,20, 585-594;1992/pers.comm.
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Sex Route Hist Notes
TD50 2Tailpvl
DR AuOp
M m cb6 eat liv hpc 60w60 kr
M m cb6 eat liv bsn 80w80 kr
M m cb6 eat liv esn 80w80 kr
M m cb6 eat liv hpc 80w80 kr
M m cb6 eat liv esn 14m23 er
M m cb6 eat liv hpc 14m23 er
M m cb6 eat liv bsn 14m23 er
M m cb6 eat liv esn 23m23 er
M m cb6 eat liv bsn 23m23 er
M m cb6 eat liv hpc 23m23 er
M m chh eat liv esn 55w55 ejkr
M m chh eat liv bsn 55w55 ejkr
M m chh eat liv hpc 55w55 ejkr
M m chh eat liv esn 65w65 ejkr
M m chh eat liv bsn 65w65 ejkr
M m chh eat liv hpc 65w65 ejkr
M m chh eat liv esn 23m23 ejr
M m chh eat liv bsn 23m23 ejr
M m chh eat liv hpc 23m23 ejr
M m chh eat liv esn 60w60 kr
M m chh eat liv hpc 60w60 kr
M m chh eat liv bsn 60w60 kr
M m chh eat liv esn 80w80 kr
M m chh eat liv hpc 80w80 kr
M m chh eat liv bsn 80w80 kr
M m chh eat liv esn 60w91 er
M m chh eat liv bsn 60w91 er
M m chh eat liv hpc 60w91 er
M m chh eat liv esn 91w91 er
M m chh eat liv hpc 91w91 er
M m chh eat liv bsn 91w91 er
PHENOLPHTHALEIN
358 M f b6c eat MXB MXB 24m24
a M f b6c eat --- mly 24m24
b M f b6c eat --- lmt 24m24
c M f b6c eat ova MXA 24m24
d M f b6c eat --- hcs 24m24
e M f b6c eat TBA MXB 24m24
f M f b6c eat liv MXB 24m24
g M f b6c eat lun MXB 24m24
359 M m b6c eat --- MXB 24m24
a M m b6c eat spl hes 24m24
b M m b6c eat --- hcs 24m24
c M m b6c eat --- lmt 24m24
d M m b6c eat TBA MXB 24m24
e M m b6c eat liv MXB 24m24
f M m b6c eat lun MXB 24m24
360 R f f34 eat amd MXA 24m24
a R f f34 eat amd MXA 24m24
b R f f34 eat TBA MXB 24m24
c R f f34 eat liv MXB 24m24
361 R m f34 eat MXB MXB 24m24
a R m f34 eat amd MXA 24m24
b R m f34 eat amd MXA 24m24
c R m f34 eat kid MXA 24m24
d R m f34 eat kid rua 24m24
e R m f34 eat thy MXA 24m24
f R m f34 eat TBA MXB 24m24
g R m f34 eat liv MXB 24m24
362 R m f34 eat kid MXA 24m24
a R m f34 eat kid rua 24m24
6-PHENYLHEXYL ISOTHIOCYANATE
363 R m f34 eat pae ana 26m26 e
a R m f34 eat pni isa 26m26 e
b R m f34 eat liv hpc 26m26 e
c R m f34 eat liv hpa 26m26 e
lOOng.. : Jug .... :.* -10.* - :*100.- .- -:1*mg - :*.1°0.- -:*1°° -:l*lg
..... :.*10
+ 508.mg Z P<.0005
748.mg Z P<.003 c
1.61gm Z P<.003 c





:+ : 1.15gm Z P<.0005
1.64gm Z Pa.006
2.68gm * P<.0005c




3.53gm Z P<.08 p
4.16gm Z P<.2 p
no dre P=1.
no dre P=1.
:+ : 250.mg Z P<.003
517.mg Z P<.006 c
533.mg Z P<.007
3.22gm * P< .005 c




with step + 975.mg * P<.0005c
1.04gm * P<.0005c
OOng. lug .... -10 *....:* 100 ....:1*-mg ...:.10 *....:..100 g. . 1




PhIP.HCl*** 100ng..:. .ug.... .10......1,00.... .1mg.. 10 :1g00
364 R m f34 eat --- lym 52w52 ersv . + .789mg
a R m f34 eat thm lym 52w52 ersv 1.07mg
b R m f34 eat itn mix 52w52 ersv 3.36mg
c R m f34 eat smi tum 52w52 ersv 5.06mg
d R m f34 eat col tum 52w52 ersv 12.6mg
365 R f f3d eat mgl adc 52w52 Cej + 5.45mg
a R f f3d eat col adc 52w52 Cej 49.7mg
b R f f3d eat liv tum 52w52 Cej no dre
366 R f f3d eat mgl adc 24m24 ej + 6.34mg
a R f f3d eat col adc 24m24 ej 30.4mg
b R f f3d eat liv nnd 24m24 ej no dre
c R f f3d eat mgl ade 24m24 ej no dre
d R f f3d eat mgl fba 24m24 ej no dre
367 R f f3d eat mgl adc 54w54 er + 3.62mg
a R f f3d eat col ade 54w54 er 17.5mg
b R f f3d eat mgl fba 54w54 er 17.5mg
368 R f f3d eat mgl mix 52w52 e + 2.87mg
a R f f3d eat mgl adc 52w52 e 3.35mg
b R f f3d eat lgi mix 52w52 e 16.3mg
c R f f3d eat mgl fba 52w52 e 16.3mg
d R f f3d eat lgi car 52w52 e 30.Omg
e R f f3d eat lgi ade 52w52 e 30.0mg
































































































































































































































358 TR465 296.mg 1.53gm 15/50
a TR465 394.mg 4.88gm 15/50
b TR465 859.mg 8.28gm 1/50
c TR465 1.0Ogm 8.68gm 0/50
d TR465 2.27gm 11.7gm 0/50
e TR465 642.mg n.s.s. 40/50
f TR465 3.96gm n.s.s. 21/50
g TR465 2.56gm n.s.s. 6/50
359 TR465 689.mg 2.53gm 1/50
a TR465 621.mg 16.2gm 0/50
b TR465 1.57gm 7.81gm 1/50
c TR465 1.37gm 11.lgm 0/50
d TR465 1.07gm n.s.s. 40/50
e TR465 3.89gm n.s.s. 27/50
f TR465 1.88gm n.s.s. 11/50
360 TR465 1.47gm n.s.s. 3/50
a TR465 1.60gm n.s.s. 3/50
b TR465 1.91gm n.s.s. 49/50
c TR465 9.90gm n.s.s. 0/50
361 TR465 123.mg 1.42gm 17/50
a TR465 257.mg 5.97gm 17/50
b TR465 261.mg 8.35gm 18/50
c TR465 1.68gm 35.5gm 0/50
d TR465 1.97gm 134.gm 0/50
e TR465 2.74gm n.s.s. 0/50
f TR465 703.mg n.s.s. 47/50
g TR465 5.67gm n.s.s. 1/50
362 TR465 609.mg 2.29gm 1/50











































































































363 2287 14.3mg n.s.s. 3/16 8.76mg 3/17
a 2287 21.3mg n.s.s. 1/16 8.76mg 1/17
b 2287 41.9mg n.s.s. 0/15 8.76mg 0/20


























.475mg 1.41mg 0/12 6.38mg 27/36
.637mg 2.06mg 0/12 6.38mg 23/36
1.63mg n.s.s. 0/12 6.38mg 10/36
2.18mg n.s.s. 0/12 6.38mg 7/36
3.80mg n.s.s. 0/12 6.38mg 3/36
2.90mg 12.Omg 0/40 20.Omg 14/30
12.2mg n.s.s. 0/40 20.Omg 2/30
30.9mg n.s.s. 0/40 20.Omg 0/30
3.51mg 13.1mg 0/30 1.25mg 2/30 5.00mg 14/30
10.5mg 584.mg 0/30 1.25mg 0/30 5.00mg 4/30
28.8mg n.s.s. 2/30 1.25mg 2/30 5.00mg 0/30
20.3mg n.s.s. 3/30 1.25mg 4/30 5.00mg 1/30
3.19mg n.s.s. 8/30 1.25mg 5/30 (5.00mg 1/30)
1.62mg 11.4mg 0/20 10.Omg 8/20
4.31mg n.s.s. 0/20 10.Omg 2/20
4.31mg n.s.s. 0/20 10.Omg 2/20
1.33mg 13.8mg 0/10 10.Omg 9/20
1.50mg 28.Omg 0/10 10.Omg 8/20
3.99mg n.s.s. 0/10 10.Omg 2/20
3.99mg n.s.s. 0/10 10.Omg 2/20
4.88mg n.s.s. 0/10 10.Omg 1/18
4.88mg n.s.s. 0/10 10.Omg 1/18
10.3mg n.s.s. 0/10 10.Omg 0/20
Environmental Health Perspectives * Vol 107, Supplement 4 * August 1999
Hecht; carc, 17,2061-2067;1996
Rao;canr, 56, 3395-3398;1996/pers .comm.
Ito;carc,12,1503-1506;1991/Shirai 1997/pers.comm.
Hasegawa;carc,14,2553-2557;1993/pers.comm.
Hasegawa;carc, 16, 2243-2246; 1995/pers .comm.
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R m f3d eat pro car 52w52 Cej
R m f3d eat col adc 52w52 Cej
R m f3d eat liv tum 52w52 Cej
R m f3d eat --- lle 24m24 ej
R m f3d eat col adc 24m24 ej
R m f3d eat liv nnd 24m24 ej
R m f3d eat mgl fba 24m24 ej
R f sdj eat mgl mix 48w48 Cer
R f sdj eat mgl adc 48w48 Cer
R f sdj eat mgl dpp 48w48 Cer
R f sdj eat mgl fba 48w48 Cer
R f sdj eat mgl mix 48w48 Cer
R f sdj eat mgl adc 48w48 Cer
R f sdj eat mgl fba 48w48 Cer
R f sdj eat mgl dpp 48w48 Cer
PIPERONYL BUTOXIDE* * *
373 M f cdl eat liv mix 52w52 e
a M f cdl eat liv hpc 52w52 e
b M f cdl eat liv hpa 52w52 e
374 M m cdl eat liv mix 52w52 e
a M m cdl eat liv hpc 52w52 e
b M m cdl eat liv hpa 52w52 e
375 R f f3d eat liv hct 96w96 e
a R f f3d eat liv hpc 96w96 e
b R f f3d eat liv hpa 96w96 e
c R f f3d eat liv ccy 96w96 e
376 R m f3d eat liv hct 95w95 e
a R m f3d eat liv hpc 95w95 e
b R m f3d eat liv hpa 95w95 e
c R m f3d eat liv ccy 95w95 e
POLICOSANOL
377 M f swi gav liv hpa 78w78 De
a M f swi gav lun ade 78w78 De
b M f swi gav lun adc 78w78 De
c M f swi gav liv hpc 78w78 De
d M f swi gav liv mix 78w78 De
378 M m swi gav liv hpc 78w78 De
a M m swi gav lun adc 78w78 De
b M m swi gav lun ade 78w78 De
c M m swi gav liv hpa 78w78 De
d M m swi gav liv mix 78w78 De
379 R f sda gav liv hct 24m24 De
380 R f sda gav liv tum 52w52 D
a R f sda gav tba tum 52w52 D
381 R m sda gav tyf mca 24m24 De
a R m sda gav liv hct 24m24 De
382 R m sda gav liv tum 52w52 D
a R m sda gav tba tum 52w52 D
POTASSIUM BICARBONATE
383 R f wsr eat ubl tpp 78w78 ekr
a R f wsr eat ubl tcc 78w78 ekr
384 R f wsr eat ubl mix 30m30 er
a R f wsr eat ubl tpp 30m30 er
b R f wsr eat ubl tcc 30m30 er
385 R m wsr eat ubl mix 78w78 ekr
a R m wsr eat ubl tcc 78w78 ekr
b R m wsr eat ubl tpp 78w78 ekr
386 R m wsr eat ubl mix 28m28 er
a R m wsr eat ubl tpp 28m28 er












.797mg * P<.005 +




10Ong*.:_*ug .... .... :u. 10 100 .... :1*-mg. . . .1 :01° - .1°* - :* lg ..... :*-1°

















































100ng. .:_*lug........... :.-100.... :1.img ....:10. 10 :1 ° . :*lg .....* -.10
±8.28gm * P<.1
no dre P=1.
+hist 12.8gm * P<.0005+
+hist 20.7gm * P<.004 +
+hist 37.1gm * P<.04 +
.> 6.40gm * P<.3
12.9gm * P<.3
13.1gm * P=1.
+hist 13.2gm * P<.05 +
+hist 17.8gm * P<.1 +
+hist 54.4gm * P<.3 +
POTASSIUM CHLORIDE*** 10Ong..: .*-ug .ug .: ....10:*.100 - :*.1,mg . : ...10.. :*-1°00.* - -:*lg ..... :*.10
387 R f wsr eat ubl mix 78w78 ekr .> no dre
388 R f wsr eat ubl tpp 30m30 er 79.5gm
a R f wsr eat ubl tcc 30m30 er no dre
389 R m wsr eat ubl mix 78w78 ekr .> no dre






PROCARBAZINE.HCl*** 1Ong ... :1ug. 10. 100 . 1mg. 10 00. : g. 10











P b cym mix --- anl 16y19 jmw
P b cym mix bra ast 16y19 jmw
P b cym mix --- lcl 16y19 jmw
P b cym mix kid hes 16y19 jmw
P b cym mix tba mal 16y19 Wjmw
P b rhe mix --- anl 16y23 jmw
P b rhe mix cec adc 16y23 jmw
P b rhe mix hum ost 16y23 jmw
P b rhe mix kid hes 16y23 jmw





















PROPRANOLOL.HCl*** 100ng. -1ug ....:..1° . .... :..1000..... :.- s* . . :10 .100.. g .10
393 R f f34 gav liv mix 88w91 rsv .> no dre P=1.
394 R m f34 gav liv mix 88w91 rsv .> no dre P=1.
PYRILAMINE MALEATE*** b00ng. :*-1ug ....-: g . 10.*- :*100 ....-:*-1mg .:*-10 -:*.1°00 ..- -:I*-g ..... :*.10
395 M f b6c eat liv mix 65w65 ek .> no dre P=1.
a M f b6c eat lun mix 65w65 ek no dre P=1.
b M f b6c eat tba mix 65w65 ek no dre P=1.
Environmental Health Perspectives * Vol 107, Supplement 4 * August 1999
GOLD ETAL.
- --- -- --- ---- -
+ :
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373 2144 347.mg 812.mg 0/51
a 2144 480.mg 1.29gm 0/51
b 2144 1.16gm 7.07gm 0/51
374 2144 172.mg 313.mg 1/52
a 2144 296.mg 589.mg 0/52
b 2144 645.mg 2.92gm 1/52
375 2143 621.mg 1.66gm 0/30
a 2143 1.22gm 4.71gm 0/30
b 2143 1.32gm 5.56gm 0/30
c 2143 4.70gm n.s.a. 0/30
376 2143 314.mg 731.mg 0/30
a 2143 508.mg 1.38gm 0/30
b 2143 634.mg 4.73gm 0/30

















































406.mg n.s.a. 1/79 50.0mg
2.37gm n.s.a. 2/79 50.0mg
3.15gm n.s.a. 2/79 50.0mg
3.64gm n.s.a. 0/79 50.0mg
4.37gm n.s.a. 1/79 50.0mg
185.mg n.s.a. 0/78 50.0mg
1.57gm n.s.a. 1/78 50.0mg
1.91gm n.s.a. 3/78 50.0mg
415.mg n.s.s. 1/78 50.0mg
4.08gm n.s.a. 1/78 50.0mg
476.mg n.s.a. 0/48 50.0mg
.464mg n.s.s. 0/20 .500mg
.464mg nass. 0/20 .500mg
3.11gm n.s.s. 0/51 50.0mg
495.mg n.s.s. 0/51 50.0mg
.464mg n.s.s. 0/20 .500mg
.464mg n.a.s. 0/20 .500mg
POTASSIUM BICARBONATE 298-14-6
383 2095m 2.03gm n.s.a. 0/15
a 2095m 1.16gm n.s.a. 0/15
384 2095n 6.43gm 36.1gm 0/48
a 2095n 8.94gm 126.gm 0/48
b 2095n 12.8gm n.s.a. 0/48
385 2095m 1.57gm n.s.a. 0/15
a 2095m 2.11gm n.s.a. 0/15
b 2095m 2.13gm n.s.a. 0/15
386 2095n 5.98gm n.s.a. 0/48
a 2095n 7.26gm n.s.a. 0/48
b 2095n 13.4gm n.s.a. 0/48
POTASSIUM CHLORIDE* ** 7447-40-7
387 2095m 2.61gm n.s.a. 0/15
388 2095n 12.9gm n.s.a. 0/48
a 2095n 24.2gm n.s.a. 0/48
389 2095m 1.95gm n.s.a. 0/15
390 2095n 16.4gm n.s.a. 0/48
PROCARBAZINE.HCl*** 366-70-1



















































































































































0/20 50.0mg 0/20 500.mg 0/20 Aleman;txlt,70,77-87;1994/pers.comm.
0/20 50.0mg 0/20 500.mg 0/20
1/51 Aleman;tcam,14,239-249;1994/pers.comm.
0/51
0/20 50.0mg 0/20 500.mg 0/20 Aleman;txlt,70,77-87;1994/pers.comm.
0/20 50.0mg 0/20 500-mg 0/20






























393 2219 146.mg n.s.a. 1/24 70.9mg 0/13
394 2219 134.mg n.s.a. 1/21 70.9mg 0/12
PYRILAMINE MALEATE*** 59-33-6
395 2326m 265.mg n.s.a. 0/12 274.mg 0/12
a 2326m 265.mg n.s.a. 0/12 274.mg 0/12
b 2326m 265.mg n.s.a. 1/12 274.mg 0/12
Zavanalla;carc, 15, 2531-2539; 1994/pers.comm.
Greenman;jact, 14, 148-157;1995/NCTR 1991
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Sex Route Hist Notes
TD50 2Tailpvl
DR AuOp
M f b6c eat lun a/a 24m24 e
M f b6c eat liv hpc 24m24 e
M f b6c eat liv hpa 24m24 e
M f b6c eat liv mix 24m24 e
M f b6c eat tba ben 24m24 e
M f b6c eat tba mal 24m24 e
M f b6c eat tba mix 24m24 e
M m b6c eat liv hpa 65w65 ek
M m b6c eat lun a/a 65w65 ek
M m b6c eat tba ben 65w65 ek
M m b6c eat tba mix 65w65 ek
M m b6c eat lun a/a 24m24 e
M m b6c eat liv hpc 24m24 e
M m b6c eat liv hpa 24m24 e
M m b6c eat liv mix 24m24 e
M m b6c eat tba ben 24m24 e
M m b6c eat tba mal 24m24 e
M m b6c eat tba mix 24m24 e
R f f34 eat liv mix 65w65 ek
R f f34 eat tba ben 65w65 ek
R f f34 eat tba mal 65w65 ek
R f f34 eat ova gcb 24m24 e
R f f34 eat liv hpc 24m24 e
R f f34 eat liv hpa 24m24 e
R f f34 eat tba mal 24m24 e
R f f34 eat tba ben 24m24 e
R f f34 eat tba mix 24m24 e
R m f34 eat liv mix 65w65 ek
R m f34 eat tba ben 65w65 ek
R m f34 eat tba mix 65w65 ek
R m f34 eat tba mal 65w65 ek
R m f34 eat liv hpc 24m24 e
R m f34 eat liv hpa 24m24 e
R m f34 eat tba mix 24m24 e
R m f34 eat tba ben 24m24 e
R m f34 eat tba mal 24m24 e
RETINOL ACETATE***
403 R f f3d wat amd phe 24m25 ej
a R f f3d wat amd phm 24m25 ej
b R f f3d wat liv nnd 24m25 ej
c R f f3d wat cli ade 24m25 ej
d R f f3d wat mgl mix 24m25 ej
e R f f3d wat thy cca 24m25 ej
f R f f3d wat tba mix 24m25 ej
404 R m f3d wat amd phe 24m25 ej
a R m f3d wat spl mnl 24m25 ej
b R m f3d wat amd phm 24m25 ej
c R m f3d wat thy cca 24m25 ej
d R m f3d wat thy mix 24m25 ej
e R m f3d wat liv nnd 24m25 ej
f R m f3d wat liv mix 24m25 ej
g R m f3d wat liv cho 24m25 ej
h R m f3d wat mgl mix 24m25 ej
i R m f3d wat liv hpc 24m25 ej
j R m f3d wat tba mix 24m25 ej

























































SACCHARIN, SODIUM* * * 10Ong...l: -.lug :0.-100 :..lmg :010°. :*- .10
406 P b cym eat tba mal 23y23 w :> no dre P=1.
407 P b rhe eat thy lym 23y23 w
a P b rhe eat tba mal 23y23 Ww
43.3mg P<.07
610.mg P<1.
SDZ 200-110 10Ong .lug :. 01° :1mg :. 1°° :. 1°
408 R m sda eat tes ldc 24m24 er + 212.mg * P<.002 +
409 R m sda eat tes ldc 24m24 er + 251.mg * P<.002 +
SODIUM CHLORIDE*** lO1Ong.--*- lug ....... ....... :10 100 1.lmg 10 10
410 R m wis eat stg tum 82w82 r .> no dre P=1.
SODIUM COPPER CHLOROPHYLLIN
411 R m f34 wat liv hpc 35w52 e
a R m f34 wat tba mix 35w52 e
412 R f f3d eat col tum 54w54 er
a R f f3d eat mgl tum 54w54 er
SODIUM DICHROMATE
413 R m wis inh lun mix 18m30 e
a R m wis inh lun adc 18m30 e
b R m wis inh liv mal 18m30 e
c R m wis inh lun ade 18m30 e
d R m wis inh phr sqc 18m30 e
e R m wis inh tba mix 18m30 e





OOng* :_ ug u..100......g.... :.:10 :100 :1g 10






STERIGMATOCYSTIN' 10Ong..:..-lug :u 10 100 .... 1mg 10






P b cym gav liv mix 17y17 jw
P b cym gav liv hpc 17y17 jw
P b cym gav liv clc 17y17 jw
P b cym gav liv hpa 17y17 jw
P b cym gav kid rcc 17y17 jw
:.*100 .... :*-lg ... 10
llOmg * P<.0005
.127mg * P<.0005+
.176mg * P< .002 +
.906mg * P<.09 +
.455mg * P<.4
1.16mg * P<.9
































































































































































































































RETINOL ACETATE*** (vitamin A, acetate) 127-47-9
403 1693m 135.mg 539.mg 3/50 68.8mg 11/49 138.mg
a 1693m 1.20gm n.s.s. 0/50 68.8mg 1/49 138.mg
b 1693m 1.20gm n.s.s. 0/50 68.8mg 1/49 138.mg
c 1693m 1.64gm n.s.s. 7/50 68.8mg 1/49 138.mg
d 1693m 955.mg n.s.s. 5/50 68.8mg 6/49 138.mg
e 1693m 251.mg n.s.s. 7/50 68.8mg 6/49 (138.mg
f 1693m 115.mg n.s.s. 39/50 68.8mg 40/49 138.mg
404 1693m 51.8mg 212.mg 18/49 60.2mg 27/50 120.mg
a 1693m 251.mg n.s.s. 1/49 60.2mg 8/50 120.mg
b 1693m 246.mg n.s.s. 3/49 60.2mg 4/50 120.mg
c 1693m 270.mg n.s.s. 3/49 60.2mg 5/50 120.mg
d 1693m 284.mg n.s.s. 6/49 60.2mg 6/50 120.mg
e 1693m 533.mg n.s.s. 1/49 60.2mg 2/50 120.mg
f 1693m 537.mg n.s.s. 2/49 60.2mg 3/50 120.mg
g 1693m 1.05gm n.s.s. 0/49 60.2mg 1/50 120.mg
h 1693m 146.mg n.s.s. 12/49 60.2mg 12/50 (120.mg
i 1693m 440.mg n.s.s. 1/49 60.2mg 0/50 120.mg
j 1693m n.s.s. n.s.s. 49/49 60.2mg 50/50 120.mg
405 2192 2.06mg n.s.s. 0/10 4.00mg 0/10
SACCHARIN, SODIUM*** 128-44-9
406 2003 6.84mg n.s.s. 3/15 17.9mg
407 2003 7.06mg n.s.s. 0/13 17.9mg
a 2003 11.4mg n.s.s. 6/74 17.9mg
SDZ 200-110 ---
408 2272m 103.mg 1.03gm 15/150 2.50mg
409 2272n 119.mg 1.12gm 1/65 6.25mg
SODIUM CHLORIDE*** 7647-14-5
410 2158 732.mg n.s.s. 0/10 1.00gm
SODIUM COPPER CHLOROPHYLLIN 28302-36-5
411 2263 34.7mg n.s.s. 0/20 33.7mg
a 2263 34.7mg n.s.s. 0/20 33.7mg
412 2195 528.mg n.s.s. 0/20 500.mg

























1982/Thorgeirsson 1994/Dalgard 1997/Thorgeirsson&Seiber pers.comm.
5/74 12.5mg 11/75 62.5mg 19/75
3/65 62.5mg 11/65







Guo;clet, 95, 161-165; 1995/pers.comm.
Hasegawa;carc, 16, 2243-2246;1995/pers.comm.
SODIUM DICHROMATE 10588-01-9
413 2346 1.40mg n.s.s. 0/37
a 2346 1.74mg n.s.s. 0/37
b 2346 2.34mg n.s.s. 0/37
c 2346 2.34mg n.s.s. 0/37
d 2346 2.34mg n.s.s. 0/37
e 2346 .268mg n.s.s. 24/37
STERIGMATOCYSTIN* * * 10048-13-2

























































Glaser; txcy, 42,219-232; 1986
5/14 Adamson;ossc, 129-156;
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Sex Route Hist Notes
P b cym gav adr coa 17y17 jw
P b cym gav ute ley 17y17 jw
P b cym gav liv chc 17y17 jw
P b cym gav tba mix 17y17 Wjw
P b cym gav tba mal 17y17 Wjw









TAMOXIFEN CITRATE 0Ong-*:* *ug.............100.... :.-1 0 * g.... :.*m-.....:.-100 .... :.0:.0g 0lg - 0....:3..0
415 M f aps orl ova gca 65w65 e + . 3.00mg
a M f aps orl lun ade 65w65 e no dre
b M f aps orl liv tum 65w65 e no dre
416 M m aps orl tes ica 65w65 e . + . 8.18mg
a M m aps orl liv mhp 65w65 e no dre
b M m aps orl liv bhp 65w65 e no dre
c M m aps orl lun ade 65w65 e no dre
417 M m aps orl tes ict 56w56 rs . _ 9.80mg
418 M m aps orl tes ict 56w56 rs . ± 9.80mg
419 M f b6c eat liv hpa 24m24 Cv _ 10l.mg
a M f b6c eat lun alc 24m24 Cv no dre
b M f b6c eat ute ley 24m24 Cv no dre
420 M f cb6 eat liv hpc 52w52 Crv .> no dre
421 M f dba eat liv hpc 52w52 Crv .> no dre
422 R f aap gav liv hpc 20m25 e .+. 17.Omg
a R f aap gav liv hpa 20m25 e 135.mg
b R f aap gav liv hcc 20m25 e 241.mg
c R f aap gav liv blc 20m25 e 706.mg
d R f aap gav liv cho 20m25 e 2.26gm
423 R m aap gav liv hpc 20m25 e .+ . 18.7mg
a R m aap gav liv hpa 20m25 e 47.9mg
b R m aap gav liv hcc 20m25 e 306.mg
c R m aap gav liv blc 20m25 e 1.1Ogm
424 R f cdr gav liv mix 52w52 ek + 1.44mg
a R f cdr gav liv hpa 52w52 ek 1.68mg
b R f cdr gav liv hpc 52w52 ek 2.12mg
425 R f cdr gav liv mix 52w65 e .+ 3.86mg
a R f cdr gav liv hpa 52w65 e 4.35mg
b R f cdr gav liv hpc 52w65 e 4.62mg
426 R f cdr gav liv hpa 52w52 ekr + . 5.80mg
a R f cdr gav liv hpc 52w52 ekr 10.3mg
427 R f cdr gav liv hpa 51w65 aer + 7.77mg
a R f cdr gav liv hpc 51w65 aer 7.77mg
428 R f f3t eat liv hpc 86w86 Cr : + 4.18mg
429 R f lew eat liv hpc 48w48 Cr (+) 1.38mg
430 R f sda gav liv hpc 39m39 + 164.mg
a R f sda gav ute fib 39m39 247.mg
b R f sda gav ute sar 39m39 487.mg
c R f sda gav liv hpa 39m39 497.mg
d R f sda gav ute sqc 39m39 497.mg
e R f sda gav vag sqc 39m39 497.mg
f R feda gav mam fbs 39m39 no dre
g R f sda gav mam mal 39m39 no dre
h R f sda gav mam ben 39m39 no dre
i R f sda gav ute agf 39m39 no dre
j R f sda gav ute car 39m39 no dre
k R f sda gav ute esp 39m39 no dre
1 R f sda gav mam adc 39m39 no dre
m R f sda gav pit ade 39m39 no dre
n R f sda gav ute adc 39m39 no dre
o R f sda gav adr phe 39m39 no dre
p R f sda gav tba mal 39m39 88.7mg
q R f sda gav tba ben 39m39 no dre
431 R f sda gav liv hpc 52w52 ekr . ± 11.8mg
432 R f sda gav liv hpc 52w65 er . + 18.9mg
433 R f sda gav liv hpc 52w52 er + . 7.56mg
434 R f sda gav liv hpc 52w65 er + 6.00mg
435 R m sda gav mam ben 39m39 ± 96.4mg
a R m sda gav liv hpc 39m39 247.mg
b R m sda gav mam adc 39m39 247.mg
c R m sda gav liv hpa 39m39 497.mg
d R m sda gav adr phe 39m39 no dre
e R m sda gav pan isa 39m39 no dre
f R m sda gav pit ade 39m39 no dre
g R m ada gav tes ldc 39m39 no dre
h R m sda gav tba mal 39m39 187.mg
i R m sda gav tba ben 39m39 no dre
436 R f ala gav liv hpc 52w52 Cr .> no dre
437 R f wil eat liv hpc 49w49 Cr 1() : 1.36mg
TANNIC ACIDS, PHARMACEUTICAL GRADE
438 R f f3d wat liv hpa 24m26 e
a R ff3d wat tba mix 24m26 e
439 R m f3d wat liv hpa 24m26 e
a R m f3d wat tba mix 24m26 e
(85.69% TANNIC ACIDS, 8.84% GALLIC ACIDS) .... 3..:* ..... :31°°- ...:.g.319 .0. :* 1°
.> 16.0gm * P=1.
620.mg * P<.5
.> no dre P=1.
noTDSO P=1.
1-trans-delta9-TETRAHYDROCANNABINOL . .: .lug ... .:*.1 . 3:*.100 - :.*In .mg..:*1- :,100 * :** g.-** 0:.*J1
440 M f b6c gav thy fca 24m24 :> no dre P=1. e
a M f b6c gav TBA MXB 24m24 no dre P=1.
b M f b6c gav liv MXB 24m24 no dre P=1.
c M f b6c gav lun MXB 24m24 13.4gm * P<.7
441 M m b6c gav thy fca 24m24 : ± 950.mg Z P<.04 e
a M m b6c gav TBA MXB 24m24 no dre P=1.
b M m b6c gav liv MXB 24m24 no dre P=1.
c M m b6c gavlun MXB 24m24 no dre P=1.





















































































415 2334m 1.40mg 8.79mg 0/23
a 2334m 78.2mg n.s.s. 0/23
b 2334m 9.11mg n.s.s. 0/23
416 2334m 4.66mg 15.4mg 0/25
a 2334m 81.0mg n.s.s. 0/25
b 2334m 101.mg n.s.s. 2/25
c 2334m 60.5mg n.s.s. 1/25
417 2334n 2.36mg n.s.s. 0/6
418 2334o 2.36mg n.s.s. 0/6
419 2323m 24.7mg n.s.s. 0/15
a 2323m 64.9mg n.s.s. 0/15
b 2323m 64.9mg n.s.s. 0/15
420 2323n 40.5mg n.s.s. 0/33
421 2323o 40.3mg n.s.s. 0/33
422 2044 12.7mg 23.4mg 0/104
a 2044 72.9mg 370.mg 1/104
b 2044 114.mg 681.mg 0/104
c 2044 204.mg n.s.s. 1/104
d 2044 367.mg n.s.a. 0/104
423 2044 13.8mg 26.Omg 1/102
a 2044 26.4mg 130.mg 1/102
b 2044 132.mg 1.04gm 0/102
c 2044 271.mg n.s.s. 0/102
424 2049m .939mg 2.27mg 0/18
a 2049m 1.10mg 2.65mg 0/18
b 2049m 1.39mg 3.40mg 0/18
425 2049n 2.56mg 6.23mg 0/21
a 2049n 2.84mg 7.11mg 0/21
b 2049n 3.01mg 7.77mg 0/21
426 2116m 2.43mg 29.2mg 0/10
a 2116m 3.43mg 59.Omg 0/10
427 2116n 2.93mg 35.9mg 0/12
a 2116n 2.93mg 35.9mg 0/12
428 2250r 1.96mg 12.8mg 0/10
429 2250u .658mg 3.59mg 0/10
430 BT5T 49.7mg n.s.s. 0/100
a BT5T 60.9mg n.s.s. 0/100
b BT5T 58.6mg n.s.s. 2/100
c BT5T 81.Omg n.s.a. 0/100
d BTST 81.0mg n.s.s. 0/100
e BTST 81.0mg n.s.s. 0/100
f BT5T 150.mg n.s.s. 1/100
g BT5T 150.mg n.s.s. 9/100
h BTST 150.mg n.s.a. 36/100
i BTST 91.9mg n.s.s. 1/100
j BT5T 91.9mg n.s.s. 1/100
k BTST 150.mg n.s.s. 13/100
1 BT5T 150.mg n.s.s. 8/100
m BTST 122.mg n.s.s. 16/100
n BTST 150.mg n.s.s. 1/100
BT5T 46.5mg n.s.s. 17/100
p BT5T 16.7mg n.s.s. 27/100
q BT5T 59.8mg n.s.s. 57/100
431 2043m 3.43mg n.s.s. 0/5
432 2043n 7.04mg 95.Omg 0/10
433 2159m 2.40mg 52.5mg 0/5
434 2159n 1.88mg 27.3mg 0/5
435 BT5T 34.8mg n.s.s. 1/100
a BT5T 60.9mg n.s.s. 0/100
b BT5T 60.9mg n.s.s. 0/100
c BT5T 81.Omg n.s.s. 0/100
d BT5T 35.4mg n.s.s. 19/100
e BT5T 123.mg n.s.S. 7/100
f BT5T 76.Omg n.s.s. 11/100
g BT5T 150.mg n.s.s. 4/100
h BT5T 20.4mg n.s.s. 24/100
i BT5T 25.3mg n.s.s. 33/100
436 2247 1.18mg n.s.s. 0/8




















































































6/52 20.0mg 37/52 35.0mg
2/52 20.0mg 6/52 35.0mg
0/52 20.Omg 4/52 35.Omg
0/52 20.0mg 2/52 35.0mg
0/52 20.0mg 1/52 35.Omg
8/51 20.Omg 34/51 35.Omg
8/51 20.Omg 11/51 (35.Omg
0/51 20.Omg 2/51 35.Omg







0/10 11.3mg 5/10 45.2mg
0/10 11.3mg 1/10 45.2mg
0/27 9.04mg 5/12 (45.2mg




























































Machishi;carc, 16, 2965-2971; l995
Carthew;carc,16,1299-1304;1995/pers.comm.
TANNIC ACIDS, PHARMACEUTICAL GRADE (85.69% TANNIC ACIDS, 8.84% GALLIC ACIDS) 1401-55-4
438 2142 2.61gm n.s.s. 0/50 130.mg 1/50 261.mg 0/50
a 2142 141.mg n.s.s. 40/50 130.mg 41/50 261.mg 43/50
439 2142 2.47gm n.s.s. 1/45 114.mg 0/47 228.mg 1/48
a 2142 n.s.s. n.s.s. 45/45 114.mg 47/47 228.mg 48/48
1-trans-delta9-TETRAHYDROCANNABINOL 1972-08-3
440 TR446 587.mg n.s.s. 4/60 89.1mg 9/60 178.mg 3/60 (356.mg 1/60)
a TR446 190.mg n.s.s. 46/60 89.1mg 31/60 (178.mg 26/60 356.mg 16/60)
b TR446 285.mg n.s.s. 22/60 89.1mg 14/60 (178.mg 11/60 356.mg 4/60)
c TR446 1.69gm n.s.s. 2/60 89.1mg 1/60 178.mg 3/60 356.mg 2/60
441 TR446 448.mg n.s.s. 0/62 89.1mg 6/60 178.mg 3/61 (355.mg 1/60)
a TR446 186.mg n.s.s. 45/62 89.1mg 33/60 (178.mg 27/61 355.mg 18/60)
b TR446 422.mg n.s.s. 31/62 89.1mg 13/60 (178.mg 9/61 355.mg 3/60)
c TR446 1.05gm nas..s. 14/62 89.1mg 14/60 178.mg 7/61 355.mg 8/60










































581Spe Strain Site Xpo+Xpt
Sex Route Hist Notes
TD5O 2Tailpvl
DR AuOp
442 R f f34 gav TBA MXB 24m24
a R f f34 gav liv MXB 24m24
443 R m f34 gav TBA MXB 24m24
a R m f34 gav liv MXB 24m24
THIABENDAZOLE***
444 R f f3d eat ubl tpp 24m24 e
a R f f3d eat liv tum 24m24 e
b R f f3d eat kid tcc 24m24 e
445 R m f3d eat pre ade 24m24 e
a R m f3d eat kid tcc 24m24 e
b R mf3d eat liv tum 24m24 e
c R m f3d eat ubl tpp 24m24 e
TOLUENE***
446 R f sda gav --- lkm 24m29
a R f sda gav orc car 24m29
b R f sda gav tba mal 24m29
c R f sda gav tba mix 24m29
447 R fsda gav --- lkm 24m33 j
a R f sda gav hed car 24m33 j
b Rf sda gav mam car 24m33 j
c R f sda gav nas car 24m33 j
d R f sda gav orc car 24m33 j
e R f sda gav tba mix 24m33 j
f R f sda gav tba mal 24m33 ej
448 R m sda gav hed car 24m29
a R m sda gav orc car 24m29
b R msda gav --- lkm 24m29
c R m sda gav edu car 24m29
d R m sda gav nas car 24m29
e R m sda gav zym car 24m29
f R m sda gav tba mal 24m29
g R m sda gav tba mix 24m29
449 R m sda gav tba mix 24m33 j
a R m sda gav tba mal 24m33 ej
TOLUENE DIISOCYANATE, COMMERCIAL C
450 M f cdl inh lun ade 24m24 es
a M f cdl inh lun car 24m24 es
b M f cdl inh liv hpc 24m24 es
c M f cdl inh liv hpa 24m24 es
d M f cdl inh tba mix 24m24 es
e M f cdl inh tba mal 24m24 es
f M f cdl inh tba ben 24m24 es
451 M m cdl inh lun ade 24m24 e
a M m cdl inh liv hpc 24m24 e
b M m cdl inh liv hpa 24m24 e
c M m cdl inh lun car 24m24 e
d M m cdl inh tba mix 24m24 e
e M m cdl inh tba mal 24m24 e
f M m cdl inh tba ben 24m24 e
452 R f cdr inh liv hpc 25m25 e
a R f cdr inh tba mal 25m25 e
b R f cdr inh tba ben 25m25 e
c R f cdr inh tba mix 25m25 e
453 R m cdr inh liv hpc 26m26 e
a R m cdr inh tba mix 26m26 e
b R m cdr inh tba ben 26m26 e
c R m cdr inh tba mal 26m26 e
TOREMIFENE CITRATE
454 R f cdr gav liv hpa 52w52 ek
a R f cdr gav liv hpc 52w52 ek
455 R f cdr gav liv hpa 52w65 e
a R f cdr gav liv hpc 52w65 e
456 R f sda gav liv tum 52w52 ek:
457 R f sda gav liv tum 52w65 er
458 R f sda gav liv mix 52w52 er
459 R f sda gav liv mix 52w65 er
460 R f sda eat liv hpa 24m24 e
a R f sda eat liv hpc 24m24 e
b R f sda eat mgl tum 24m24 e
c R f sda eat pit tum 24m24 e
461 R m sda eat liv hpc 24m24 e
a R m sda eat liv hpa 24m24 e
b R msda eat mgl tum 24m24 e
c R msda eat pit tum 24m24 e
d R msda eat tes tum 24m24 e
1°Ong
> no dre P=1.
243.mg Z P<.06
> no dre P=1.
no dre P=1.








































































TRICHLOROACETIC ACID 10Ong. .:.* lug : * .-.10 .- -:*100 ....-:*-1mg :* 10.*- ...:.* -100 ....-:.lg :..10
462 M f b6c wat liv hpc 51w51 Cekr (+) 576.mg * P<.0005+
a M f b6c wat liv hpa 51w51 Cekr 891.mg * P<.3
463 M f b6c wat liv hpa 82w82 Cer + 688.mg * P<.0005+
a M f b6c wat liv hpc 82w82 Cer 916.mg * P<.0005+
464 M m b6c wat liv hpc 61w61 er + 513.mg P<.002 +
a M m b6c wat liv hpa 61w61 er 551.mg P<.03
465 R m f34 wat liv hpc 24m24 C .> 5.48gm * P<.2
a R m f34 wat liv hpa 24m24 C 6.72gm * P<.7
b R m f34 wat liv mix 24m24 C 6.72gm * Pa.7
TRIC HLOROETHYLENE (WITHOUT EPICHLOROHYDRIN)*** .... :.-100 .... :.-.lng....:* 1m0 :. -100 .... *- g ..... :*-10
466 M m b6c wat liv hpc 61w61 er + 16.Omg P<.08







































































RefNum LoConf UpConf Cntrl lDose lInc 2Dose 2Inc Citation or Pathology
442 TR446 19.8mg n.s.s. 44/51 8.86mg 42/51 17.7mg
a TR446 73.0Omg n.s.s. 0/51 8.86mg 0/51 17.7mg
443 TR446 24.55mg n.s.s. 42/52 8. 93mg 37/51 17. 9mg
a TR446 229.mg n.s.s. 5/52 8.93mg 0/51 17.9mg
THIABENDAZOLE*** (2- (4-thiazolyl) -benzimazole) 148-79-8
444 2314 1.24gm n.s.s. 0/29 25.Omg 0/30 50.Omg
a 2314 81.7mg n.s.s. 0/29 25.Omg 0/30 50.Omg
b 2314 81.7mg n.s.s. 0/29 25.0mg 0/30 50.0mg
445 2314 278.mg 1.87gm 0/30 20.Omg 1/30 40.Omg
a 2314 750.mg n.s.s. 0/29 20.Omg 0/30 40.Omg
b 2314 65.9mg n.s.s. 0/29 20.0mg 0/30 40.0mg

























Fujii; fctx, 29, 771-775;1991
TOLUENE*** (monomethyl benzene) 108-88-3
446 BT910 1.62gm n.s.s. 3/50 387.mg
a BT910 1.96gm n.s.s. 1/50 387.mg
b BT910 834.mg n.s.s. 11/50 387.mg
c BT910 845.mg n.s.s. 35/50 387.mg
447 BT903m 696.mg 52.1gm 1/50 237.mg
a BT903m 1.43gm n.s.s. 0/50 237.mg
b BT903m 644.mg n.s.s. 7/50 237.mg
c BT903m 1.92gm n.s.s. 0/50 237.mg
d BT903m 1.92gm n.s.s. 0/50 237.mg
e BT903m 98.7mg 1.07gm 30/50 237.mg
f BT903m 281.mg 3.19gm 10/49 237.mg
448 BT910 914.mg 20.4gm 1/50 387.mg
a BT910 1.06gm 10.3gm 0/50 387.mg
b BT910 1.23gm n.s.s. 5/50 387.mg
c BT910 2.99gm n.s.s. 0/50 387.mg
d BT910 2.99gm n.s.s. 0/50 387.mg
e BT910 5.57gm n.s.s. 1/50 387.mg
f BT910 583.mg n.s.s. 12/50 387.mg
g BT910 482.mg n.s.s. 27/50 387.mg
449 BT903m 184.mg n.s.s. 29/50 237.mg






















TOLUENE DIISOCYANATE, COMMERCIAL GRADE (2,4 (80%)- AND 2,6 (20%)-)***
450 2178 .422mg n.s.s. 23/90 .112mg 20/90 (.336mg 11/89)
a 2178 1.22mg n.s.s. 4/90 .112mg 2/90 (.336mg 0/89)
b 2178 4.72mg n.s.s. 0/90 .112mg 1/90 .336mg 0/89
c 2178 6.31mg n.s.s. 5/90 .112mg 0/90 .336mg 1/89
d 2178 .233mg n.s.s. 56/90 .112mg 50/90 (.336mg 22/89)
e 2178 .344mg n.s.s. 30/90 .112mg 27/90 (.336mg 10/89)
f 2178 .389mg n.s.s. 39/90 .112mg 31/90 (.336mg 14/89)
451 2178 .136mg n.s.s. 17/90 93.3ug 31/90 (.280mg 22/90)
a 2178 .370mg n.s.s. 24/90 93.3ug 20/90 (.280mg 12/90)
b 2178 .376mg n.s.s. 21/90 93.3ug 18/90 (.280mg 9/90)
c 2178 2.45mg n.s.s. 6/90 93.3ug 4/90 .280mg 4/90
d 2178 96.lug n.s.s. 64/90 93.3ug 65/90 (.280mg 43/90)
e 2178 .186mg n.s.s. 39/90 93.3ug 39/90 (.280mg 23/90)
f 2178 1.08mg n.s.s. 38/90 93.3ug 44/90 .280mg 29/90
452 2178 1.34mg n.s.s. 0/104 26.7ug 0/105 80.Oug 1/105
a 2178 .247mg n.s.s. 21/104 26.7ug 18/105 80.Oug 25/105
b 2178 80.lug n.s.s. 102/104 26.7ug 94/105 80.Oug 96/105
c 2178 46.5ug n.s.s. 104/104 26.7ug 98/105 80.Oug 101/105
453 2178 1.03mg n.s.s. 0/104 18.7ug 1/104 56.Oug 0/104
a 2178 76.3ug n.s.s. 86/104 18.7ug 67/104 56.Oug 81/104
b 2178 .103mg n.s.s. 77/104 18.7ug 64/104 56.Oug 71/104








454 2049m 7.95mg n.s.s. 0/18
a 2049m 7.95mg n.s.s. 0/18
455 2049n 17.6mg n.s.s. 0/21
a 2049n 17.6mg n.s.s. 0/21
456 2043m 2.47mg n.s.s. 0/5
457 2043n 6.18mg n.s.s. 0/10
458 2159m 2.47mg n.s.s. 0/5
459 2159n 2.58mg n.s.s. 0/5
460 2276 96.5mg n.s.s. 0/50
a 2276 1.07mg n.s.s. 0/50
b 2276 152.mg n.s.s. 30/50
c 2276 57.6mg n.s.s. 42/49
461 2276 92.4mg n.s.s. 1/50
a 2276 55.2mg n.s.s. 3/50
b 2276 130.mg n.s.s. 0/50
c 2276 157.mg n.s.s. 26/48
d 2276 185.mg n.s.s. 5/50
TRICHLOROACETIC ACID 76-03-9
462 2191m 218.mg 2.40gm 0/40
a 2191m 212.mg n.s.s. 1/40
463 2191n 334.mg 2.31gm 2/90
a 2191n 421.mg 3.25gm 2/90
464 2071 220.mg 1.97gm 0/22
a 2071 211.mg n.s.s. 2/22
465 2327 893.mg n.s.s. 0/29
a 2327 623.mg n.s.s. 1/29

































































































































Herren-Freund;txap, 90, 183-189; 198/
DeAngelo; jtxe, 52,425-445; 1997
TRICHLOROETHYLENE (WITHOUT EPICHLOROHYDRIN)*** (TCE) 79-01-6
466 2071 4.83mg n.s.s. 0/22 6.67mg 3/32 Herren-Freund;txap, 90,183-189;1987
Environmental Health Perspectives * Vol 107, Supplement 4 * August 1999
Brkly Code
583Spe Strain Site Xpo+Xpt
Sex Route Hist Notes
TD50 2Tailpvl
DR AuOp
a M m b6c wat liv hpa 61w61 er
N- (TRICHLOROMETHYLTHIO) PHTHALIMI
467 M f cdl eat dgt mix 26m26 e
a M f cdl eat duo adc 26m26 e
b M f cdl eat duo ade 26m26 e
c M f cdl eat stn pam 26m2C6 e
468 M m cdl eat dgt mix 26m26 e
a M m cdl eat duo adc 26m26 e
b M m cdl eat duo ade 26m26 e
c M m cdl eat stn pam 26m26 e
469 R f cdr eat thy cca 24m24 r
a R f cdr eat thy ccr 24m24 r
b R f cdr eat thy mix 24m24 r
470 R m cdr eat tes ict 24m24 r
a R m cdr eat thy mix 24m24 r
b R m cdr eat thy cca 24m24 r
471 R f f34 eat --- mly 24m24 e
472 R m f34 eat --- mly 24m24 e
TRIFLURALIN, TECHNICAL GRADE...
473 M f nmr eat liv hpa 24m24
a M f nmr eat lun abt 24m24
b M f nmr eat tba tum 24m24
474 M m nmr eat liv hpc 24m24
a M m nmr eat lun abt 24m24
b M m nmr eat liv hpa 24m24
c M m nmr eat tba tum 24m24
475 R f wis eat liv hpa 28m28
a R f wis eat liv hpc 28m28
b R f wis eat tba tum 28m28
476 R m wis eat bra mnr 28m28
a R m wis eat liv hpa 28m28
b R m wis eat liv hpc 28m28
c R m wis eat tba tum 28m28
1,2, 4-TRIMETHYLBENZENE
477 R f sda gav tba mix 24m29
a R f sda gav tba mal 24m29
478 R m sda gav hed car 24m29
a R m sda gav zym car 24m29
b R m sda gav edu car 24m29
c R m sda gav orc car 24m29
d R m sda gav nas ene 24m29
e R m sda gav tba mix 24m29
f R m sda gav tba mal 24m29
TRIPROLIDINE. HCl MONOHYDRATE
479 M f b6c eat liv mix 65w65 e
a M f b6c eat lun mix 65w65 e
b M f b6c eat tba ben 65w65 e
c M f b6c eat tba mal 65w65 e
480 M f b6c eat liv hpc 24m24 e
a M f b6c eat liv mix 24m24 e
b M f b6c eat lun mix 24m24 e
c M f b6c eat liv hpa 24m24 e
d M f b6c eat tba mix 24m24 e
e M f b6c eat tba mal 24m24 e
f M b6c eat tba ben 24m24 e
481 M m b6c eat liv hpa 65w65 e
a M m b6c eat liv hpc 65w65 e
b M mb6c eat lun a/a 65w65 e
c M m b6c eat tba ben 65w65 e
d M m b6c eat tba mal 65w65 e
482 M m b6c eat liv hpa 24m24 e
a M m b6c eat liv mix 24m24 e
b M m b6c eat liv hpc 24m24 e
c M m b6c eat lun mix 24m24 e
d M m b6c eat tba ben 24m24 E
e M m b6c eat tba mal 24m24 e
f M m b6c eat tba mix 24m24 e
483 R f f34 eat liv mix 65w65 e
a R f f34 eat tba mix 65w65 e
b R f f34 eat tba mal 65w65 e
c R f f34 eat tba ben 65w65 e
484 R f f34 eat liv hpa 24m24 e
a R ff34 eat liv hpc 24m24 e
b R f f34 eat tba mix 24m24 e
c R f f34 eat tba ben 24m24 e
d R f f34 eat tba mal 24m24 e
485 R m f34 eat liv mix 65w65 e
a R m f34 eat tba ben 65w65 e
b R m f34 eat tba mix 65w65 e
c R m f34 eat tba mal 65w65 e
486 R m f34 eat liv hpc 24m24 c
a R m f34 eat liv hpa 24m24 e
b R m f34 eat tba ben 24m24 e
c R m f34 eat tba mal 24m24 E
d R m f34 eat tba mix 24m24 c
DE*** ..:. lug :.-10 :.-100 :mg *10 :.-100 ..g..... 10
r .+ 2.38gm Z P<.0005+
r 3.31gm * P<.0005+
r 7.28gm *P .0005+
r no dre P=1.
r + 2.19gm Z P<.0005+
r 2.40gm *P .0005+
mr 10.3gm * P<.0005+
!r 13.4gm * P<.006 +
> no dre P=1.
no dre P=1.
no dre P=1.
+ 839.mg * P<.05
2.94gm Z P<.6
no dre P=1.
r 947.mg * P<.07
r + 1.07gm * P<.1





















































































































URETHANE' 10Ong..*: * - lug .:*-10. : 100 *1mg .. :_10 100 1.. -0lg .. ... 10
487 P b cym eat MXB MXB 5y23 jw 16.4mg P<.004






































RefNum LoConf UpConf Cntrl lDose lInc 2Dose 2Inc Citation or Pathology
Brkly Code
a 2071 6.06mg n.s.s. 2/22 6.67mg 3/32

































































































Quest;rtxp, 17, 19-34; 1993/pers.comm.
TRIFLURALIN, TECHNICAL GRADE*** 1582-09-8
473 2315 570.mg n.s.s. 0/50 6.50mg 0/50
a 2315 260.mg n.s.s. 6/50 6.50mg 8/50
b 2315 151.mg n.s.s. 34/50 6.50mg 37/50
474 2315 249.mg n.s.s. 1/50 6.00mg 3/50
a 2315 146.mg n.s.s. 12/50 6.00mg 19/50
b 2315 320.mg n.s.s. 5/50 6.00mg 8/50
c 2315 41.6mg n.s.s. 28/50 6.00mg 36/50
475 2315 1.45gm n.s.s. 0/60 10.Omg 0/60
a 2315 2.04gm n.s.s. 0/60 10.Omg 0/60
b 2315 344.mg n.s.s. 43/60 10.Omg 42/60
476 2315 513.mg 4.77gm 0/60 8.00mg 1/60
a 2315 941.mg 341.gm 0/60 8.00mg 0/60
b 2315 1.46gm n.s.s. 1/60 8.00mg 2/60
c 2315 228.mg n.s.s. 37/60 8.00mg 33/60
1,2,4-TRIMETHYLBENZENE 95-63-6
477 BT913 567.mg n.s.s. 35/50
a BT913 1.12gm n.s.s. 11/50
478 BT913 1.42gm n.s.s. 1/50
a BT913 2.46gm n.s.s. 1/50
b BT913 2.99gm n.s.s. 0/50
c BT913 2.99gm n.s.s. 0/50
d BT913 2.99gm n.s.s. 0/50
e BT913 441.mg n.s.s. 27/50











479 2254m 601.mg n.s.s. 0/12 622.mg
a 2254m 601.mg n.s.s. 0/12 622.mg
b 2254m 601.mg n.s.s. 1/12 622.mg
c 2254m 601.mg n.s.s. 0/12 622.mg
480 2254n 559.mg n.s.s. 2/47 77.0mg
a 2254n 2.73gm n.s.s. 4/47 77.0mg
b 2254n 4.31gm n.s.s. 5/47 77.Omg
c 2254n 5.09gm n.s.s. 2/47 77.0mg
d 2254n 926.mg n.s.s. 25/47 77.Omg
e 2254n 1.02gm n.s.s. 17/47 77.0mg
f 2254n 2.47gm n.s.s. 9/47 77.Omg
481 2254m 50.4mg n.s.s. 2/12 71.8mg
a 2254m 50.4mg n.s.s. 0/12 71.8mg
b 2254m 326.mg n.s.s. 1/12 574.mg
c 2254m 362.mg n.s.s. 2/12 574.mg
d 2254m 554.mg n.s.s. 0/12 574.mg
482 2254n 882.mg n.s.s. 9/48 71.1mg
a 2254n 816.mg n.s.s. 13/48 71.1mg
b 2254n 3.42gm n.s.s. 5/48 71.1mg
c 2254n 6.07gm n.s.s. 11/48 71.1mg
d 2254n 1.52gm n.s.s. 20/48 71.1mg
e 2254n 2.64gm n.s.s. 16/48 71.1mg
f 2254n 1.31gm n.s.s. 28/48 71.1mg
483 2255m 115.mg n.s.s. 0/12 120.mg
a 2255m 63.4mg n.s.s. 4/12 120.mg
b 2255m 67.8mg n.s.s. 1/12 120.mg
c 2255m 80.7mg n.s.s. 3/12 120.mg
484 2255n 1.33gm n.s.s. 0/48 14.8mg
a 2255n 1.33gm n.s.s. 0/48 14.8mg
b 2255n 123.mg n.s.s. 42/48 14.8mg
c 2255n 129.mg n.s.s. 39/48 14.8mg
d 2255n 404.mg n.s.s. 16/48 14.8mg
485 2255m 8.40mg n.s.s. 0/12 12.Omg
a 2255m 18.7mg n.s.s. 10/12 95.6mg
b 2255m 20.7mg n.s.s. 11/12 95.6mg
c 2255m 92.4mg n.s.s. 2/12 95.6mg
486 2255n 84.7mg n.s.s. 0/47 11.8mg
a 2255n 764.mg n.s.s. 1/47 11.8mg
b 2255n 18.Omg n.s.s. 45/47 11.8mg
c 2255n 174.mg n.s.s. 25/47 11.8mg


























































































































URETHANE*** (ethyl carbamate) 51-79-6





































1982/Thorgeirsson 1994/Dalgard 1997/Thorgeirsson&Seiber pers.comm.

















585Spe Strain Site Xpo+Xpt
Sex Route Hist Notes
P b cym eat
P b cym eat
P b cym eat
P b cym eat
P b cym eat
P b cym eat
P b cym eat
P b rhe eat
P b rhe eat
P b rhe eat
P b rhe eat
P b rhe eat
P b rhe eat
P b rhe eat
P b rhe eat



















































VANADYL SULFATE*** b10Ong ...:lug :_ :100° .. :1mg :* 10 ... :_100 .lg_ - - :_10
489 R m wis wat liv tum 52w52 ev .> no dre P=1.
VINYL ACETATE`
490 M f cdl inh lun tum 52w52 kr
491 M f cdl inh lun tum 70w86 kr
492 M fcdl inh lun tum 82w82 kr
493 M f cdl inh lun tum 24m24 r
494 M m cdl inh lun tum 52w52 kr
495 M m cdl inh lun tum 70w85 kr
496 M m cdl inh lun tum 82w82 kr
497 M m cdl inh lun sqc 24m24 r
a M m cdl inh lun adc 24m24 r
498 M f swi wat ute mal 18m35 g
a M f swi wat eso sqc 18m35 g
b M fswi wat for ama 18m35 g
c M f swi wat ute adc 18m35 g
d M f swi wat ton sqc 18m35 g
e M f swi wat for sqc 18m35 g
f M f swi wat lun mix 18m35 g
M f swi wat lun ade 18m35 g
h M fswi wat ute ley 18m35 g
i M f swi wat ute lei 18m35 g
j M fswi wat lun adc 18m35 g
k M f swi wat sto adc 18m35 g
1 M fswi wat eso ama 18m35 g
m M f swi wat orc sqc 18m35 g
n M f swi wat zym car 18m35 g
M fswi wat liv hpc 18m35 g
p M f swi wat tba ben 18m35 g
q M f swi wat tba mal 18m35 g
499 M m swi wat lun ade 18m31 g
a M m swi wat for ama 18m31 g
b M m swi wat orc sqc 18m31 g
c M m swi wat ton sqc 18m31 g
d M m swi wat sto adc 18m31 g
e M m swi wat lun mix 18m31 g
f M m swi wat lun adc 18m31 g
g M m swi wat liv hpc 18m31 g
h M m swi wat tba mal 18m31 g
i M m swi wat tba ben 18m31 g
500 R f cdr inh lun tum 52w52 kr
501 R f cdr inh lun tum 70w86 kr
502 R f cdr inh lun tum 82w82 kr
503 R f cdr inh nse sqc 24m24 er
a R f cdr inh lar sqc 24m24 er
b R f cdr inh lun ade 24m24 er
504 R m cdr inh lun tum 52w52 kr
505 R m cdr inh lun tum 70w85 kr
506 R m cdr inh lun tum 82w82 kr
507 R m cdr inh nse mix 24m24 er
a R m cdr inh nse ben 24m24 er
b R m cdr inh nse pai 24m24 er
c R m cdr inh nse mal 24m24 er
d R m cdr inh nse sqc 24m24 er
e R m cdr inh nse cic 24m24 er
f R m cdr inh lun tum 24m24 er
R m cdr inh nse sqp 24m24 er
XYLENE MIXTURE (50.31% m-XYLENE, 2
508 R f sda gav -- lkm 24m29
a R f sda gav hed car 24m29
b R f sda gav orc car 24m29
c R f sda gav edu car 24m29
d R f sda gav zym car 24m29
e R f sda gav tba mal 24m29
f R f sda gav tba mix 24m29
509 R f sda gav hed car 24m33 j
a R f sda gav mam car 24m33 j
b R fsda gav --- lkm 24m33 j
c R f sda gav tba mix 24m33 j
d R f sda gav tba mal 24m33 ej
510 R m sda gav hed car 24m29
a R m sda gav orc car 24m29
b R msda gav --- lkm 24m29
c R m sda gav edu car 24m29
OOng.










3.92gm * P<.005 +
5.64gm * P<.002 +
6.85gm * P<.003 +
5.57gm * P<.03
8.76gm * P<.05 +
































758 .mg * P<.0005+
1.24gm * P<.005 +
1.55gm * P<.005













































































































































489 2217 3.10mg n.s.s. 0/5 25.Omg 0/5 37.3mg 0/5 61.3mg 0/5 Dai;phtx, 75,265-273; 1994
VINYL ACETATE*** 108-05-4
490 2167m 21.4mg n.s.s.
491 2167n 47.6mg n.s.s.
492 2167o 53.2mg n.s.s.
493 2167r 513.mg n.s.s.
494 2167m 17.8mg n.s.s.
495 2167n 39.2mg n.s.s.
496 21670 44.3mg n.s.s.
497 2167r 5.22gm n.s.s.
a 2167r 428.mg n.s.s.
498 BT52 1.70gm 39.6gm
a BT52 2.30gm 22.1gm
b BT52 2.6Ogm 36.8am
c BTS2 2.09gm n.s.s.
d BT52 3.03gm n.s.s.
e BT52 3.54gm n.s.s.
f BT52 1.94gm n.s.s.
g BT52 2.22gm n.s.s.
h BT52 4.67gm n.s.s.
i BT52 4.67gm n.s.s.
j BT52 4.50gm n.s.s.
k BT52 5.86gm n.s.s.
1 BT52 5.86gm n.s.s.
m BT52 5.86gm n.s.s.
n BT52 5.86gm n.s.s.
BT52 1.41gm n.s.s.
p BT52 851.mg n.s.s.
q BT52 680.mg n.s.s.
499 BT52 852.mg n.s.s.
a BT52 1.52gm n.s.s.
b BT52 1.52gm n.s.s.
c BTS2 1.52gm n.s.s.
d BT52 1.52gm n.s.s.
e BT52 778.mg n.s.s.
f BT52 1.12gm n.s.s.
g BT52 1.21gm n.s.s.
h BT52 191.mg n.s.s.
i BT52 676.mg n.s.s.
500 2167m 5.09mg n.s.s.
501 2167n 11.3mg n.s.s.
502 2167a 12.7mg n.s.s.
503 2167r 767.mg 18.2gm
a 2167r 1.47gm n.s.s.
b 2167r 122.mg n.s.s.
504 2167m 3.56mg n.s.s.
505 2167n 7.84mg n.s.s.
506 2167o 8.86mg n.s.s.
507 2167r 343.mg 2.31gm
a 2167r 469.mg 10.4gm
b 2167r 535.mg 12.9gm
c 2167r 629.mg n.s.s.
d 2167r 771.mg n.s.s.
e 2167r 1.03gm n.s.s.
f 2167r 84.5mg n.s.s.


















































































































































































































































































































Bogdanffy; faat, 23, 215-229; 1994
Maltoni;anya, 837,209-238;1997

















XYLENE MIXTURE (50.31% m-XYLENE, 26.9% o-XYLENE, 22.24% p-XYLENE)*** (CAS# 108-38-3, 95-47-6, and 106-42-3) mixture
508 BT911 1.24gm in.s.s. 3/50 387.mg 7/50 Maltoni;anya,837,15-52;1997
a BT911 1.40gm n.s.s. 3/50 387.mg 6/50
b BT911 1.64gm n.s.s. 1/50 387.mg 4/50
c BT911 2.46gm n.s.s. 1/50 387.mg 2/50
d BT911 5.57gm n.s.s. 1/50 387.mg 0/50
e BT911 652.mg n.s.s. 11/50 387.mg 18/50
f BT911 697.mg n.s.s. 35/50 387.mg 31/50
509 BT904m 979.mg 420.gm 0/50 237.mg 4/40 Maltoni;ajim,7,415-446;1985/1997a
a BT904m 581.mg n.s.s. 7/50 237.mg 11/40
b BT904m 1.24gm n.s.s. 1/50 237.mg 3/40
c BT904m 132.mg 10.4gm 30/50 237.mg 34/40
d BT904m 262.mg 2.26gm 10/49 237.mg 22/40
510 BT911 1.25gm n.s.s. 1/50 387.mg 6/50 Maltoni;anya,837,15-52;1997
a BT911 1.53gm n.s.s. 0/50 387.mg 4/50
b BT911 1.40gm n.s.s. 5/50 387.mg 7/50
c BT911 2.99gm n.s.s. 0/50 387.mg 1/50



















Spe Strain Site Xpo+Xpt TD5O 2Tailpvl
Sex Route Hist Notes DR AuOp
d R m sda gav zym car 24m29 no dre P=1.
e R m sda gav tba mal 24m29 1.82gm P<.2
f R m sda gav tba mix 24m29 4.07gm P<.7
511 R m sda gav orc car 24m33 j . ± 5.82gm P<.07
a R m sda gav --- lkm 24m33 j 4.17gm P<.3
b R m sda gav hed car 24m33 j +hist 5.17gm P<.3 +
c R m sda gav zym car 24m33 j 58.4gm P<.9
d R m sda gav tba mal 24m33 ej 1.67gm P<.3
e R m sda gav tba mix 24m33 j no dre P=1.
ZATOSETRON MALEATE 100 ng*.:. ug............. :..10*. . . . :10. j . 10 0 .... :.: ..... :..100.... :*lg ..... :*1
512 R f f34 gav liv tum 52w52 rv .> no dre P=1.
513 R m f34 gav liv tum 52w52 r .> no dre P=1.
Environmental Health Perspectaves Vol 107. Supplemknt 4 a August 1999 seeCARCINOGENIC POTENCY DATA5SE
RefNum LoConf UpConf Cntrl iDose lInc 2Dose 2Inc Citation or Pathology
d BT911 3.39gm n.s,s. 1/50 387.mg 1/50
e BT911 627.mg n.s.s. 12/50 387.mg 19/50
f BT911 528.mg n.s.a. 27/50 387.mg 29/50
511 BT904m 1.43gm n.s.s. 0/50 237.mg 2/40
a BT904m 991.mg n.s.a. 3/50 237.mg 5/40
b BT904m 1.24gm n.s.s. 1/50 237.mg 3/40
c BT904m 2.13gm n.s.s. 1/50 237.mg 1/40
d BT904m 483.mg n.s.s. 11/45 237.mg 14/38
e BT904m 446.mg n.s.s. 29/50 237.mg 23/40
ZATOSETRON MALEATE (LY277359 maleate) 123482-23-5
512 2165 7.20mg n.s.a. 0/15 13.3mg 0/15 40.0mg 0/15 140.mg 0/15
513 2165 7.12mg n.s.s. 0/15 13.3mg 0/15 40.0mg 0/15 120.mg 0/15
Maltonisajim, 7,415-446s 1985/1997a
Bendeles faat, 22. 494-504s1994
Environmental Health Perspectivs * Vol 107, Supplement 4 * Agust 1999
Brkly Code
589